data_2kyl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kyl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.917 0.389 . . . . 2.38 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.59 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.52 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.27 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.88 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.66 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.09 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.79 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.69 111.255 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CE2' HG21 ' A' ' 80' ' ' ILE . 98.4 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.107 0.48 . . . . 0.92 110.627 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.87 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 1.22 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.97 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.625 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.86 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.44 109.613 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.87 110.662 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 1.45 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.42 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.82 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.41 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.64 107.28 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.96 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.61 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.57 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.94 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.63 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.38 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.28 111.265 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.22 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.82 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.84 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.36 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.46 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.75 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.93 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.46 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.43 109.183 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.61 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 1.19 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.521 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 1.23 111.864 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.521 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 1.07 111.091 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 1.09 108.663 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.9 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.9 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.36 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 1.08 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.87 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.72 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.98 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 1.04 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 1.42 108.281 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.442 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.68 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 1.32 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.75 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 73' ' ' HIS . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.85 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.32 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 1.2 110.383 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 17' ' ' TYR . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 1.3 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.44 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' HD22 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.09 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.3 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.54 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.89 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.411 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 1.2 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 1.03 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 1.21 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 1.07 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 54' ' ' LEU . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.34 111.65 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.39 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.59 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.6 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.92 109.978 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.625 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.1 0.476 . . . . 2.39 110.765 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.442 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 1.26 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.92 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.76 110.974 -177.476 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.594 0.235 . . . . 2.38 111.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.59 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.52 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.27 112.742 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.88 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.66 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.09 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.79 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.69 111.608 -179.616 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE2' HG21 ' A' ' 80' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.92 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.87 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 1.22 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.97 108.187 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.86 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.44 109.166 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.87 111.079 -179.13 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.45 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.42 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.82 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.41 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.64 106.81 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.56 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.96 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.491 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.61 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.57 109.259 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.94 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.63 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.38 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.28 111.534 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.22 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.82 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.84 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.36 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.46 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.75 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.491 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.93 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.46 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.43 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.61 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 1.19 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.412 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 1.23 111.613 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.412 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.07 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 1.09 108.164 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.9 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.9 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.36 110.913 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 1.08 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.87 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.72 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.98 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 1.04 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' CG2' ' HG2' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 1.42 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.68 111.14 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 1.32 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HG2' ' CG2' ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.75 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.85 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.642 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.32 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 1.2 110.436 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 17' ' ' TYR . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 1.1 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 1.3 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.44 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.09 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.3 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.54 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.89 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 HG21 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 1.2 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 1.03 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 1.21 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 1.07 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 54' ' ' LEU . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.34 111.919 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.39 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.59 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.6 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.92 109.159 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.66 0.267 . . . . 2.39 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 1.26 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.92 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.76 110.571 -177.701 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.996 0.426 . . . . 2.38 110.416 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.59 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.52 112.11 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.27 112.594 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.88 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.66 110.883 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 49' ' ' ALA . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.09 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.79 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.41 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.69 110.917 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 83.3 m-85 . . . . . 0 CA--C 1.516 -0.328 0 CA-C-O 121.401 0.619 . . . . 0.92 109.476 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.87 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 1.22 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.97 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.86 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.44 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.87 111.224 -178.846 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.45 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.42 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.82 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.64 107.117 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.96 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.61 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.57 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.94 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.63 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.38 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.28 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.22 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.82 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.84 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.36 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.46 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.75 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.93 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.46 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.43 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 92' ' ' THR . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.61 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 1.19 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.448 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 1.23 111.806 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.448 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 1.07 111.089 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 1.09 108.63 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.9 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.9 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.36 110.558 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 1.08 110.885 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.87 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.72 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.98 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 1.04 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG23 ' OG1' ' A' ' 74' ' ' THR . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 1.42 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.488 ' ND1' ' HB3' ' A' ' 23' ' ' ALA . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.68 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 1.32 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 71' ' ' LEU . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.75 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.85 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.32 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 1.2 110.123 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.445 HG21 ' CE1' ' A' ' 17' ' ' TYR . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 1.1 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 1.3 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.44 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.09 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.3 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.54 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.89 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 1.2 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 1.03 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 1.21 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 1.07 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.34 111.8 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 59' ' ' LEU . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.39 107.973 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.59 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.6 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.92 109.73 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.915 0.388 . . . . 2.39 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 1.26 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.92 108.743 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.422 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.76 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 2.38 110.588 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.59 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.52 111.897 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.27 112.707 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.88 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.66 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.09 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.79 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.69 111.151 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' HG23 ' A' ' 80' ' ' ILE . 98.6 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.467 0.651 . . . . 0.92 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.87 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 1.22 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.97 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.86 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.44 109.452 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.87 110.382 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.0 0.429 . . . . 1.45 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.42 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.82 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.41 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.64 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.96 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.61 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.57 109.389 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.94 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.63 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.38 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.28 111.335 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.22 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.82 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.84 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.36 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.46 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.75 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.93 110.672 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.46 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.43 109.63 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.61 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 1.19 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.423 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 1.23 111.985 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.423 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 1.07 110.797 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 1.09 109.357 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.9 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.9 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.36 111.154 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 1.08 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.87 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.72 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.98 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 1.04 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 1.42 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.68 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 1.32 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 73' ' ' HIS . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.75 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.85 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.627 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.32 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 1.2 110.068 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 17' ' ' TYR . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 1.1 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 1.3 112.568 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.44 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.09 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.3 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.54 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.89 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 1.2 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 1.03 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 1.21 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 1.07 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.463 HG21 HD21 ' A' ' 54' ' ' LEU . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.34 112.252 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.39 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.59 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.6 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.92 109.286 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.545 -0.168 . . . . 2.39 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 73' ' ' HIS . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 1.26 111.596 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . 0.458 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.92 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.76 111.096 -177.295 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.961 0.41 . . . . 2.38 110.613 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.59 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.52 111.353 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.27 113.512 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.88 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.66 110.44 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 49' ' ' ALA . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.09 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.79 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.69 110.632 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 80' ' ' ILE . 91.7 m-85 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92 110.932 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.87 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 1.22 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.97 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.86 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.44 109.742 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.87 111.387 -178.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.502 0.668 . . . . 1.45 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.42 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.82 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.41 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.64 107.563 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.96 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.477 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.61 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 HG21 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.57 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.94 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.63 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.38 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.28 111.7 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.22 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.82 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.84 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.36 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.46 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.75 109.963 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.93 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.43 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.61 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 1.19 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 1.23 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 1.07 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 1.09 108.549 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.9 109.875 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.9 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.36 111.13 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 1.08 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.72 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 1.04 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 ' CG ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 1.42 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.68 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.589 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 1.32 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.75 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.85 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.32 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 1.2 110.123 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.557 HG21 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 1.1 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 1.3 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.44 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.09 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.3 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.54 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.89 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 83' ' ' SER . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 1.2 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 1.03 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 1.07 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.463 HG22 HD21 ' A' ' 54' ' ' LEU . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.34 111.613 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.39 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.59 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.6 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.92 110.219 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.426 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.663 0.268 . . . . 2.39 111.117 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 1.26 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.92 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.76 110.863 -177.604 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.856 0.36 . . . . 2.38 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.59 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.52 111.811 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.27 112.582 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' ' 53' ' ' GLY . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.88 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.66 110.068 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 49' ' ' ALA . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.09 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.79 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 . . . . . 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.69 110.917 179.39 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE2' HG22 ' A' ' 80' ' ' ILE . 72.9 m-85 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 108.387 -0.968 . . . . 0.92 108.387 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.87 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 1.22 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.97 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.86 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.44 109.761 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.87 110.489 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.703 -0.48 . . . . 1.45 109.703 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.412 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.42 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.82 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.41 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.64 106.955 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.96 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.61 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.57 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.94 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.63 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.38 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.28 111.769 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.22 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.82 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.84 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.36 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.429 ' C ' HD13 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.46 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.75 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.93 111.407 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.46 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.43 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' HG21 ' A' ' 92' ' ' THR . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.61 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 1.19 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 1.23 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 1.07 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 1.09 108.749 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.534 HD22 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.9 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.9 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.36 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 1.08 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.87 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.72 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.98 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 1.04 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.507 HG21 ' CG ' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 1.42 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.68 111.867 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 1.32 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.75 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.85 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 1.2 110.137 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 87' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 1.1 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 1.3 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.44 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.09 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.3 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.54 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.89 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG21 HG21 ' A' ' 80' ' ' ILE . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 1.2 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 1.03 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 1.21 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 1.07 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 HG22 HD21 ' A' ' 54' ' ' LEU . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.34 111.338 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 59' ' ' LEU . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.39 107.895 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.59 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.6 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.92 109.563 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.48 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 109.658 -0.497 . . . . 2.39 109.658 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 1.26 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.92 108.383 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.76 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.787 0.327 . . . . 2.38 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.59 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.52 111.818 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.27 113.0 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 HD11 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.88 109.422 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.66 110.408 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.09 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.79 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.69 111.533 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' CE2' HG23 ' A' ' 80' ' ' ILE . 85.4 m-85 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.92 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.87 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 1.22 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.97 108.281 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.86 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.44 109.364 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.87 110.952 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.491 0.662 . . . . 1.45 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.42 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.82 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.41 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.64 107.133 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.96 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.61 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.57 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.94 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.63 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.38 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.28 111.642 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.22 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.82 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.84 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.36 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' C ' HD11 ' A' ' 8' ' ' ILE . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.46 114.028 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.75 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.93 111.268 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.46 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.43 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.61 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 1.19 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 1.23 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 1.07 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 1.09 108.43 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.525 HD22 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.9 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.9 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.36 110.719 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 1.08 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.72 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.98 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 1.04 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG21 ' CG ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 1.42 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.68 111.284 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 1.32 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.75 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.85 109.325 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.32 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 1.2 110.059 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 1.1 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 1.3 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.44 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.09 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.3 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.462 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.54 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.89 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 1.2 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 1.03 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 1.21 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 1.07 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 54' ' ' LEU . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.34 112.096 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.39 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.59 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.6 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.92 109.786 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.705 0.288 . . . . 2.39 110.655 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 1.26 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.92 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.76 110.469 -177.742 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 121.111 0.482 . . . . 2.38 110.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.59 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.52 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.27 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.88 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.66 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 49' ' ' ALA . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.09 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.79 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.69 110.792 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' A' ' 80' ' ' ILE . 87.6 m-85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.21 -0.663 . . . . 0.92 109.21 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.87 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 1.22 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.97 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.595 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.86 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.44 110.601 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.87 109.841 179.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.191 0.52 . . . . 1.45 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.42 109.359 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.82 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.41 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.64 106.989 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.96 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.61 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.57 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.94 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.63 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.38 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.28 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.22 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.82 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.84 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.36 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.46 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.75 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.93 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.46 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.43 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.61 109.226 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 1.19 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 1.23 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 1.07 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 1.09 108.721 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.9 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.9 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.36 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 1.08 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.87 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.72 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.98 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 1.04 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 1.42 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.68 111.648 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.4 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 1.32 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.75 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.85 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.32 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 1.2 110.028 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 1.1 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 1.3 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.44 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.09 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.3 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.54 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.89 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG21 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 1.2 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 1.03 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 1.21 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 1.07 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.462 HG22 HD21 ' A' ' 54' ' ' LEU . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.34 111.593 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.39 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.59 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.6 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.92 109.338 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.886 0.374 . . . . 2.39 111.023 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 1.26 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.92 108.08 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.76 110.292 -178.227 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 2.38 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.59 110.771 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.52 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.27 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.88 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.66 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.09 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.79 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.69 109.915 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' H ' HG22 ' B' ' 109' ' ' VAL . 80.8 m-85 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.549 0.69 . . . . 0.92 109.474 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.87 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 1.22 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.97 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.86 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.44 109.48 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.87 110.45 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 121.401 0.619 . . . . 1.45 109.984 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.42 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.82 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.64 106.944 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.509 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.96 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.437 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.61 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.57 109.621 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.94 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.63 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.38 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.28 111.351 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.22 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.82 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.84 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.36 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.46 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.75 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.93 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.46 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.43 109.724 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.61 109.552 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 1.19 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 1.23 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 1.07 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 1.09 108.755 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.468 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.9 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.9 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.36 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 1.08 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.87 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.72 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.98 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 1.04 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 1.42 108.328 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.68 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 1.32 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.75 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 73' ' ' HIS . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.85 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.32 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 1.2 109.848 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 17' ' ' TYR . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 1.1 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 1.3 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.44 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.09 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.3 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.54 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.89 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG22 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 1.2 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 1.03 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 1.21 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 1.07 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.473 HG21 HD21 ' A' ' 54' ' ' LEU . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.34 112.03 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.39 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.59 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.6 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.92 109.556 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.849 -0.797 . . . . 2.39 108.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 1.26 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.92 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.76 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.742 0.306 . . . . 2.38 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.59 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.52 111.502 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.27 113.202 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 8' ' ' ILE . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.88 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.66 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.09 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.79 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.69 110.455 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 107.721 -1.215 . . . . 0.92 107.721 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.87 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 1.22 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.97 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.86 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.44 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 37' ' ' HIS . 13.7 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.87 110.524 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.183 0.516 . . . . 1.45 110.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.42 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.82 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.41 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.64 106.715 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.419 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.96 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.61 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.57 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.94 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.63 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.38 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.28 112.043 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.22 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.82 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.84 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.36 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' C ' HD11 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.46 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.75 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.93 110.865 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.46 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.43 109.351 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.61 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 1.19 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.505 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 1.23 111.778 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.505 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 1.07 110.46 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 1.09 108.941 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.509 HD22 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.9 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.9 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.36 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 1.08 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.87 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.72 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.98 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 1.04 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.491 HG21 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 1.42 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.512 ' CD2' ' HG1' ' B' ' 107' ' ' THR . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.68 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 1.32 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' CG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.75 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.85 109.538 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.32 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 1.2 110.256 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 1.1 110.905 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 1.3 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.44 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.09 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.3 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.54 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.89 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 1.2 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 1.03 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 1.21 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 1.07 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.34 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.39 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.59 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.6 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.92 109.181 179.336 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.425 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.843 0.354 . . . . 2.39 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.512 ' HG1' ' CD2' ' A' ' 73' ' ' HIS . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 1.26 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.92 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.76 110.349 -178.404 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.854 -0.499 . . . . 1.79 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.48 -56.82 4.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.939 -0.648 . . . . 1.47 112.406 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -95.68 103.21 15.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.874 -0.417 . . . . 1.54 109.874 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt -142.97 -43.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 2.38 110.644 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.59 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.52 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.27 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.88 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.66 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.09 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.79 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 -69.21 131.84 45.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.69 111.255 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.47 66.53 0.71 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.584 -0.524 . . . . 1.93 109.584 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.74 -54.69 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.894 -0.882 . . . . 1.9 110.894 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -159.05 -47.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.32 -0.622 . . . . 4.5 109.32 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 5.1 mmmm -82.34 157.96 23.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.599 -0.728 . . . . 3.64 110.724 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CE2' HG21 ' A' ' 80' ' ' ILE . 98.4 m-85 -103.05 -7.8 21.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.92 110.627 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.87 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 1.22 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.97 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.625 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.86 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' B' ' 104' ' ' THR . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.44 109.613 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt -79.15 159.03 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.87 110.662 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -140.09 132.46 28.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.289 0.566 . . . . 4.66 111.305 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.47 119.12 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.225 -1.028 . . . . 2.25 108.225 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 40.8 m-85 -66.17 139.06 58.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.333 0.587 . . . . 2.32 111.572 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.6 mmt -71.34 134.31 46.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.808 -1.087 . . . . 2.32 110.249 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.41 63.76 3.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.99 -0.624 . . . . 2.77 113.065 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -167.83 -59.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.671 0.272 . . . . 2.66 110.972 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 m -110.17 -154.83 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.721 0.296 . . . . 2.77 110.807 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.0 -10.78 22.21 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.701 0.762 . . . . 2.9 109.68 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 148.95 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.549 -1.205 . . . . 1.91 110.967 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.3 p90 -113.23 172.14 7.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.35 -0.841 . . . . 1.62 110.652 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.53 99.02 5.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.878 -1.056 . . . . 2.11 109.058 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -85.47 130.72 35.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 1.45 111.096 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.42 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.82 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.41 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.64 107.28 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.96 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.61 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.57 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.94 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.63 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.38 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.28 111.265 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.22 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.82 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.84 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.36 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.46 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.75 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.407 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.93 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.46 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.43 109.183 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.61 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 1.19 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.521 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 1.23 111.864 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.521 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 1.07 111.091 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 1.09 108.663 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.448 HD22 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.9 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.9 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.36 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 1.08 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.87 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.72 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.98 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 1.04 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 1.42 108.281 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.442 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.68 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 1.32 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.75 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 73' ' ' HIS . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.85 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.32 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 1.2 110.383 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 17' ' ' TYR . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 1.3 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.44 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' HD22 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.09 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.3 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.54 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.89 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.411 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 1.2 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 1.03 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 1.21 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 1.07 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 HD21 ' A' ' 54' ' ' LEU . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.34 111.65 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.39 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.59 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.6 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -104.57 125.71 50.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.92 109.978 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 115.102 -0.954 . . . . 2.29 109.768 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.476 0.453 0 N-CA-C 111.161 -0.361 . . . . 6.58 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -72.99 -18.15 61.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.409 . . . . 4.24 110.417 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.13 23.28 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.685 -0.688 . . . . 5.16 111.296 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.627 ' O ' ' HB ' ' B' ' 104' ' ' THR . 27.7 mt-10 -72.05 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 5.22 110.382 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -113.14 1.52 15.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.229 0.538 . . . . 4.23 109.956 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -67.89 -79.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 4.48 111.399 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.491 ' HB2' ' NE ' ' A' ' 25' ' ' ARG . 16.7 m80 -93.22 -18.91 21.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.98 0.419 . . . . 5.37 110.344 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.627 ' HB ' ' O ' ' B' ' 100' ' ' GLU . 89.0 m -75.99 103.31 5.99 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.711 -0.477 . . . . 3.64 109.711 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -74.18 161.76 29.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 3.06 111.356 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.625 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -151.61 123.39 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.97 -0.559 . . . . 2.39 110.765 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.442 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 1.26 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.92 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.518 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.76 110.974 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.216 -0.354 . . . . 1.79 112.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.36 -58.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.641 . . . . 1.47 111.777 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 m -85.5 121.28 27.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.58 -0.526 . . . . 1.54 109.58 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt -157.15 -59.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.523 -0.308 . . . . 2.38 111.191 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.59 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.52 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.27 112.742 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.88 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.66 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.09 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.79 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.96 156.8 32.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.69 111.608 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 16' ' ' LYS . . . -130.8 -146.03 0.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.572 -0.74 . . . . 1.93 109.934 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 -66.13 2.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.515 -0.85 . . . . 1.9 112.538 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -134.82 -8.97 2.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.542 0.201 . . . . 4.5 111.542 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -135.95 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.243 -0.28 . . . . 3.64 110.243 -179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE2' HG21 ' A' ' 80' ' ' ILE . 96.6 m-85 -98.04 -5.39 34.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.202 0.525 . . . . 0.92 109.942 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.87 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 1.22 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.97 108.187 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.56 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.86 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.44 109.166 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt -91.31 134.1 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.87 111.079 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' B' ' 101' ' ' ASP . 3.9 mpt_? -105.97 100.83 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.993 -0.549 . . . . 4.66 110.517 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.8 t -105.89 136.11 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.376 -0.829 . . . . 2.25 108.79 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.08 142.95 53.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.48 0.657 . . . . 2.32 110.985 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.433 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 1.2 mmt -72.59 -21.09 61.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.113 -0.949 . . . . 2.32 110.908 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 22.29 64.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 2.77 111.528 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -114.45 -51.25 2.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.913 0.387 . . . . 2.66 110.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 p -152.11 -109.49 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.488 . . . . 2.77 110.865 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.72 -16.52 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.726 0.774 . . . . 2.9 109.045 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -59.07 149.21 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.573 -1.194 . . . . 1.91 111.175 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD1' ' HG3' ' A' ' 25' ' ' ARG . 42.0 p90 -118.5 174.25 6.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.505 -0.77 . . . . 1.62 111.234 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 28' ' ' MET . 0.2 OUTLIER -125.67 102.94 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.564 -1.198 . . . . 2.11 109.315 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -83.97 115.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.284 0.564 . . . . 1.45 110.422 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.42 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.82 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.41 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.64 106.81 176.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.56 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.96 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.491 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.61 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.57 109.259 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.94 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.63 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.38 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.28 111.534 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.22 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.82 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.84 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.36 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.46 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.75 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.491 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.93 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.46 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.43 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.61 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 1.19 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 1.23 111.613 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.412 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.07 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 1.09 108.164 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.9 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.9 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.36 110.913 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 1.08 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.87 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.72 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.98 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 1.04 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' CG2' ' HG2' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 1.42 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.68 111.14 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.514 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 1.32 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HG2' ' CG2' ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.75 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.85 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.642 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.32 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 1.2 110.436 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 17' ' ' TYR . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 1.1 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 1.3 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.44 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.09 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.3 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.54 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.89 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 HG21 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 1.2 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 1.03 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 1.21 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 1.07 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 54' ' ' LEU . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.34 111.919 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.39 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.59 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.6 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.36 125.55 46.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.92 109.159 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 115.573 -0.74 . . . . 2.29 110.451 -178.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.475 0.42 0 N-CA-C 110.469 -0.627 . . . . 6.58 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.59 150.67 34.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.688 -0.856 . . . . 4.24 108.688 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.8 0.296 . . . . 5.16 111.8 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -153.79 124.66 7.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.682 0.277 . . . . 5.22 111.557 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 27.8 t0 -73.15 105.46 4.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.769 -0.826 . . . . 4.23 108.769 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -70.1 -89.5 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 4.48 112.053 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.75 86.36 6.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.212 0.529 . . . . 5.37 110.724 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.65 94.75 1.03 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.407 -0.815 . . . . 3.64 111.21 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 49.7 mt-30 -106.31 130.04 54.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.754 -0.461 . . . . 3.06 109.754 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -137.05 131.25 46.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.467 -0.333 . . . . 2.39 111.148 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 1.26 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.92 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.51 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.76 110.571 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.13 -0.388 . . . . 1.79 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.34 -51.4 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.05 -0.595 . . . . 1.47 112.021 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -107.25 93.49 4.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.159 0.504 . . . . 1.54 110.382 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -129.08 -41.63 1.42 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.567 -0.742 . . . . 2.38 110.416 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.59 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.52 112.11 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.27 112.594 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.88 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.66 110.883 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 49' ' ' ALA . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.09 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.79 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 -68.98 139.85 55.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.69 110.917 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.53 52.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.48 0.657 . . . . 1.93 109.997 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 -93.04 1.8 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.629 -0.714 . . . . 1.9 111.578 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -108.04 -25.76 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.191 0.519 . . . . 4.5 110.627 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' B' ' 108' ' ' LYS . 28.5 mtpt -114.73 177.89 4.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.686 -0.688 . . . . 3.64 111.414 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 48' ' ' PRO . 83.3 m-85 -118.77 -7.26 10.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.92 109.476 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.87 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 1.22 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.97 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.86 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.44 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -86.23 144.6 9.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.87 111.224 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -106.9 111.22 23.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.529 -0.76 . . . . 4.66 110.568 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -115.53 123.98 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.569 . . . . 2.25 110.357 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -75.49 143.1 42.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.131 0.491 . . . . 2.32 110.546 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.1 mmt -70.67 138.77 50.96 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.231 -0.895 . . . . 2.32 109.825 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.92 57.0 4.96 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.967 -0.635 . . . . 2.77 112.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.03 -57.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 2.66 110.622 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.433 ' HB2' HG11 ' A' ' 33' ' ' VAL . 1.6 m -110.27 -157.66 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 2.77 110.643 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.02 -8.31 21.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.14 0.495 . . . . 2.9 110.467 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 31' ' ' SER . 7.7 p -61.45 148.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.229 -0.896 . . . . 1.91 111.215 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -102.65 172.73 6.69 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.339 -0.846 . . . . 1.62 110.944 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 108.21 5.62 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.324 -1.307 . . . . 2.11 108.654 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.23 112.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.363 0.601 . . . . 1.45 110.789 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.42 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.82 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.64 107.117 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.96 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.61 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.57 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.94 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.63 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.689 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.38 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.28 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.22 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.82 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.84 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.36 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.46 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.75 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.93 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.46 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.43 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 92' ' ' THR . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.61 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 1.19 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.448 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 1.23 111.806 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.448 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 1.07 111.089 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 1.09 108.63 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.9 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.9 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.36 110.558 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 1.08 110.885 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.87 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.72 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.98 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 1.04 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG23 ' OG1' ' A' ' 74' ' ' THR . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 1.42 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.488 ' ND1' ' HB3' ' A' ' 23' ' ' ALA . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.68 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 1.32 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 71' ' ' LEU . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.75 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.85 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.32 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 1.2 110.123 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.445 HG21 ' CE1' ' A' ' 17' ' ' TYR . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 1.1 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 1.3 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.44 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.09 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.3 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.54 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.89 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 1.2 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 1.03 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 1.21 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 1.07 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.34 111.8 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 59' ' ' LEU . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.39 107.973 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.59 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.6 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.21 122.46 35.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.92 109.73 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.656 -0.688 . . . . 2.29 110.237 -179.429 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.5 0 N-CA-C 110.464 -0.629 . . . . 6.58 110.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.78 -166.01 0.23 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.46 0.475 . . . . 4.24 110.175 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.73 -78.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.005 -0.278 . . . . 5.16 111.075 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -132.73 149.3 52.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 5.22 111.239 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -137.87 25.31 2.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 4.23 110.042 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 -50.61 8.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 4.48 110.075 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -112.44 78.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.814 -0.81 . . . . 5.37 108.814 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.9 p -127.67 172.71 10.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.293 -0.867 . . . . 3.64 110.013 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -132.22 164.1 27.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.049 -0.26 . . . . 3.06 110.319 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 2.4 tt -146.99 129.37 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.915 0.388 . . . . 2.39 110.875 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 1.26 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.92 108.743 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.422 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.76 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.945 -0.462 . . . . 1.79 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.88 -45.03 8.66 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.749 -0.739 . . . . 1.47 112.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -75.2 116.18 15.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 1.54 110.953 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -165.82 -58.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.797 -0.638 . . . . 2.38 110.588 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.59 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.52 111.897 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.27 112.707 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.88 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.66 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.09 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.79 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 -74.37 136.96 42.47 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.69 111.151 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.3 84.73 2.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.278 -0.419 . . . . 1.93 110.2 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.04 -89.3 0.57 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.773 -0.727 . . . . 1.9 112.129 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -132.47 7.28 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.496 0.189 . . . . 4.5 110.993 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' B' ' 109' ' ' VAL . 0.0 OUTLIER -139.66 167.9 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.539 -0.301 . . . . 3.64 110.477 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' HG23 ' A' ' 80' ' ' ILE . 98.6 m-85 -106.15 -6.96 18.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.467 0.651 . . . . 0.92 109.7 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.87 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 1.22 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.97 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.86 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' O ' HG21 ' B' ' 104' ' ' THR . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.44 109.452 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt -94.0 132.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.87 110.382 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 23.0 ttt85 -102.64 119.83 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.033 -0.53 . . . . 4.66 111.108 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.53 176.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.652 -1.24 . . . . 2.25 107.652 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -126.81 149.18 49.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 2.32 111.011 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.8 mmm -93.58 117.4 30.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.064 -0.971 . . . . 2.32 109.782 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.36 84.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.133 -0.556 . . . . 2.77 112.074 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -176.43 -52.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.213 0.53 . . . . 2.66 110.075 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.6 m -130.4 -155.04 0.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.759 -0.655 . . . . 2.77 110.497 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 11.53 38.64 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.513 0.673 . . . . 2.9 109.393 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -77.34 146.67 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.102 -0.954 . . . . 1.91 110.389 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -109.11 165.84 11.3 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.116 -0.947 . . . . 1.62 110.944 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.57 99.12 6.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.814 -1.085 . . . . 2.11 109.886 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.28 118.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.0 0.429 . . . . 1.45 110.384 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.42 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.82 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.41 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.64 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.96 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.61 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.57 109.389 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.94 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.63 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.38 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.28 111.335 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.22 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.82 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.84 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.36 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.46 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.75 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.93 110.672 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.46 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.43 109.63 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.61 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 1.19 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.423 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 1.23 111.985 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.423 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 1.07 110.797 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 1.09 109.357 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.9 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.9 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.36 111.154 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 1.08 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.87 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.72 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.98 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 1.04 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 1.42 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.68 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 1.32 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' CG ' HG22 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 73' ' ' HIS . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.75 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.85 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.627 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.32 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 1.2 110.068 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 17' ' ' TYR . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 1.1 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 1.3 112.568 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.44 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.09 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.3 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.54 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.89 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 1.2 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 1.03 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 1.21 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 1.07 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.463 HG21 HD21 ' A' ' 54' ' ' LEU . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.34 112.252 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.39 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.59 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.6 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -91.84 122.48 34.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.92 109.286 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.123 -0.944 . . . . 2.29 109.394 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo . . . . . 0 N--CA 1.478 0.604 0 N-CA-C 110.075 -0.779 . . . . 6.58 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.2 -173.65 3.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.72 0.295 . . . . 4.24 110.695 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.78 -148.4 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.963 -0.562 . . . . 5.16 110.218 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.431 ' HB3' ' OE1' ' B' ' 102' ' ' GLN . 9.6 mm-40 -77.84 70.51 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 5.22 110.387 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 8.2 p-10 -87.88 37.2 0.79 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 4.23 111.861 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.431 ' OE1' ' HB3' ' B' ' 100' ' ' GLU . 19.6 mp0 -59.63 -50.37 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 4.48 110.454 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -92.47 82.35 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.224 -0.658 . . . . 5.37 109.224 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -109.83 147.21 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.013 -0.54 . . . . 3.64 111.532 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.12 144.17 47.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 3.06 109.521 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.63 121.28 18.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.558 -0.292 . . . . 2.39 110.545 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.436 ' HG1' ' CD2' ' A' ' 73' ' ' HIS . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 1.26 111.596 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.458 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.92 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.76 111.096 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.614 -0.594 . . . . 1.79 111.614 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.35 -81.72 1.59 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.808 -0.71 . . . . 1.47 111.543 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -73.03 113.71 10.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.899 0.38 . . . . 1.54 110.05 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.62 -43.69 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.206 -0.452 . . . . 2.38 110.613 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.59 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.52 111.353 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.27 113.512 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.88 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.66 110.44 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 49' ' ' ALA . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.09 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.79 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 -70.82 142.62 51.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.69 110.632 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 16' ' ' LYS . . . -99.26 -8.79 24.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.267 0.556 . . . . 1.93 110.036 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.0 -41.99 1.48 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.668 -0.697 . . . . 1.9 111.368 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.0 -37.79 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.507 0.194 . . . . 4.5 110.79 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 1.3 mtmp? -132.76 167.77 19.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 3.64 110.691 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 80' ' ' ILE . 91.7 m-85 -95.43 -10.58 29.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92 110.932 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.87 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 1.22 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.97 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.86 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' B' ' 105' ' ' GLN . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.44 109.742 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.441 ' HA ' ' CG2' ' B' ' 104' ' ' THR . 12.3 pt -80.44 133.64 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.87 111.387 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' B' ' 103' ' ' HIS . 29.4 mtt180 -107.75 108.67 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 4.66 110.208 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -109.27 120.48 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.529 -0.76 . . . . 2.25 109.53 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -66.74 144.69 56.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.299 0.571 . . . . 2.32 110.626 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.0 mmm -67.27 -17.88 64.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.04 -0.982 . . . . 2.32 111.131 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.71 -53.72 4.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.068 -0.587 . . . . 2.77 113.353 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -85.31 14.18 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.841 0.353 . . . . 2.66 111.436 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.419 ' OG ' HG13 ' A' ' 33' ' ' VAL . 37.6 t -162.92 179.13 7.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.332 -0.395 . . . . 2.77 110.817 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -90.87 -14.46 31.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.035 0.922 . . . . 2.9 108.705 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG13 ' OG ' ' A' ' 31' ' ' SER . 7.4 p -71.2 147.5 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.542 -1.208 . . . . 1.91 110.681 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.24 170.43 8.01 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.266 -0.879 . . . . 1.62 110.448 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 99.35 5.34 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.354 -1.294 . . . . 2.11 108.611 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -84.73 123.32 39.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.502 0.668 . . . . 1.45 111.139 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.42 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.82 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.41 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.64 107.563 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.96 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.477 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.61 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG21 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.57 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.94 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.63 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.38 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.28 111.7 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.22 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.82 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.84 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.36 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.46 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.75 109.963 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.93 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.43 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.61 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 1.19 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 1.23 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 1.07 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 1.09 108.549 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.9 109.875 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.9 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.36 111.13 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 1.08 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.72 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 1.04 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 ' CG ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 1.42 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.68 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.589 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 1.32 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.75 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.85 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.32 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 1.2 110.123 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.557 HG21 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 1.1 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 1.3 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.44 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.09 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.3 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.54 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.89 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' HB ' ' CB ' ' A' ' 83' ' ' SER . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 1.2 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 1.03 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 1.21 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 1.07 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.463 HG22 HD21 ' A' ' 54' ' ' LEU . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.34 111.613 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.39 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.59 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.6 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.87 120.88 39.05 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.92 110.219 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.495 -0.775 . . . . 2.29 109.548 -179.464 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.475 0.422 0 N-CA-C 109.828 -0.874 . . . . 6.58 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 p90 47.71 -171.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.419 1.087 . . . . 4.24 113.388 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -162.87 154.4 17.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 5.16 109.221 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 74.62 159.74 0.22 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.006 0.816 . . . . 5.22 112.285 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . 0.493 ' O ' HG22 ' B' ' 104' ' ' THR . 10.9 t70 -162.82 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.445 -0.798 . . . . 4.23 109.387 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 57.7 -134.98 1.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.549 -0.75 . . . . 4.48 111.202 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.587 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 23.3 t-80 -78.33 84.3 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.137 0.494 . . . . 5.37 110.556 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.493 HG22 ' O ' ' B' ' 101' ' ' ASP . 11.0 p -98.08 151.86 19.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.989 -0.55 . . . . 3.64 110.921 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 2.6 mp0 -100.36 135.1 42.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.731 -0.84 . . . . 3.06 108.731 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.426 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt -130.12 124.14 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.663 0.268 . . . . 2.39 111.117 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 1.26 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.92 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.488 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.76 110.863 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.003 -0.439 . . . . 1.79 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.32 -60.41 1.31 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 1.47 112.635 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -65.7 112.75 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 1.54 111.481 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt -155.42 -52.63 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 2.38 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.59 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.52 111.811 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.27 112.582 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' ' 53' ' ' GLY . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.88 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.66 110.068 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 49' ' ' ALA . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.09 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.79 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -65.48 141.95 58.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.69 110.917 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 16' ' ' LYS . . . -119.43 -42.49 2.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.366 -0.379 . . . . 1.93 110.636 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.58 -88.76 0.12 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.967 -0.635 . . . . 1.9 111.868 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -81.29 -36.24 30.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.839 0.352 . . . . 4.5 110.603 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 51.2 mtpt -138.55 153.88 48.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.131 -0.486 . . . . 3.64 110.654 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE2' HG22 ' A' ' 80' ' ' ILE . 72.9 m-85 -78.63 1.15 23.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.387 -0.968 . . . . 0.92 108.387 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.87 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 1.22 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.97 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.86 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.44 109.761 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt -83.83 147.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.87 110.489 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' NH2' ' HB3' ' B' ' 103' ' ' HIS . 15.5 ttm180 -113.53 129.82 56.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.156 -0.475 . . . . 4.66 111.214 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.61 108.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.058 -0.719 . . . . 2.25 109.058 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -70.36 139.45 51.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.576 0.703 . . . . 2.32 111.811 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.6 mmm -82.17 139.0 34.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.477 -1.238 . . . . 2.32 110.02 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.91 72.11 2.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.992 -0.623 . . . . 2.77 111.659 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -155.79 -58.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 2.66 111.201 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -140.57 -145.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.277 -0.419 . . . . 2.77 110.915 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.21 -9.19 53.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.833 0.825 . . . . 2.9 109.112 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.96 145.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.969 -1.469 . . . . 1.91 110.645 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.83 167.21 19.95 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.318 -0.855 . . . . 1.62 111.04 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.13 114.86 22.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.805 -1.089 . . . . 2.11 109.534 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.35 117.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.703 -0.48 . . . . 1.45 109.703 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.412 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.42 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.82 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.41 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.64 106.955 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.491 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.96 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.61 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.57 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.94 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.63 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.38 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.28 111.769 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.22 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.82 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.84 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.36 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.429 ' C ' HD13 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.46 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.75 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.93 111.407 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.46 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.43 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' HG21 ' A' ' 92' ' ' THR . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.61 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 1.19 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 1.23 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 1.07 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 1.09 108.749 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.534 HD22 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.9 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.9 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.36 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 1.08 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.87 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.72 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.98 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 1.04 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.507 HG21 ' CG ' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 1.42 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' B' ' 105' ' ' GLN . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.68 111.867 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.534 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 1.32 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.75 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.85 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 1.2 110.137 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG21 HG21 ' A' ' 87' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 1.1 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 1.3 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.44 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.09 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.3 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.54 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.89 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG21 HG21 ' A' ' 80' ' ' ILE . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 1.2 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 1.03 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 1.21 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 1.07 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 HG22 HD21 ' A' ' 54' ' ' LEU . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.34 111.338 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 59' ' ' LEU . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.39 107.895 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.59 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.6 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.53 118.81 21.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.92 109.563 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 115.475 -0.784 . . . . 2.29 110.19 -178.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.649 -0.558 . . . . 6.58 110.649 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 19.8 t80 63.6 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.91 0.756 . . . . 4.24 111.796 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -45.79 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.191 0.52 . . . . 5.16 110.545 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.46 160.68 26.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.429 -0.805 . . . . 5.22 109.069 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.75 -23.56 0.23 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.104 -0.239 . . . . 4.23 111.568 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -179.4 -47.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.136 0.493 . . . . 4.48 110.09 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.525 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 8.1 t-160 -158.39 115.6 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 5.37 109.63 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.5 155.53 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.995 -0.548 . . . . 3.64 110.492 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 1.6 mp0 -115.68 164.6 14.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 3.06 111.587 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.48 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt -157.45 118.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.668 -0.696 . . . . 2.39 109.658 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 1.26 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.92 108.383 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.76 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.339 -0.304 . . . . 1.79 112.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.56 -64.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.129 -0.557 . . . . 1.47 111.813 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -93.51 98.86 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 1.54 110.257 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt -138.66 -46.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 2.38 111.044 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.59 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.52 111.818 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.27 113.0 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.41 HD11 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.88 109.422 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.66 110.408 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.09 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.79 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 -67.42 143.46 56.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.69 111.533 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.57 80.44 1.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.04 -0.527 . . . . 1.93 109.688 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.17 -78.92 1.52 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.48 -0.648 . . . . 1.9 111.48 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -139.87 -4.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.218 . . . . 4.5 111.104 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 9.2 mtpm? -129.63 170.54 13.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.506 0.193 . . . . 3.64 110.986 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' CE2' HG23 ' A' ' 80' ' ' ILE . 85.4 m-85 -107.4 -7.7 16.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.92 111.277 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.87 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 1.22 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.97 108.281 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.86 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.44 109.364 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt -109.19 128.06 65.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.87 110.952 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -91.76 89.16 6.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.255 0.55 . . . . 4.66 110.441 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -83.72 115.98 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.234 -0.439 . . . . 2.25 110.012 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 74.2 m-85 -74.92 136.55 41.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.568 0.699 . . . . 2.32 111.011 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 33.1 mmt -87.27 143.23 27.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.761 -1.109 . . . . 2.32 110.875 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.25 68.72 2.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.943 -0.646 . . . . 2.77 111.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 2.66 110.07 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.2 m -135.46 -137.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.774 -0.648 . . . . 2.77 109.783 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -101.47 1.15 37.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.056 0.932 . . . . 2.9 109.229 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.36 144.64 14.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 113.787 -1.551 . . . . 1.91 111.679 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -122.5 165.81 15.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 1.62 109.678 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -131.24 98.89 4.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.851 -1.068 . . . . 2.11 108.785 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p -75.51 110.64 10.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.615 -0.72 . . . . 1.45 110.989 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.42 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.82 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.41 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.64 107.133 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.54 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.96 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.61 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.57 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.94 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.63 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.38 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.28 111.642 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.22 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.82 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.84 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.36 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' C ' HD11 ' A' ' 8' ' ' ILE . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.46 114.028 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.75 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.93 111.268 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.46 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.43 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.61 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 1.19 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 1.23 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 1.07 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 1.09 108.43 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.525 HD22 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.9 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.9 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.36 110.719 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 1.08 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.87 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.72 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.98 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 1.04 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG21 ' CG ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 1.42 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.68 111.284 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 1.32 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.75 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.85 109.325 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.32 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 1.2 110.059 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 1.1 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 1.3 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.44 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.09 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.3 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.462 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.54 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.89 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 1.2 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 1.03 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 1.21 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 1.07 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.445 HG22 HD21 ' A' ' 54' ' ' LEU . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.34 112.096 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.39 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.59 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.6 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.06 111.68 19.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.92 109.786 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.418 -0.801 . . . . 2.29 109.737 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 N--CA 1.477 0.555 0 N-CA-C 110.44 -0.639 . . . . 6.58 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.75 118.48 31.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.168 -0.469 . . . . 4.24 110.2 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.86 132.79 9.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 5.16 110.955 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.37 29.99 5.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.388 -0.823 . . . . 5.22 113.1 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -106.95 -35.46 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.861 0.363 . . . . 4.23 110.504 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -131.32 127.43 37.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.043 -0.526 . . . . 4.48 109.958 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -126.41 44.63 2.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 5.37 110.617 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' B' ' 105' ' ' GLN . 0.2 OUTLIER -69.54 -82.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 3.64 111.782 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.41 ' H ' ' HB ' ' B' ' 104' ' ' THR . 1.8 mm-40 -116.28 146.33 42.47 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.801 -0.36 . . . . 3.06 111.33 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt -152.87 122.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 2.39 110.655 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 1.26 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.92 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.554 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.76 110.469 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.994 -0.443 . . . . 1.79 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.17 -78.53 0.91 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.891 -0.671 . . . . 1.47 112.589 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 111.02 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.953 0.406 . . . . 1.54 111.143 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt -140.47 -43.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.561 . . . . 2.38 110.231 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.59 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.52 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.27 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.88 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.66 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 49' ' ' ALA . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.09 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.79 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 -69.22 168.58 13.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.69 110.792 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -159.39 -134.33 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.392 -0.367 . . . . 1.93 111.071 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.88 -106.07 0.64 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.846 -0.692 . . . . 1.9 112.425 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -17.4 36.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.651 0.263 . . . . 4.5 111.02 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 11.9 ptmt -144.75 158.11 43.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.917 0.389 . . . . 3.64 111.028 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE1' HG21 ' A' ' 80' ' ' ILE . 87.6 m-85 -75.83 4.53 7.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.674 -0.694 . . . . 0.92 109.21 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 16' ' ' LYS . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.87 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 1.22 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.97 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.595 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.86 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.44 110.601 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -82.24 131.51 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.87 109.841 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 9.2 ttm180 -91.6 114.84 27.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 4.66 111.798 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -106.82 151.11 8.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 107.181 -1.414 . . . . 2.25 107.181 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.6 146.93 38.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.995 -0.682 . . . . 2.32 111.627 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.0 mmt -82.46 109.52 16.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.826 -1.079 . . . . 2.32 108.804 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.28 54.89 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.233 -0.508 . . . . 2.77 113.449 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -12.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.493 0.187 . . . . 2.66 111.474 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 32' ' ' ASP . 2.1 p -155.31 -151.1 0.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.253 -0.179 . . . . 2.77 111.276 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.464 ' H ' ' HB2' ' A' ' 31' ' ' SER . 6.7 t70 -115.75 -0.14 13.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.514 0.673 . . . . 2.9 110.414 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -75.42 150.41 6.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.15 -0.932 . . . . 1.91 110.914 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -101.91 166.14 10.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.036 0.922 . . . . 1.62 111.065 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 101.52 4.5 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.812 -1.54 . . . . 2.11 108.337 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.43 124.37 38.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.191 0.52 . . . . 1.45 111.253 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.42 109.359 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.82 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.41 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.64 106.989 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.96 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.61 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.57 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.94 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.63 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.38 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.28 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.22 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.82 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.84 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.36 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.46 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 91' ' ' THR . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.75 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.93 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.46 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.43 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.61 109.226 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 1.19 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 1.23 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 1.07 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 1.09 108.721 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.9 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.9 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.36 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 1.08 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.87 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.72 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.98 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 1.04 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 1.42 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.68 111.648 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.4 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 1.32 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.75 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.85 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.32 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 1.2 110.028 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.496 HG21 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 1.1 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 1.3 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.44 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.09 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.3 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.54 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.89 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG21 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 1.2 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 1.03 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 1.21 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 1.07 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.462 HG22 HD21 ' A' ' 54' ' ' LEU . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.34 111.593 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.39 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.59 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.6 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.45 121.62 43.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.92 109.338 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.375 -0.829 . . . . 2.29 109.827 -178.757 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.477 0.542 0 N-CA-C 110.208 -0.728 . . . . 6.58 110.208 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -99.05 153.13 19.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.575 0.226 . . . . 4.24 110.56 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.4 -146.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.492 -0.776 . . . . 5.16 111.58 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.22 45.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 5.22 111.133 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 12.0 t70 -67.97 137.53 55.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 4.23 111.55 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -137.72 11.75 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.462 -0.79 . . . . 4.48 109.768 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -173.24 81.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.533 -0.758 . . . . 5.37 109.659 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.41 ' HB ' ' NH2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -84.66 106.68 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.078 -0.51 . . . . 3.64 110.555 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -72.77 154.93 40.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.543 -0.299 . . . . 3.06 110.261 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -153.02 132.16 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 2.39 111.023 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 1.26 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.92 108.08 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.581 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.76 110.292 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.002 -0.439 . . . . 1.79 112.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.58 -81.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 1.47 111.89 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.69 110.69 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.003 -0.369 . . . . 1.54 110.003 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -153.55 -38.53 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.268 -0.424 . . . . 2.38 111.019 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.59 110.771 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.52 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.27 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.88 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.66 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 49' ' ' ALA . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.09 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.79 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 -75.27 143.24 43.11 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.69 109.915 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -120.97 -132.45 0.3 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.643 -0.253 . . . . 1.93 110.699 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.82 -67.79 0.89 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.738 -0.744 . . . . 1.9 112.771 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -49.48 5.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.639 0.257 . . . . 4.5 111.172 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 6.5 ptpt -128.5 168.09 16.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 3.64 110.54 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' H ' HG22 ' B' ' 109' ' ' VAL . 80.8 m-85 -74.49 3.3 7.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.549 0.69 . . . . 0.92 109.474 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.87 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 1.22 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.97 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.86 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' B' ' 104' ' ' THR . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.44 109.48 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.39 144.14 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.87 110.45 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -107.0 93.04 4.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 4.66 110.509 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.32 116.22 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 2.25 109.417 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 43.4 m-85 -77.49 140.86 39.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.334 0.588 . . . . 2.32 111.495 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 14.7 mmt -74.27 123.71 25.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.82 -1.082 . . . . 2.32 109.494 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.86 73.57 0.65 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.131 -0.557 . . . . 2.77 112.938 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.65 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 2.66 110.268 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -123.07 -150.72 0.46 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 2.77 111.02 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -99.39 -17.08 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.78 0.8 . . . . 2.9 110.105 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.37 147.39 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.548 -1.205 . . . . 1.91 112.144 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 45.2 p90 -116.84 164.1 15.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.727 -1.124 . . . . 1.62 110.252 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.51 103.45 7.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.596 -1.184 . . . . 2.11 109.615 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.88 106.45 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.401 0.619 . . . . 1.45 109.984 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.42 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.82 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.64 106.944 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.509 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.96 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.61 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.57 109.621 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.94 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.63 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.38 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 13' ' ' ALA . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.28 111.351 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.22 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.82 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.84 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.36 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.46 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 91' ' ' THR . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.75 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.93 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.46 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.43 109.724 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.61 109.552 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 1.19 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 1.23 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 1.07 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 1.09 108.755 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.468 HD22 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.9 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.9 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.36 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 1.08 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.87 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.72 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.98 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 1.04 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 1.42 108.328 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.68 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 1.32 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 71' ' ' LEU . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.75 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 73' ' ' HIS . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.85 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.32 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 1.2 109.848 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 17' ' ' TYR . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 1.1 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 1.3 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.44 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.09 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.3 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.54 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.89 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG22 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 1.2 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 1.03 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 1.21 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 1.07 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.473 HG21 HD21 ' A' ' 54' ' ' LEU . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.34 112.03 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.39 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.59 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.6 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -107.4 119.21 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.92 109.556 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 115.441 -0.799 . . . . 2.29 110.181 -179.106 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 N--CA 1.48 0.711 0 N-CA-C 110.367 -0.666 . . . . 6.58 110.367 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -120.52 172.08 8.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.524 -0.307 . . . . 4.24 110.319 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -93.01 -78.42 0.42 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.672 0.273 . . . . 5.16 110.455 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.32 159.15 40.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.884 0.373 . . . . 5.22 110.696 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.83 125.09 41.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.834 -0.621 . . . . 4.23 110.447 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.75 169.72 10.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.553 -0.536 . . . . 4.48 109.553 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -93.4 107.55 19.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 5.37 110.282 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -135.09 -81.35 0.43 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.743 -0.662 . . . . 3.64 109.842 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -136.8 153.1 50.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.147 0.499 . . . . 3.06 111.294 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -156.06 123.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.404 -0.816 . . . . 2.39 108.849 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 1.26 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.92 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.76 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.011 -0.436 . . . . 1.79 112.011 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.54 -85.3 1.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.778 -0.725 . . . . 1.47 112.02 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -72.35 102.95 3.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.075 -0.343 . . . . 1.54 110.075 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt -129.29 -53.05 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.487 -0.324 . . . . 2.38 110.791 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.59 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.52 111.502 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.27 113.202 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 8' ' ' ILE . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.88 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.66 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.466 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.09 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.79 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 -71.29 151.32 44.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.69 110.455 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -122.54 -43.25 2.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.122 -0.49 . . . . 1.93 110.325 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.99 -72.52 0.27 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.945 -0.645 . . . . 1.9 111.572 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -85.74 -39.11 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.863 0.363 . . . . 4.5 110.345 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 47.9 mtpt -142.67 164.28 30.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 3.64 110.161 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -84.51 -2.54 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.721 -1.215 . . . . 0.92 107.721 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.87 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 1.22 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.97 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.86 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.44 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 37' ' ' HIS . 13.7 pt -86.51 127.69 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.87 110.524 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -102.35 109.37 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.628 -0.715 . . . . 4.66 110.998 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 t -109.09 166.5 4.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.367 -1.345 . . . . 2.25 107.367 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.15 145.13 47.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.645 0.657 . . . . 2.32 111.14 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mmm -78.47 114.87 17.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.148 -0.933 . . . . 2.32 110.239 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.29 73.06 0.74 Allowed Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.127 -0.488 . . . . 2.77 112.966 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.89 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.553 -0.536 . . . . 2.66 109.553 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -132.88 -167.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.752 -0.658 . . . . 2.77 109.765 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -95.57 -11.86 26.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 2.9 110.27 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.82 149.52 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.532 -1.213 . . . . 1.91 111.893 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -106.55 166.23 10.71 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.943 -1.026 . . . . 1.62 111.122 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.75 100.22 5.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.39 -1.277 . . . . 2.11 109.015 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p -89.77 119.85 37.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.183 0.516 . . . . 1.45 110.329 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.42 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.82 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.41 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.64 106.715 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.419 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.96 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.61 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.57 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.94 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.63 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.38 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.28 112.043 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.22 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.82 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.84 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.36 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' C ' HD11 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.46 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.75 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.93 110.865 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.46 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.43 109.351 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.61 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 1.19 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.505 ' HG1' ' CE1' ' A' ' 62' ' ' HIS . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 1.23 111.778 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.505 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 1.07 110.46 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 1.09 108.941 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.509 HD22 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.9 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.9 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.36 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 1.08 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.87 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.72 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.98 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 1.04 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.491 HG21 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 1.42 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.512 ' CD2' ' HG1' ' B' ' 107' ' ' THR . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.68 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 1.32 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' CG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.75 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.85 109.538 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.32 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 1.2 110.256 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 1.1 110.905 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 1.3 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.44 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.09 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.3 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.54 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.89 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 1.2 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 1.03 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 1.21 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 1.07 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.34 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.39 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.59 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.6 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.33 122.9 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.92 109.181 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.654 . . . . 2.29 110.044 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 N-CA-C 110.659 -0.554 . . . . 6.58 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 54.1 p90 44.01 32.4 0.63 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.292 1.037 . . . . 4.24 112.383 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -128.96 -42.89 1.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.927 -0.578 . . . . 5.16 110.605 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -85.77 63.77 8.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.206 -0.452 . . . . 5.22 110.557 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' B' ' 102' ' ' GLN . 10.9 t70 -74.03 -75.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.759 -0.46 . . . . 4.23 109.759 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.409 ' HG2' ' OD1' ' B' ' 101' ' ' ASP . 73.6 mm-40 -118.25 -48.01 2.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 4.48 110.551 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -144.6 145.22 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 5.37 109.896 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.29 143.21 27.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.573 -0.529 . . . . 3.64 109.573 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -117.77 144.67 45.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.833 -0.347 . . . . 3.06 110.567 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.425 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt -135.65 128.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 2.39 111.171 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.512 ' HG1' ' CD2' ' A' ' 73' ' ' HIS . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 1.26 110.872 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.92 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.492 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.76 110.349 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.917 0.389 . . . . 1.95 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.48 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.4299999999999999 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.23 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.1899999999999999 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.26 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.04 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.5600000000000001 111.255 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' A' ' 10' ' ' ILE . 98.4 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.107 0.48 . . . . 0.92000000000000004 110.627 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.80000000000000004 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 0.92000000000000004 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.67000000000000004 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.635 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.6599999999999999 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.0700000000000001 109.613 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.4199999999999999 110.662 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 1.22 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.3400000000000001 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.81999999999999995 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.3300000000000001 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.1000000000000001 107.28 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.8200000000000001 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.46 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.3700000000000001 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.9399999999999999 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.5600000000000001 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.3700000000000001 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.21 111.265 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.1899999999999999 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.46 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.8400000000000001 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.3600000000000001 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.3899999999999999 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.6799999999999999 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.78 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.3899999999999999 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.4299999999999999 109.183 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.1899999999999999 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.80000000000000004 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 0.85999999999999999 111.864 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.94999999999999996 111.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD23 ' A' ' 79' ' ' LEU . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 0.58999999999999997 108.663 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.3600000000000001 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 0.90000000000000002 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.59999999999999998 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.3899999999999999 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.97999999999999998 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 0.82999999999999996 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 0.81999999999999995 108.281 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.439 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.59999999999999998 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 0.56999999999999995 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.37 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.28999999999999998 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.3200000000000001 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.649 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 0.57999999999999996 110.383 178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 63' ' ' VAL . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.63 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 0.78000000000000003 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.0800000000000001 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.29 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.5 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.5800000000000001 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 0.94999999999999996 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 0.95999999999999996 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 0.85999999999999999 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.81999999999999995 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.65 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.24 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.52 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.53 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.9199999999999999 109.978 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.635 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.1 0.476 . . . . 1.6799999999999999 110.765 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.439 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.80000000000000004 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.3900000000000001 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 17' ' ' TYR . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.3999999999999999 110.974 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.594 0.235 . . . . 1.95 111.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.4299999999999999 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.23 112.742 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.1899999999999999 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.26 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.6399999999999999 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.5600000000000001 111.608 -179.616 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' HG21 ' A' ' 10' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.92000000000000004 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.80000000000000004 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 0.92000000000000004 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 76' ' ' VAL . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.67000000000000004 108.187 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.6599999999999999 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.0700000000000001 109.166 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.4199999999999999 111.079 -179.13 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.22 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.3400000000000001 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.81999999999999995 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.3300000000000001 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.1000000000000001 106.81 176.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.8200000000000001 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.46 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 56' ' ' GLN . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 109.259 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.9399999999999999 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.5600000000000001 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.3700000000000001 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.21 111.534 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.1899999999999999 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.46 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.8400000000000001 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.3600000000000001 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.3899999999999999 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.6799999999999999 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.3899999999999999 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.4299999999999999 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.1899999999999999 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 0.80000000000000004 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 0.85999999999999999 111.613 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 0.94999999999999996 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 79' ' ' LEU . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 0.58999999999999997 108.164 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.577 HD21 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.90000000000000002 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' HD21 ' A' ' 79' ' ' LEU . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.3600000000000001 110.913 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 0.90000000000000002 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.59999999999999998 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.3899999999999999 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.97999999999999998 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 0.82999999999999996 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.679 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 0.81999999999999995 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.408 ' ND1' ' HB2' ' A' ' 23' ' ' ALA . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.59999999999999998 111.14 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 0.56999999999999995 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.679 ' H ' HG23 ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.37 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.28999999999999998 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.3200000000000001 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 0.57999999999999996 110.436 178.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 63' ' ' VAL . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 0.63 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 0.78000000000000003 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.0 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.577 ' HB3' HD21 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.0800000000000001 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.29 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.5 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.5800000000000001 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 0.94999999999999996 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 0.95999999999999996 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 0.85999999999999999 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 62' ' ' HIS . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 0.81999999999999995 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.0900000000000001 111.919 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.24 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.52 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.53 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.9199999999999999 109.159 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.66 0.267 . . . . 1.6799999999999999 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 0.80000000000000004 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.3900000000000001 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.3999999999999999 110.571 -177.701 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.996 0.426 . . . . 1.95 110.416 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.48 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.4299999999999999 112.11 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.23 112.594 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.1899999999999999 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.26 110.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 17' ' ' TYR . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.04 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.6399999999999999 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.5600000000000001 110.917 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 10' ' ' ILE . 83.3 m-85 . . . . . 0 CA--C 1.516 -0.328 0 CA-C-O 121.401 0.619 . . . . 0.92000000000000004 109.476 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.80000000000000004 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 0.92000000000000004 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.67000000000000004 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.6599999999999999 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.0700000000000001 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.4199999999999999 111.224 -178.846 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.22 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.3400000000000001 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.81999999999999995 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.3300000000000001 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.1000000000000001 107.117 176.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.8200000000000001 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.429 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.46 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.3700000000000001 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.9399999999999999 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.5600000000000001 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.701 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.3700000000000001 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.21 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.1899999999999999 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.46 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.8400000000000001 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.3600000000000001 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.3899999999999999 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.6799999999999999 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.78 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.3899999999999999 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.4299999999999999 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.1899999999999999 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 0.80000000000000004 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.85999999999999999 111.806 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 0.94999999999999996 111.089 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' HD23 ' A' ' 79' ' ' LEU . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 0.58999999999999997 108.63 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.90000000000000002 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.90000000000000002 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.716 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.3600000000000001 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 0.90000000000000002 110.885 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.59999999999999998 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.3899999999999999 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.97999999999999998 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 0.82999999999999996 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.788 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 0.81999999999999995 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HG22 ' A' ' 76' ' ' VAL . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.59999999999999998 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 0.56999999999999995 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.788 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.37 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.474 ' HA ' HD12 ' A' ' 80' ' ' ILE . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.28999999999999998 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.3200000000000001 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 0.57999999999999996 110.123 178.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 0.78000000000000003 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.0 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.0800000000000001 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.29 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.406 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.5 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.5800000000000001 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 0.94999999999999996 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 0.95999999999999996 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 0.85999999999999999 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 0.81999999999999995 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.0900000000000001 111.8 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.24 107.973 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.52 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.53 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.9199999999999999 109.73 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.4 tt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.915 0.388 . . . . 1.6799999999999999 110.875 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 0.80000000000000004 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.3900000000000001 108.743 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.418 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.3999999999999999 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 1.95 110.588 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.48 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.4299999999999999 111.897 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.23 112.707 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.1899999999999999 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.26 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.04 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.6399999999999999 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.5600000000000001 111.151 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 80' ' ' ILE . 98.6 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.467 0.651 . . . . 0.92000000000000004 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.80000000000000004 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.466 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 0.92000000000000004 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.67000000000000004 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.6599999999999999 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.0700000000000001 109.452 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.4199999999999999 110.382 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.0 0.429 . . . . 1.22 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.3400000000000001 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.81999999999999995 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.3300000000000001 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.1000000000000001 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.8200000000000001 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.46 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 56' ' ' GLN . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.3700000000000001 109.389 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.5600000000000001 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.3700000000000001 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.21 111.335 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.1899999999999999 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.46 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.8400000000000001 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.3600000000000001 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.3899999999999999 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.6799999999999999 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.78 110.672 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.3899999999999999 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.1899999999999999 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 0.80000000000000004 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 0.85999999999999999 111.985 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 0.94999999999999996 110.797 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.58999999999999997 109.357 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.512 HD21 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.90000000000000002 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.90000000000000002 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.3600000000000001 111.154 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 0.90000000000000002 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.59999999999999998 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.3899999999999999 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.97999999999999998 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.525 HD12 HG12 ' A' ' 76' ' ' VAL . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 0.82999999999999996 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 0.81999999999999995 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.59999999999999998 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 0.56999999999999995 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.73 ' H ' HG23 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 71' ' ' LEU . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.37 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.28999999999999998 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.3200000000000001 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 0.57999999999999996 110.068 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 0.63 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.78000000000000003 112.568 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.0800000000000001 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.29 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.5 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.5800000000000001 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 0.94999999999999996 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 0.95999999999999996 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 0.85999999999999999 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.0900000000000001 112.252 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.24 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.52 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.53 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.9199999999999999 109.286 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.545 -0.168 . . . . 1.6799999999999999 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.596 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.3900000000000001 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 17' ' ' TYR . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.3999999999999999 111.096 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.961 0.41 . . . . 1.95 110.613 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.4299999999999999 111.353 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.23 113.512 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.1899999999999999 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.26 110.44 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' HB3' ' A' ' 17' ' ' TYR . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.04 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.6399999999999999 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.5600000000000001 110.632 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CE2' HG22 ' A' ' 80' ' ' ILE . 91.7 m-85 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92000000000000004 110.932 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.80000000000000004 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 0.92000000000000004 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.67000000000000004 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.6599999999999999 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.0700000000000001 109.742 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.4199999999999999 111.387 -178.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.502 0.668 . . . . 1.22 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.3400000000000001 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.81999999999999995 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.3300000000000001 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.1000000000000001 107.563 176.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.8200000000000001 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.46 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.3700000000000001 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.9399999999999999 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.5600000000000001 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.3700000000000001 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.21 111.7 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.1899999999999999 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.46 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.8400000000000001 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.3600000000000001 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.3899999999999999 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.6799999999999999 109.963 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.78 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.3899999999999999 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.1899999999999999 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 0.80000000000000004 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 0.85999999999999999 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.94999999999999996 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 79' ' ' LEU . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 0.58999999999999997 108.549 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 87' ' ' VAL . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.90000000000000002 109.875 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.90000000000000002 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.3600000000000001 111.13 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 0.90000000000000002 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.59999999999999998 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.3899999999999999 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.97999999999999998 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 0.82999999999999996 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 0.81999999999999995 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.59999999999999998 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 0.56999999999999995 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.709 ' H ' HG23 ' A' ' 72' ' ' VAL . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.37 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.28999999999999998 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.3200000000000001 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 0.57999999999999996 110.123 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 0.63 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 0.78000000000000003 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.629 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.29 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.5 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.5800000000000001 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 0.94999999999999996 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 0.95999999999999996 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 0.85999999999999999 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 0.81999999999999995 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.0900000000000001 111.613 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.24 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.52 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.53 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.9199999999999999 110.219 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.443 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.663 0.268 . . . . 1.6799999999999999 111.117 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 0.80000000000000004 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.3900000000000001 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.3999999999999999 110.863 -177.604 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.856 0.36 . . . . 1.95 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.48 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.4299999999999999 111.811 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.23 112.582 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 10' ' ' ILE . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.1899999999999999 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.26 110.068 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' HB3' ' A' ' 17' ' ' TYR . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.04 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.6399999999999999 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 . . . . . 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.5600000000000001 110.917 179.39 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HB3' HG21 ' A' ' 10' ' ' ILE . 72.9 m-85 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 108.387 -0.968 . . . . 0.92000000000000004 108.387 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.80000000000000004 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 0.92000000000000004 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.67000000000000004 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.6599999999999999 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.0700000000000001 109.761 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.489 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.703 -0.48 . . . . 1.22 109.703 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.3400000000000001 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.81999999999999995 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.3300000000000001 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.1000000000000001 106.955 176.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.8200000000000001 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.46 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.3700000000000001 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.9399999999999999 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.5600000000000001 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.3700000000000001 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.21 111.769 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.1899999999999999 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.46 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.8400000000000001 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.3600000000000001 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.3899999999999999 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.567 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.6799999999999999 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.78 111.407 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.3899999999999999 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.4299999999999999 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 59' ' ' LEU . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.1899999999999999 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 0.80000000000000004 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 0.85999999999999999 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 0.94999999999999996 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 79' ' ' LEU . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 0.58999999999999997 108.749 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.576 HD21 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.90000000000000002 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.90000000000000002 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 79' ' ' LEU . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.3600000000000001 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 0.90000000000000002 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.59999999999999998 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.3899999999999999 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.97999999999999998 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 0.82999999999999996 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 0.81999999999999995 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.59999999999999998 111.867 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 0.56999999999999995 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' HG22 ' A' ' 72' ' ' VAL . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.37 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.28999999999999998 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.3200000000000001 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 0.57999999999999996 110.137 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 63' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.63 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.78000000000000003 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.0 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.576 ' HB3' HD21 ' A' ' 64' ' ' ASN . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.0800000000000001 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.29 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.5 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.5800000000000001 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 0.94999999999999996 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 0.95999999999999996 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 0.85999999999999999 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 0.81999999999999995 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 111.338 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.24 107.895 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.52 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.53 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.9199999999999999 109.563 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.491 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 109.658 -0.497 . . . . 1.6799999999999999 109.658 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 0.80000000000000004 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.3900000000000001 108.383 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.3999999999999999 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.787 0.327 . . . . 1.95 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.4299999999999999 111.818 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.23 113.0 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.1899999999999999 109.422 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.26 110.408 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 17' ' ' TYR . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.6399999999999999 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.5600000000000001 111.533 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 10' ' ' ILE . 85.4 m-85 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.92000000000000004 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.80000000000000004 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 0.92000000000000004 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 76' ' ' VAL . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.67000000000000004 108.281 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.6599999999999999 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.0700000000000001 109.364 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.4199999999999999 110.952 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.491 0.662 . . . . 1.22 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.3400000000000001 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.81999999999999995 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.3300000000000001 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.642 HG11 HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.1000000000000001 107.133 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.8200000000000001 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.46 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.3700000000000001 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.9399999999999999 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.5600000000000001 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.3700000000000001 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.21 111.642 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.1899999999999999 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.46 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.8400000000000001 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.3600000000000001 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.3899999999999999 114.028 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.642 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.6799999999999999 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.78 111.268 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.3899999999999999 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.4299999999999999 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.1899999999999999 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.80000000000000004 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 0.85999999999999999 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.748 ' HB ' HD23 ' A' ' 79' ' ' LEU . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 0.58999999999999997 108.43 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.90000000000000002 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.90000000000000002 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.3600000000000001 110.719 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 0.90000000000000002 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.59999999999999998 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.3899999999999999 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.97999999999999998 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 0.82999999999999996 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 0.81999999999999995 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' O ' HG22 ' A' ' 76' ' ' VAL . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.59999999999999998 111.284 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 0.56999999999999995 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 21' ' ' LEU . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.28999999999999998 109.325 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.3200000000000001 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.748 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 0.57999999999999996 110.059 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.29 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.5 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.5800000000000001 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 0.94999999999999996 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 0.95999999999999996 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 0.85999999999999999 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 0.81999999999999995 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.0900000000000001 112.096 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.24 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.52 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.53 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.9199999999999999 109.786 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.705 0.288 . . . . 1.6799999999999999 110.655 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 0.80000000000000004 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.3900000000000001 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.3999999999999999 110.469 -177.742 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 121.111 0.482 . . . . 1.95 110.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.48 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.4299999999999999 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.23 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.1899999999999999 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.26 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 17' ' ' TYR . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.04 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.6399999999999999 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.5600000000000001 110.792 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' HB3' HG21 ' A' ' 10' ' ' ILE . 87.6 m-85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.21 -0.663 . . . . 0.92000000000000004 109.21 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.80000000000000004 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 0.92000000000000004 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.67000000000000004 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.6599999999999999 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.0700000000000001 110.601 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 37' ' ' HIS . 10.7 pt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.4199999999999999 109.841 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.191 0.52 . . . . 1.22 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 24' ' ' ILE . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.3400000000000001 109.359 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.81999999999999995 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.3300000000000001 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.1000000000000001 106.989 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.486 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.8200000000000001 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.46 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.3700000000000001 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.9399999999999999 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.5600000000000001 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.3700000000000001 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.21 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.1899999999999999 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.46 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.8400000000000001 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.3600000000000001 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.3899999999999999 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.6799999999999999 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.78 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.3899999999999999 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.4299999999999999 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.1899999999999999 109.226 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 0.80000000000000004 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 0.85999999999999999 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.94999999999999996 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 80' ' ' ILE . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.58999999999999997 108.721 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.90000000000000002 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.90000000000000002 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.3600000000000001 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 0.90000000000000002 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.59999999999999998 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.97999999999999998 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 0.82999999999999996 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' H ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 0.81999999999999995 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.59999999999999998 111.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 0.56999999999999995 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.37 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.3200000000000001 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 0.57999999999999996 110.028 177.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.527 HG22 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 0.63 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 0.78000000000000003 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 64' ' ' ASN . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.0800000000000001 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.29 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.5 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.5800000000000001 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 80' ' ' ILE . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 0.94999999999999996 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 0.95999999999999996 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 0.85999999999999999 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 0.81999999999999995 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.0900000000000001 111.593 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.24 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.52 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.53 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.9199999999999999 109.338 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.886 0.374 . . . . 1.6799999999999999 111.023 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.80000000000000004 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.3900000000000001 108.08 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.3999999999999999 110.292 -178.227 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 1.95 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.48 110.771 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.4299999999999999 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.23 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.1899999999999999 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.26 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.6399999999999999 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.5600000000000001 109.915 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' HB3' HG21 ' A' ' 10' ' ' ILE . 80.8 m-85 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.549 0.69 . . . . 0.92000000000000004 109.474 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.80000000000000004 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 0.92000000000000004 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.67000000000000004 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.6599999999999999 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.0700000000000001 109.48 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.4199999999999999 110.45 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 121.401 0.619 . . . . 1.22 109.984 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.3400000000000001 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.81999999999999995 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.3300000000000001 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.1000000000000001 106.944 176.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.8200000000000001 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.46 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.463 HG23 ' HG2' ' A' ' 56' ' ' GLN . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.3700000000000001 109.621 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.9399999999999999 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.3700000000000001 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.21 111.351 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.1899999999999999 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.46 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.8400000000000001 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.3600000000000001 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.3899999999999999 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.6799999999999999 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.78 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.3899999999999999 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.4299999999999999 109.724 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.1899999999999999 109.552 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 0.80000000000000004 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 0.94999999999999996 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 80' ' ' ILE . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 0.58999999999999997 108.755 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.504 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.3600000000000001 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 0.90000000000000002 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.529 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.3899999999999999 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.97999999999999998 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.82999999999999996 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.677 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 0.81999999999999995 108.328 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.59999999999999998 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 0.56999999999999995 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.677 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.37 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.28999999999999998 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.3200000000000001 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 0.57999999999999996 109.848 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.512 HG13 HG11 ' A' ' 63' ' ' VAL . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 0.63 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 0.78000000000000003 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.0 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.0800000000000001 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.29 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.5 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.5800000000000001 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 0.94999999999999996 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 0.95999999999999996 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 0.85999999999999999 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 0.81999999999999995 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.0900000000000001 112.03 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.52 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.53 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.9199999999999999 109.556 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.849 -0.797 . . . . 1.6799999999999999 108.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 0.80000000000000004 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.3900000000000001 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.3999999999999999 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.742 0.306 . . . . 1.95 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.48 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.4299999999999999 111.502 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.23 113.202 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.1899999999999999 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.26 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.6399999999999999 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.5600000000000001 110.455 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' B' ' 109' ' ' VAL . 71.0 m-85 . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 107.721 -1.215 . . . . 0.92000000000000004 107.721 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.80000000000000004 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.67000000000000004 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.6599999999999999 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.0700000000000001 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 37' ' ' HIS . 13.7 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.4199999999999999 110.524 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.183 0.516 . . . . 1.22 110.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.3400000000000001 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.81999999999999995 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.3300000000000001 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.1000000000000001 106.715 176.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.8200000000000001 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.46 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.3700000000000001 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.9399999999999999 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.5600000000000001 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.3700000000000001 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.21 112.043 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.1899999999999999 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.46 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.8400000000000001 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.3600000000000001 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.3899999999999999 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.6799999999999999 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.78 110.865 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.3899999999999999 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.4299999999999999 109.351 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.1899999999999999 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 0.80000000000000004 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 0.85999999999999999 111.778 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 0.94999999999999996 110.46 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.701 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 0.58999999999999997 108.941 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.90000000000000002 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.90000000000000002 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 79' ' ' LEU . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.3600000000000001 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 0.90000000000000002 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.59999999999999998 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.3899999999999999 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.97999999999999998 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 0.82999999999999996 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 0.81999999999999995 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 76' ' ' VAL . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.59999999999999998 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.601 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 0.56999999999999995 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.653 ' CG ' HG22 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.37 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' ILE . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.28999999999999998 109.538 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.3200000000000001 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 0.57999999999999996 110.256 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 0.63 110.905 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 0.78000000000000003 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.0 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.0800000000000001 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.29 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.5 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.5800000000000001 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 0.94999999999999996 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 0.95999999999999996 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 0.85999999999999999 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 0.81999999999999995 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.0900000000000001 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.24 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.52 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.53 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.9199999999999999 109.181 179.336 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.438 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.843 0.354 . . . . 1.6799999999999999 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 0.80000000000000004 110.872 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.3900000000000001 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 17' ' ' TYR . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.3999999999999999 110.349 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.854 -0.499 . . . . 1.5 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.48 -56.82 4.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.939 -0.648 . . . . 1.3 112.406 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -95.68 103.21 15.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.874 -0.417 . . . . 1.54 109.874 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt -142.97 -43.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 1.95 110.644 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.48 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.4299999999999999 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.23 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.1899999999999999 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.26 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.04 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.6399999999999999 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 -69.21 131.84 45.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.5600000000000001 111.255 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -116.47 66.53 0.71 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.584 -0.524 . . . . 1.9299999999999999 109.584 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.74 -54.69 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.894 -0.882 . . . . 1.6399999999999999 110.894 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -159.05 -47.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.32 -0.622 . . . . 4.0 109.32 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 5.1 mmmm -82.34 157.96 23.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.599 -0.728 . . . . 3.0600000000000001 110.724 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' A' ' 10' ' ' ILE . 98.4 m-85 -103.05 -7.8 21.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.92000000000000004 110.627 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.80000000000000004 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 0.92000000000000004 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.67000000000000004 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.635 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.6599999999999999 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 104' ' ' THR . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.0700000000000001 109.613 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.63 ' HA ' HG23 ' B' ' 104' ' ' THR . 12.2 pt -79.15 159.03 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.4199999999999999 110.662 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' NE ' ' HB2' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -140.09 132.46 28.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.289 0.566 . . . . 4.04 111.305 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.47 119.12 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.225 -1.028 . . . . 1.72 108.225 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 40.8 m-85 -66.17 139.06 58.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.333 0.587 . . . . 2.1000000000000001 111.572 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.6 mmt -71.34 134.31 46.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.808 -1.087 . . . . 2.0499999999999998 110.249 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.41 63.76 3.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.99 -0.624 . . . . 2.77 113.065 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -167.83 -59.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.671 0.272 . . . . 2.6200000000000001 110.972 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.621 ' HB2' HG12 ' A' ' 33' ' ' VAL . 24.2 m -110.17 -154.83 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.721 0.296 . . . . 2.6099999999999999 110.807 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.0 -10.78 22.21 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.701 0.762 . . . . 2.8999999999999999 109.68 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 31' ' ' SER . 6.0 p -63.18 148.95 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.549 -1.205 . . . . 1.75 110.967 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.3 p90 -113.23 172.14 7.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.35 -0.841 . . . . 1.53 110.652 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.53 99.02 5.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.878 -1.056 . . . . 1.6499999999999999 109.058 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -85.47 130.72 35.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 1.22 111.096 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.3400000000000001 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.81999999999999995 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.3300000000000001 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.1000000000000001 107.28 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.8200000000000001 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.46 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.3700000000000001 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.9399999999999999 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.5600000000000001 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.3700000000000001 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.21 111.265 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.1899999999999999 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.46 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.8400000000000001 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.3600000000000001 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.3899999999999999 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.6799999999999999 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.78 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.3899999999999999 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.4299999999999999 109.183 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.1899999999999999 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.80000000000000004 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 0.85999999999999999 111.864 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.94999999999999996 111.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD23 ' A' ' 79' ' ' LEU . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 0.58999999999999997 108.663 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.3600000000000001 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 0.90000000000000002 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.59999999999999998 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.3899999999999999 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.97999999999999998 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 0.82999999999999996 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 0.81999999999999995 108.281 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.439 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.59999999999999998 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 0.56999999999999995 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.37 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.28999999999999998 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.3200000000000001 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.649 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 0.57999999999999996 110.383 178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 63' ' ' VAL . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.63 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 0.78000000000000003 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.0800000000000001 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.29 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.5 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.5800000000000001 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 0.94999999999999996 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 0.95999999999999996 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 0.85999999999999999 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.81999999999999995 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.65 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.24 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.52 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.53 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -104.57 125.71 50.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.9199999999999999 109.978 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 115.102 -0.954 . . . . 2.1600000000000001 109.768 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.476 0.453 0 N-CA-C 111.161 -0.361 . . . . 6.0300000000000002 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -72.99 -18.15 61.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.409 . . . . 3.4100000000000001 110.417 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.13 23.28 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.685 -0.688 . . . . 5.1600000000000001 111.296 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' B' ' 104' ' ' THR . 27.7 mt-10 -72.05 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 5.2199999999999998 110.382 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -113.14 1.52 15.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.229 0.538 . . . . 4.2300000000000004 109.956 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -67.89 -79.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 3.8100000000000001 111.399 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.492 ' HB2' ' NE ' ' A' ' 25' ' ' ARG . 16.7 m80 -93.22 -18.91 21.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.98 0.419 . . . . 4.6100000000000003 110.344 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' B' ' 100' ' ' GLU . 89.0 m -75.99 103.31 5.99 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.711 -0.477 . . . . 3.1000000000000001 109.711 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -74.18 161.76 29.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 2.4900000000000002 111.356 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.635 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -151.61 123.39 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.97 -0.559 . . . . 1.6799999999999999 110.765 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.439 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.80000000000000004 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.3900000000000001 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.529 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.3999999999999999 110.974 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.216 -0.354 . . . . 1.5 112.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.36 -58.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.641 . . . . 1.3 111.777 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 m -85.5 121.28 27.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.58 -0.526 . . . . 1.54 109.58 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt -157.15 -59.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.523 -0.308 . . . . 1.95 111.191 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.4299999999999999 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.23 112.742 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.1899999999999999 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.26 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.6399999999999999 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.96 156.8 32.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.5600000000000001 111.608 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -130.8 -146.03 0.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.572 -0.74 . . . . 1.9299999999999999 109.934 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 -66.13 2.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.515 -0.85 . . . . 1.6399999999999999 112.538 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -134.82 -8.97 2.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.542 0.201 . . . . 4.0 111.542 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -135.95 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.243 -0.28 . . . . 3.0600000000000001 110.243 -179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' HG21 ' A' ' 10' ' ' ILE . 96.6 m-85 -98.04 -5.39 34.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.202 0.525 . . . . 0.92000000000000004 109.942 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.80000000000000004 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 0.92000000000000004 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 76' ' ' VAL . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.67000000000000004 108.187 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.6599999999999999 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.0700000000000001 109.166 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt -91.31 134.1 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.4199999999999999 111.079 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' B' ' 101' ' ' ASP . 3.9 mpt_? -105.97 100.83 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.993 -0.549 . . . . 4.04 110.517 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.8 t -105.89 136.11 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.376 -0.829 . . . . 1.72 108.79 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.08 142.95 53.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.48 0.657 . . . . 2.1000000000000001 110.985 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HB2' HG13 ' A' ' 33' ' ' VAL . 1.2 mmt -72.59 -21.09 61.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.113 -0.949 . . . . 2.0499999999999998 110.908 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 22.29 64.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 2.77 111.528 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -114.45 -51.25 2.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.913 0.387 . . . . 2.6200000000000001 110.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 p -152.11 -109.49 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.488 . . . . 2.6099999999999999 110.865 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.72 -16.52 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.726 0.774 . . . . 2.8999999999999999 109.045 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 28' ' ' MET . 2.9 p -59.07 149.21 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.573 -1.194 . . . . 1.75 111.175 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 25' ' ' ARG . 42.0 p90 -118.5 174.25 6.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.505 -0.77 . . . . 1.53 111.234 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 28' ' ' MET . 0.2 OUTLIER -125.67 102.94 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.564 -1.198 . . . . 1.6499999999999999 109.315 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -83.97 115.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.284 0.564 . . . . 1.22 110.422 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.3400000000000001 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.81999999999999995 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.3300000000000001 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.1000000000000001 106.81 176.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.8200000000000001 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.46 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 56' ' ' GLN . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 109.259 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.9399999999999999 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.5600000000000001 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.3700000000000001 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.21 111.534 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.1899999999999999 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.46 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.8400000000000001 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.3600000000000001 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.3899999999999999 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.6799999999999999 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.3899999999999999 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.4299999999999999 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.1899999999999999 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 0.80000000000000004 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 0.85999999999999999 111.613 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 0.94999999999999996 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 79' ' ' LEU . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 0.58999999999999997 108.164 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.577 HD21 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.90000000000000002 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' HD21 ' A' ' 79' ' ' LEU . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.3600000000000001 110.913 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 0.90000000000000002 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.59999999999999998 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.3899999999999999 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.97999999999999998 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 0.82999999999999996 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.679 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 0.81999999999999995 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.408 ' ND1' ' HB2' ' A' ' 23' ' ' ALA . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.59999999999999998 111.14 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 0.56999999999999995 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.679 ' H ' HG23 ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.37 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.28999999999999998 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.3200000000000001 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 0.57999999999999996 110.436 178.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 63' ' ' VAL . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 0.63 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 0.78000000000000003 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.0 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.577 ' HB3' HD21 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.0800000000000001 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.29 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.5 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.5800000000000001 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 0.94999999999999996 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 0.95999999999999996 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 0.85999999999999999 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 62' ' ' HIS . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 0.81999999999999995 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.0900000000000001 111.919 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.24 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.52 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.53 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.36 125.55 46.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.9199999999999999 109.159 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 115.573 -0.74 . . . . 2.1600000000000001 110.451 -178.902 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.475 0.42 0 N-CA-C 110.469 -0.627 . . . . 6.0300000000000002 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.59 150.67 34.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.688 -0.856 . . . . 3.4100000000000001 108.688 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.8 0.296 . . . . 5.1600000000000001 111.8 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -153.79 124.66 7.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.682 0.277 . . . . 5.2199999999999998 111.557 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 27.8 t0 -73.15 105.46 4.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.769 -0.826 . . . . 4.2300000000000004 108.769 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -70.1 -89.5 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 3.8100000000000001 112.053 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.75 86.36 6.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.212 0.529 . . . . 4.6100000000000003 110.724 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.65 94.75 1.03 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.407 -0.815 . . . . 3.1000000000000001 111.21 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 49.7 mt-30 -106.31 130.04 54.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.754 -0.461 . . . . 2.4900000000000002 109.754 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -137.05 131.25 46.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.467 -0.333 . . . . 1.6799999999999999 111.148 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 0.80000000000000004 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.3900000000000001 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.515 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.3999999999999999 110.571 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.13 -0.388 . . . . 1.5 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.34 -51.4 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.05 -0.595 . . . . 1.3 112.021 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -107.25 93.49 4.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.159 0.504 . . . . 1.54 110.382 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -129.08 -41.63 1.42 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.567 -0.742 . . . . 1.95 110.416 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.48 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.4299999999999999 112.11 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.23 112.594 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.1899999999999999 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.26 110.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 17' ' ' TYR . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.04 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.6399999999999999 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 -68.98 139.85 55.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.5600000000000001 110.917 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -125.53 52.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.48 0.657 . . . . 1.9299999999999999 109.997 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 -93.04 1.8 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.629 -0.714 . . . . 1.6399999999999999 111.578 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -108.04 -25.76 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.191 0.519 . . . . 4.0 110.627 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' B' ' 108' ' ' LYS . 28.5 mtpt -114.73 177.89 4.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.686 -0.688 . . . . 3.0600000000000001 111.414 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 10' ' ' ILE . 83.3 m-85 -118.77 -7.26 10.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.92000000000000004 109.476 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.80000000000000004 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 0.92000000000000004 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.67000000000000004 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.6599999999999999 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.0700000000000001 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -86.23 144.6 9.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.4199999999999999 111.224 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -106.9 111.22 23.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.529 -0.76 . . . . 4.04 110.568 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -115.53 123.98 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.569 . . . . 1.72 110.357 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -75.49 143.1 42.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.131 0.491 . . . . 2.1000000000000001 110.546 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.1 mmt -70.67 138.77 50.96 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.231 -0.895 . . . . 2.0499999999999998 109.825 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.92 57.0 4.96 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.967 -0.635 . . . . 2.77 112.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.03 -57.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 2.6200000000000001 110.622 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.6 m -110.27 -157.66 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 2.6099999999999999 110.643 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.02 -8.31 21.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.14 0.495 . . . . 2.8999999999999999 110.467 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 31' ' ' SER . 7.7 p -61.45 148.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.229 -0.896 . . . . 1.75 111.215 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -102.65 172.73 6.69 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.339 -0.846 . . . . 1.53 110.944 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 108.21 5.62 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.324 -1.307 . . . . 1.6499999999999999 108.654 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.23 112.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.363 0.601 . . . . 1.22 110.789 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.3400000000000001 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.81999999999999995 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.3300000000000001 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.1000000000000001 107.117 176.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.8200000000000001 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.429 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.46 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.3700000000000001 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.9399999999999999 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.5600000000000001 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.701 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.3700000000000001 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.21 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.1899999999999999 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.46 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.8400000000000001 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.3600000000000001 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.3899999999999999 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.6799999999999999 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.78 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.3899999999999999 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.4299999999999999 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.1899999999999999 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 0.80000000000000004 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.85999999999999999 111.806 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 0.94999999999999996 111.089 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' HD23 ' A' ' 79' ' ' LEU . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 0.58999999999999997 108.63 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.90000000000000002 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.90000000000000002 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.716 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.3600000000000001 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 0.90000000000000002 110.885 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.59999999999999998 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.3899999999999999 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.97999999999999998 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 0.82999999999999996 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.788 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 0.81999999999999995 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HG22 ' A' ' 76' ' ' VAL . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.59999999999999998 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 0.56999999999999995 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.788 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.37 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.474 ' HA ' HD12 ' A' ' 80' ' ' ILE . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.28999999999999998 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.3200000000000001 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 0.57999999999999996 110.123 178.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 0.78000000000000003 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.0 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.0800000000000001 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.29 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.406 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.5 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.5800000000000001 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 0.94999999999999996 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 0.95999999999999996 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 0.85999999999999999 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 0.81999999999999995 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.0900000000000001 111.8 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.24 107.973 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.52 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.53 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.21 122.46 35.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.9199999999999999 109.73 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.656 -0.688 . . . . 2.1600000000000001 110.237 -179.429 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.5 0 N-CA-C 110.464 -0.629 . . . . 6.0300000000000002 110.464 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.78 -166.01 0.23 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.46 0.475 . . . . 3.4100000000000001 110.175 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.73 -78.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.005 -0.278 . . . . 5.1600000000000001 111.075 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -132.73 149.3 52.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 5.2199999999999998 111.239 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -137.87 25.31 2.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 4.2300000000000004 110.042 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -83.0 -50.61 8.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 3.8100000000000001 110.075 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -112.44 78.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.814 -0.81 . . . . 4.6100000000000003 108.814 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.9 p -127.67 172.71 10.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.293 -0.867 . . . . 3.1000000000000001 110.013 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -132.22 164.1 27.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.049 -0.26 . . . . 2.4900000000000002 110.319 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.4 tt -146.99 129.37 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.915 0.388 . . . . 1.6799999999999999 110.875 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 0.80000000000000004 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.3900000000000001 108.743 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.418 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.3999999999999999 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.945 -0.462 . . . . 1.5 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.88 -45.03 8.66 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.749 -0.739 . . . . 1.3 112.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -75.2 116.18 15.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 1.54 110.953 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -165.82 -58.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.797 -0.638 . . . . 1.95 110.588 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.48 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.4299999999999999 111.897 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.23 112.707 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.1899999999999999 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.26 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.04 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.6399999999999999 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 -74.37 136.96 42.47 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.5600000000000001 111.151 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.3 84.73 2.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.278 -0.419 . . . . 1.9299999999999999 110.2 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.04 -89.3 0.57 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.773 -0.727 . . . . 1.6399999999999999 112.129 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -132.47 7.28 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.496 0.189 . . . . 4.0 110.993 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' B' ' 109' ' ' VAL . 0.0 OUTLIER -139.66 167.9 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.539 -0.301 . . . . 3.0600000000000001 110.477 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 80' ' ' ILE . 98.6 m-85 -106.15 -6.96 18.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.467 0.651 . . . . 0.92000000000000004 109.7 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.80000000000000004 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.466 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 0.92000000000000004 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.67000000000000004 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.6599999999999999 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' O ' HG22 ' B' ' 104' ' ' THR . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.0700000000000001 109.452 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt -94.0 132.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.4199999999999999 110.382 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 23.0 ttt85 -102.64 119.83 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.033 -0.53 . . . . 4.04 111.108 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 27' ' ' TYR . 2.4 t -114.53 176.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.652 -1.24 . . . . 1.72 107.652 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' H ' HG12 ' A' ' 26' ' ' VAL . 1.1 m-85 -126.81 149.18 49.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 111.011 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.464 ' HB2' HG13 ' A' ' 33' ' ' VAL . 95.8 mmm -93.58 117.4 30.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.064 -0.971 . . . . 2.0499999999999998 109.782 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.36 84.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.133 -0.556 . . . . 2.77 112.074 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -176.43 -52.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.213 0.53 . . . . 2.6200000000000001 110.075 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.6 m -130.4 -155.04 0.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.759 -0.655 . . . . 2.6099999999999999 110.497 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 11.53 38.64 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.513 0.673 . . . . 2.8999999999999999 109.393 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 28' ' ' MET . 7.8 p -77.34 146.67 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.102 -0.954 . . . . 1.75 110.389 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -109.11 165.84 11.3 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.116 -0.947 . . . . 1.53 110.944 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.57 99.12 6.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.814 -1.085 . . . . 1.6499999999999999 109.886 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.28 118.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.0 0.429 . . . . 1.22 110.384 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.3400000000000001 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.81999999999999995 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.3300000000000001 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.1000000000000001 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.8200000000000001 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.46 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 56' ' ' GLN . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.3700000000000001 109.389 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.9399999999999999 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.5600000000000001 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.3700000000000001 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.21 111.335 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.1899999999999999 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.46 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.8400000000000001 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.3600000000000001 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.3899999999999999 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.6799999999999999 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.78 110.672 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.3899999999999999 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.4299999999999999 109.63 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.1899999999999999 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 0.80000000000000004 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 0.85999999999999999 111.985 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 0.94999999999999996 110.797 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.58999999999999997 109.357 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.512 HD21 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.90000000000000002 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.90000000000000002 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.3600000000000001 111.154 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 0.90000000000000002 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.59999999999999998 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.3899999999999999 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.97999999999999998 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.525 HD12 HG12 ' A' ' 76' ' ' VAL . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 0.82999999999999996 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 0.81999999999999995 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.59999999999999998 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 0.56999999999999995 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.73 ' H ' HG23 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 71' ' ' LEU . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.37 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.28999999999999998 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.3200000000000001 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 0.57999999999999996 110.068 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 0.63 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.78000000000000003 112.568 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.0800000000000001 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.29 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.5 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.5800000000000001 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 0.94999999999999996 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 0.95999999999999996 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 0.85999999999999999 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.0900000000000001 112.252 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.24 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.52 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.53 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -91.84 122.48 34.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.9199999999999999 109.286 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.123 -0.944 . . . . 2.1600000000000001 109.394 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo . . . . . 0 N--CA 1.478 0.604 0 N-CA-C 110.075 -0.779 . . . . 6.0300000000000002 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.2 -173.65 3.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.72 0.295 . . . . 3.4100000000000001 110.695 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.78 -148.4 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.963 -0.562 . . . . 5.1600000000000001 110.218 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.436 ' HB3' ' OE1' ' B' ' 102' ' ' GLN . 9.6 mm-40 -77.84 70.51 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 5.2199999999999998 110.387 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 8.2 p-10 -87.88 37.2 0.79 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 4.2300000000000004 111.861 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' B' ' 100' ' ' GLU . 19.6 mp0 -59.63 -50.37 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 3.8100000000000001 110.454 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -92.47 82.35 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.224 -0.658 . . . . 4.6100000000000003 109.224 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -109.83 147.21 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.013 -0.54 . . . . 3.1000000000000001 111.532 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.12 144.17 47.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 2.4900000000000002 109.521 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.63 121.28 18.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.558 -0.292 . . . . 1.6799999999999999 110.545 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 0.80000000000000004 111.596 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.3900000000000001 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.3999999999999999 111.096 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.614 -0.594 . . . . 1.5 111.614 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.35 -81.72 1.59 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.808 -0.71 . . . . 1.3 111.543 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -73.03 113.71 10.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.899 0.38 . . . . 1.54 110.05 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.62 -43.69 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.206 -0.452 . . . . 1.95 110.613 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.4299999999999999 111.353 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.23 113.512 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.1899999999999999 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.26 110.44 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' HB3' ' A' ' 17' ' ' TYR . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.04 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.6399999999999999 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 -70.82 142.62 51.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.5600000000000001 110.632 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -99.26 -8.79 24.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.267 0.556 . . . . 1.9299999999999999 110.036 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.0 -41.99 1.48 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.668 -0.697 . . . . 1.6399999999999999 111.368 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.0 -37.79 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.507 0.194 . . . . 4.0 110.79 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 1.3 mtmp? -132.76 167.77 19.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 3.0600000000000001 110.691 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CE2' HG22 ' A' ' 80' ' ' ILE . 91.7 m-85 -95.43 -10.58 29.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92000000000000004 110.932 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.80000000000000004 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 0.92000000000000004 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.67000000000000004 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.6599999999999999 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.0700000000000001 109.742 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' B' ' 104' ' ' THR . 12.3 pt -80.44 133.64 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.4199999999999999 111.387 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' B' ' 103' ' ' HIS . 29.4 mtt180 -107.75 108.67 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 4.04 110.208 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -109.27 120.48 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.529 -0.76 . . . . 1.72 109.53 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 11.9 m-85 -66.74 144.69 56.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.299 0.571 . . . . 2.1000000000000001 110.626 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.0 mmm -67.27 -17.88 64.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.04 -0.982 . . . . 2.0499999999999998 111.131 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.71 -53.72 4.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.068 -0.587 . . . . 2.77 113.353 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -85.31 14.18 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.841 0.353 . . . . 2.6200000000000001 111.436 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' HG12 ' A' ' 33' ' ' VAL . 37.6 t -162.92 179.13 7.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.332 -0.395 . . . . 2.6099999999999999 110.817 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -90.87 -14.46 31.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.035 0.922 . . . . 2.8999999999999999 108.705 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 31' ' ' SER . 7.4 p -71.2 147.5 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.542 -1.208 . . . . 1.75 110.681 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 52.5 p90 -108.24 170.43 8.01 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.266 -0.879 . . . . 1.53 110.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 99.35 5.34 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.354 -1.294 . . . . 1.6499999999999999 108.611 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -84.73 123.32 39.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.502 0.668 . . . . 1.22 111.139 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.3400000000000001 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.81999999999999995 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.3300000000000001 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.1000000000000001 107.563 176.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.8200000000000001 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.46 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.3700000000000001 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.9399999999999999 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.5600000000000001 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.3700000000000001 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.21 111.7 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.1899999999999999 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.46 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.8400000000000001 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.3600000000000001 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.3899999999999999 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.6799999999999999 109.963 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.78 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.3899999999999999 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.4299999999999999 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.1899999999999999 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 0.80000000000000004 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 0.85999999999999999 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.94999999999999996 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 79' ' ' LEU . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 0.58999999999999997 108.549 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 87' ' ' VAL . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.90000000000000002 109.875 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.90000000000000002 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.3600000000000001 111.13 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 0.90000000000000002 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.59999999999999998 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.3899999999999999 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.97999999999999998 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 0.82999999999999996 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 0.81999999999999995 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.59999999999999998 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 0.56999999999999995 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.709 ' H ' HG23 ' A' ' 72' ' ' VAL . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.37 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.28999999999999998 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.3200000000000001 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 0.57999999999999996 110.123 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 0.63 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 0.78000000000000003 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.629 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.29 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.5 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.5800000000000001 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 0.94999999999999996 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 0.95999999999999996 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 0.85999999999999999 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 0.81999999999999995 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.0900000000000001 111.613 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.24 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.52 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.53 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.87 120.88 39.05 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.9199999999999999 110.219 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.495 -0.775 . . . . 2.1600000000000001 109.548 -179.464 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.475 0.422 0 N-CA-C 109.828 -0.874 . . . . 6.0300000000000002 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 p90 47.71 -171.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.419 1.087 . . . . 3.4100000000000001 113.388 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -162.87 154.4 17.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 5.1600000000000001 109.221 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 74.62 159.74 0.22 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.006 0.816 . . . . 5.2199999999999998 112.285 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ASP . . . . . 0.531 ' O ' HG23 ' B' ' 104' ' ' THR . 10.9 t70 -162.82 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.445 -0.798 . . . . 4.2300000000000004 109.387 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 57.7 -134.98 1.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.549 -0.75 . . . . 3.8100000000000001 111.202 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.596 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 23.3 t-80 -78.33 84.3 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.137 0.494 . . . . 4.6100000000000003 110.556 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ASP . 11.0 p -98.08 151.86 19.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.989 -0.55 . . . . 3.1000000000000001 110.921 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 2.6 mp0 -100.36 135.1 42.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.731 -0.84 . . . . 2.4900000000000002 108.731 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.443 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt -130.12 124.14 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.663 0.268 . . . . 1.6799999999999999 111.117 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 0.80000000000000004 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.3900000000000001 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.509 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.3999999999999999 110.863 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.003 -0.439 . . . . 1.5 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.32 -60.41 1.31 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 1.3 112.635 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -65.7 112.75 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 1.54 111.481 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt -155.42 -52.63 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.48 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.4299999999999999 111.811 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.23 112.582 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 10' ' ' ILE . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.1899999999999999 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.26 110.068 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' HB3' ' A' ' 17' ' ' TYR . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.04 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.6399999999999999 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -65.48 141.95 58.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.5600000000000001 110.917 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -119.43 -42.49 2.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.366 -0.379 . . . . 1.9299999999999999 110.636 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.58 -88.76 0.12 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.967 -0.635 . . . . 1.6399999999999999 111.868 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -81.29 -36.24 30.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.839 0.352 . . . . 4.0 110.603 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 51.2 mtpt -138.55 153.88 48.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.131 -0.486 . . . . 3.0600000000000001 110.654 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HB3' HG21 ' A' ' 10' ' ' ILE . 72.9 m-85 -78.63 1.15 23.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.387 -0.968 . . . . 0.92000000000000004 108.387 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.80000000000000004 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 0.92000000000000004 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.67000000000000004 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.6599999999999999 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.0700000000000001 109.761 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt -83.83 147.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.4199999999999999 110.489 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' NH2' ' HB3' ' B' ' 103' ' ' HIS . 15.5 ttm180 -113.53 129.82 56.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.156 -0.475 . . . . 4.04 111.214 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.61 108.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 15.3 m-85 -70.36 139.45 51.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.576 0.703 . . . . 2.1000000000000001 111.811 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.6 mmm -82.17 139.0 34.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.477 -1.238 . . . . 2.0499999999999998 110.02 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.91 72.11 2.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.992 -0.623 . . . . 2.77 111.659 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -155.79 -58.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 2.6200000000000001 111.201 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -140.57 -145.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.277 -0.419 . . . . 2.6099999999999999 110.915 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.21 -9.19 53.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.833 0.825 . . . . 2.8999999999999999 109.112 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.96 145.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.969 -1.469 . . . . 1.75 110.645 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 39.0 p90 -131.83 167.21 19.95 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.318 -0.855 . . . . 1.53 111.04 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.13 114.86 22.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.805 -1.089 . . . . 1.6499999999999999 109.534 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.35 117.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.703 -0.48 . . . . 1.22 109.703 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.3400000000000001 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.81999999999999995 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.3300000000000001 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.1000000000000001 106.955 176.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.8200000000000001 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.46 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.3700000000000001 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.9399999999999999 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.5600000000000001 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.3700000000000001 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.21 111.769 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.1899999999999999 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.46 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.8400000000000001 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.3600000000000001 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.3899999999999999 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.567 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.6799999999999999 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.78 111.407 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.3899999999999999 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.4299999999999999 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 59' ' ' LEU . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.1899999999999999 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 0.80000000000000004 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 0.85999999999999999 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 0.94999999999999996 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 79' ' ' LEU . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 0.58999999999999997 108.749 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.576 HD21 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.90000000000000002 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.90000000000000002 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 79' ' ' LEU . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.3600000000000001 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 0.90000000000000002 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.59999999999999998 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.3899999999999999 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.97999999999999998 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 0.82999999999999996 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 0.81999999999999995 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' B' ' 105' ' ' GLN . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.59999999999999998 111.867 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 0.56999999999999995 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' HG22 ' A' ' 72' ' ' VAL . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.37 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.28999999999999998 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.3200000000000001 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 0.57999999999999996 110.137 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 63' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.63 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.78000000000000003 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.0 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.576 ' HB3' HD21 ' A' ' 64' ' ' ASN . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.0800000000000001 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.29 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.5 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.5800000000000001 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 0.94999999999999996 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 0.95999999999999996 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 0.85999999999999999 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 0.81999999999999995 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.0900000000000001 111.338 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.24 107.895 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.52 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.53 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.53 118.81 21.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.9199999999999999 109.563 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 115.475 -0.784 . . . . 2.1600000000000001 110.19 -178.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.649 -0.558 . . . . 6.0300000000000002 110.649 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 19.8 t80 63.6 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.91 0.756 . . . . 3.4100000000000001 111.796 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -45.79 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.191 0.52 . . . . 5.1600000000000001 110.545 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.46 160.68 26.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.429 -0.805 . . . . 5.2199999999999998 109.069 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.75 -23.56 0.23 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.104 -0.239 . . . . 4.2300000000000004 111.568 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -179.4 -47.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.136 0.493 . . . . 3.8100000000000001 110.09 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.538 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 22.7 t60 -158.39 115.6 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 4.6100000000000003 109.63 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -120.5 155.53 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.995 -0.548 . . . . 3.1000000000000001 110.492 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -115.68 164.6 14.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 2.4900000000000002 111.587 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.491 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt -157.45 118.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.668 -0.696 . . . . 1.6799999999999999 109.658 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 0.80000000000000004 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.416 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.3900000000000001 108.383 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.3999999999999999 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.339 -0.304 . . . . 1.5 112.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.56 -64.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.129 -0.557 . . . . 1.3 111.813 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -93.51 98.86 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 1.54 110.257 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt -138.66 -46.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.044 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.4299999999999999 111.818 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.23 113.0 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.1899999999999999 109.422 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.26 110.408 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 17' ' ' TYR . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.6399999999999999 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 -67.42 143.46 56.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.5600000000000001 111.533 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -128.57 80.44 1.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.04 -0.527 . . . . 1.9299999999999999 109.688 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.17 -78.92 1.52 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.48 -0.648 . . . . 1.6399999999999999 111.48 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -139.87 -4.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.218 . . . . 4.0 111.104 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 9.2 mtpm? -129.63 170.54 13.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.506 0.193 . . . . 3.0600000000000001 110.986 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 10' ' ' ILE . 85.4 m-85 -107.4 -7.7 16.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.92000000000000004 111.277 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.80000000000000004 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 0.92000000000000004 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 76' ' ' VAL . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.67000000000000004 108.281 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.6599999999999999 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.0700000000000001 109.364 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt -109.19 128.06 65.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.4199999999999999 110.952 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -91.76 89.16 6.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.255 0.55 . . . . 4.04 110.441 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -83.72 115.98 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.234 -0.439 . . . . 1.72 110.012 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 74.2 m-85 -74.92 136.55 41.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.568 0.699 . . . . 2.1000000000000001 111.011 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 33.1 mmt -87.27 143.23 27.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.761 -1.109 . . . . 2.0499999999999998 110.875 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.25 68.72 2.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.943 -0.646 . . . . 2.77 111.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 2.6200000000000001 110.07 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.2 m -135.46 -137.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.774 -0.648 . . . . 2.6099999999999999 109.783 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -101.47 1.15 37.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.056 0.932 . . . . 2.8999999999999999 109.229 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.36 144.64 14.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 113.787 -1.551 . . . . 1.75 111.679 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -122.5 165.81 15.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 1.53 109.678 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -131.24 98.89 4.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.851 -1.068 . . . . 1.6499999999999999 108.785 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p -75.51 110.64 10.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.615 -0.72 . . . . 1.22 110.989 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.3400000000000001 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.81999999999999995 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.3300000000000001 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.642 HG11 HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.1000000000000001 107.133 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.8200000000000001 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.46 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.3700000000000001 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.9399999999999999 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.5600000000000001 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.3700000000000001 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.21 111.642 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.1899999999999999 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.46 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.8400000000000001 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.3600000000000001 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.3899999999999999 114.028 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.642 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.6799999999999999 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.78 111.268 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.3899999999999999 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.4299999999999999 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.1899999999999999 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.80000000000000004 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 0.85999999999999999 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 0.94999999999999996 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.748 ' HB ' HD23 ' A' ' 79' ' ' LEU . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 0.58999999999999997 108.43 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.90000000000000002 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.90000000000000002 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.3600000000000001 110.719 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 0.90000000000000002 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.59999999999999998 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.3899999999999999 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.97999999999999998 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 0.82999999999999996 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 0.81999999999999995 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' O ' HG22 ' A' ' 76' ' ' VAL . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.59999999999999998 111.284 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 0.56999999999999995 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 21' ' ' LEU . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.28999999999999998 109.325 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.3200000000000001 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.748 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 0.57999999999999996 110.059 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.29 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.5 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.5800000000000001 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 0.94999999999999996 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 0.95999999999999996 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 0.85999999999999999 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 0.81999999999999995 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.0900000000000001 112.096 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.24 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.52 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.53 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.06 111.68 19.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.9199999999999999 109.786 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.418 -0.801 . . . . 2.1600000000000001 109.737 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 N--CA 1.477 0.555 0 N-CA-C 110.44 -0.639 . . . . 6.0300000000000002 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.75 118.48 31.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.168 -0.469 . . . . 3.4100000000000001 110.2 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.405 ' HA ' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -156.86 132.79 9.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 5.1600000000000001 110.955 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.37 29.99 5.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.388 -0.823 . . . . 5.2199999999999998 113.1 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -106.95 -35.46 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.861 0.363 . . . . 4.2300000000000004 110.504 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -131.32 127.43 37.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.043 -0.526 . . . . 3.8100000000000001 109.958 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -126.41 44.63 2.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 4.6100000000000003 110.617 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -82.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 3.1000000000000001 111.782 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.8 mm-40 -116.28 146.33 42.47 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.801 -0.36 . . . . 2.4900000000000002 111.33 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt -152.87 122.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.6799999999999999 110.655 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 0.80000000000000004 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.3900000000000001 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.566 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.3999999999999999 110.469 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.994 -0.443 . . . . 1.5 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.17 -78.53 0.91 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.891 -0.671 . . . . 1.3 112.589 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 111.02 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.953 0.406 . . . . 1.54 111.143 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt -140.47 -43.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.561 . . . . 1.95 110.231 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.48 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.4299999999999999 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.23 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.1899999999999999 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.26 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 17' ' ' TYR . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.04 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.6399999999999999 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 -69.22 168.58 13.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.5600000000000001 110.792 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -159.39 -134.33 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.392 -0.367 . . . . 1.9299999999999999 111.071 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.88 -106.07 0.64 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.846 -0.692 . . . . 1.6399999999999999 112.425 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -17.4 36.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.651 0.263 . . . . 4.0 111.02 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 11.9 ptmt -144.75 158.11 43.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.917 0.389 . . . . 3.0600000000000001 111.028 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' HB3' HG21 ' A' ' 10' ' ' ILE . 87.6 m-85 -75.83 4.53 7.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.674 -0.694 . . . . 0.92000000000000004 109.21 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 16' ' ' LYS . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.80000000000000004 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 0.92000000000000004 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.67000000000000004 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.6599999999999999 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.0700000000000001 110.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 37' ' ' HIS . 10.7 pt -82.24 131.51 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.4199999999999999 109.841 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 9.2 ttm180 -91.6 114.84 27.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 4.04 111.798 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -106.82 151.11 8.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 107.181 -1.414 . . . . 1.72 107.181 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.6 146.93 38.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.995 -0.682 . . . . 2.1000000000000001 111.627 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.0 mmt -82.46 109.52 16.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.826 -1.079 . . . . 2.0499999999999998 108.804 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.28 54.89 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.233 -0.508 . . . . 2.77 113.449 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -12.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.493 0.187 . . . . 2.6200000000000001 111.474 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' ASP . 2.1 p -155.31 -151.1 0.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.253 -0.179 . . . . 2.6099999999999999 111.276 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 31' ' ' SER . 6.7 t70 -115.75 -0.14 13.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.514 0.673 . . . . 2.8999999999999999 110.414 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -75.42 150.41 6.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.15 -0.932 . . . . 1.75 110.914 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -101.91 166.14 10.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.036 0.922 . . . . 1.53 111.065 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 101.52 4.5 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.812 -1.54 . . . . 1.6499999999999999 108.337 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.43 124.37 38.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.191 0.52 . . . . 1.22 111.253 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 24' ' ' ILE . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.3400000000000001 109.359 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.81999999999999995 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.3300000000000001 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.1000000000000001 106.989 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.486 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.8200000000000001 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.46 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.3700000000000001 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.9399999999999999 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.5600000000000001 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.3700000000000001 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.21 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.1899999999999999 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.46 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.8400000000000001 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.3600000000000001 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.3899999999999999 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.6799999999999999 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.78 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.3899999999999999 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.4299999999999999 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.1899999999999999 109.226 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 0.80000000000000004 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 0.85999999999999999 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.94999999999999996 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 80' ' ' ILE . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.58999999999999997 108.721 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.90000000000000002 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.90000000000000002 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.3600000000000001 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 0.90000000000000002 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.59999999999999998 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.3899999999999999 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.97999999999999998 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 0.82999999999999996 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' H ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 0.81999999999999995 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.59999999999999998 111.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 0.56999999999999995 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.37 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.3200000000000001 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 0.57999999999999996 110.028 177.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.527 HG22 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 0.63 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 0.78000000000000003 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 64' ' ' ASN . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.0800000000000001 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.29 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.5 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.5800000000000001 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 80' ' ' ILE . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 0.94999999999999996 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 0.95999999999999996 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 0.85999999999999999 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 0.81999999999999995 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.0900000000000001 111.593 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.24 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.52 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.53 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.45 121.62 43.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.9199999999999999 109.338 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.375 -0.829 . . . . 2.1600000000000001 109.827 -178.757 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.477 0.542 0 N-CA-C 110.208 -0.728 . . . . 6.0300000000000002 110.208 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -99.05 153.13 19.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.575 0.226 . . . . 3.4100000000000001 110.56 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.4 -146.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.492 -0.776 . . . . 5.1600000000000001 111.58 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.22 45.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 5.2199999999999998 111.133 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 12.0 t70 -67.97 137.53 55.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 4.2300000000000004 111.55 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -137.72 11.75 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.462 -0.79 . . . . 3.8100000000000001 109.768 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -173.24 81.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.533 -0.758 . . . . 4.6100000000000003 109.659 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.42 ' HB ' ' NH2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -84.66 106.68 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.078 -0.51 . . . . 3.1000000000000001 110.555 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.4 mm100 -72.77 154.93 40.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.543 -0.299 . . . . 2.4900000000000002 110.261 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -153.02 132.16 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 1.6799999999999999 111.023 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.80000000000000004 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.3900000000000001 108.08 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.589 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.3999999999999999 110.292 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.002 -0.439 . . . . 1.5 112.002 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.58 -81.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 1.3 111.89 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.69 110.69 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.003 -0.369 . . . . 1.54 110.003 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -153.55 -38.53 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.268 -0.424 . . . . 1.95 111.019 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.48 110.771 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.4299999999999999 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.23 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.1899999999999999 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.26 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.6399999999999999 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 -75.27 143.24 43.11 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.5600000000000001 109.915 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -120.97 -132.45 0.3 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.643 -0.253 . . . . 1.9299999999999999 110.699 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.82 -67.79 0.89 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.738 -0.744 . . . . 1.6399999999999999 112.771 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -49.48 5.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.639 0.257 . . . . 4.0 111.172 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 6.5 ptpt -128.5 168.09 16.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 3.0600000000000001 110.54 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.527 ' H ' HG23 ' B' ' 109' ' ' VAL . 80.8 m-85 -74.49 3.3 7.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.549 0.69 . . . . 0.92000000000000004 109.474 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.80000000000000004 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 0.92000000000000004 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.67000000000000004 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.6599999999999999 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.0700000000000001 109.48 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.39 144.14 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.4199999999999999 110.45 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -107.0 93.04 4.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 4.04 110.509 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.32 116.22 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 1.72 109.417 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 43.4 m-85 -77.49 140.86 39.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.334 0.588 . . . . 2.1000000000000001 111.495 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HB2' HG13 ' A' ' 33' ' ' VAL . 14.7 mmt -74.27 123.71 25.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.82 -1.082 . . . . 2.0499999999999998 109.494 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.86 73.57 0.65 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.131 -0.557 . . . . 2.77 112.938 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.65 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 2.6200000000000001 110.268 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HB2' HG12 ' A' ' 33' ' ' VAL . 13.8 m -123.07 -150.72 0.46 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 2.6099999999999999 111.02 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -99.39 -17.08 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.78 0.8 . . . . 2.8999999999999999 110.105 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 28' ' ' MET . 7.5 p -54.37 147.39 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.548 -1.205 . . . . 1.75 112.144 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 45.2 p90 -116.84 164.1 15.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.727 -1.124 . . . . 1.53 110.252 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.51 103.45 7.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.596 -1.184 . . . . 1.6499999999999999 109.615 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.88 106.45 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.401 0.619 . . . . 1.22 109.984 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.3400000000000001 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.81999999999999995 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.3300000000000001 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.1000000000000001 106.944 176.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.8200000000000001 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.46 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG23 ' HG2' ' A' ' 56' ' ' GLN . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.3700000000000001 109.621 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.9399999999999999 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.5600000000000001 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.3700000000000001 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.21 111.351 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.1899999999999999 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.46 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.8400000000000001 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.3600000000000001 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.3899999999999999 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.6799999999999999 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.78 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.3899999999999999 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.4299999999999999 109.724 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.1899999999999999 109.552 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 0.80000000000000004 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 0.94999999999999996 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 80' ' ' ILE . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 0.58999999999999997 108.755 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.504 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.3600000000000001 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 0.90000000000000002 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.529 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.3899999999999999 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.97999999999999998 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.82999999999999996 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.677 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 0.81999999999999995 108.328 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.59999999999999998 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 0.56999999999999995 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.677 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.37 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.28999999999999998 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.3200000000000001 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 0.57999999999999996 109.848 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.512 HG13 HG11 ' A' ' 63' ' ' VAL . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 0.63 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 0.78000000000000003 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.0 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.0800000000000001 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.29 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.5 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.5800000000000001 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 0.94999999999999996 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 0.95999999999999996 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 0.85999999999999999 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 0.81999999999999995 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.0900000000000001 112.03 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.52 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.53 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -107.4 119.21 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.9199999999999999 109.556 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 115.441 -0.799 . . . . 2.1600000000000001 110.181 -179.106 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 N--CA 1.48 0.711 0 N-CA-C 110.367 -0.666 . . . . 6.0300000000000002 110.367 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -120.52 172.08 8.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.524 -0.307 . . . . 3.4100000000000001 110.319 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -93.01 -78.42 0.42 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.672 0.273 . . . . 5.1600000000000001 110.455 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.32 159.15 40.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.884 0.373 . . . . 5.2199999999999998 110.696 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.83 125.09 41.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.834 -0.621 . . . . 4.2300000000000004 110.447 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.75 169.72 10.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.553 -0.536 . . . . 3.8100000000000001 109.553 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -93.4 107.55 19.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 4.6100000000000003 110.282 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -135.09 -81.35 0.43 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.743 -0.662 . . . . 3.1000000000000001 109.842 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.689 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 6.3 mp0 -136.8 153.1 50.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.147 0.499 . . . . 2.4900000000000002 111.294 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -156.06 123.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.404 -0.816 . . . . 1.6799999999999999 108.849 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 0.80000000000000004 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.3900000000000001 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.3999999999999999 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.011 -0.436 . . . . 1.5 112.011 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.54 -85.3 1.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.778 -0.725 . . . . 1.3 112.02 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -72.35 102.95 3.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.075 -0.343 . . . . 1.54 110.075 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt -129.29 -53.05 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.487 -0.324 . . . . 1.95 110.791 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.48 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.4299999999999999 111.502 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.23 113.202 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.1899999999999999 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.26 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.6399999999999999 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 -71.29 151.32 44.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.5600000000000001 110.455 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -122.54 -43.25 2.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.122 -0.49 . . . . 1.9299999999999999 110.325 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.99 -72.52 0.27 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.945 -0.645 . . . . 1.6399999999999999 111.572 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -85.74 -39.11 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.863 0.363 . . . . 4.0 110.345 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 47.9 mtpt -142.67 164.28 30.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 3.0600000000000001 110.161 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' B' ' 109' ' ' VAL . 71.0 m-85 -84.51 -2.54 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.721 -1.215 . . . . 0.92000000000000004 107.721 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.80000000000000004 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 0.92000000000000004 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.67000000000000004 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.6599999999999999 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.0700000000000001 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' B' ' 99' ' ' ASP . 13.7 pt -86.51 127.69 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.4199999999999999 110.524 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -102.35 109.37 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.628 -0.715 . . . . 4.04 110.998 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 t -109.09 166.5 4.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.367 -1.345 . . . . 1.72 107.367 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.15 145.13 47.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.645 0.657 . . . . 2.1000000000000001 111.14 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mmm -78.47 114.87 17.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.148 -0.933 . . . . 2.0499999999999998 110.239 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.29 73.06 0.74 Allowed Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.127 -0.488 . . . . 2.77 112.966 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.89 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.553 -0.536 . . . . 2.6200000000000001 109.553 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.589 ' HB2' HG12 ' A' ' 33' ' ' VAL . 49.2 m -132.88 -167.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.752 -0.658 . . . . 2.6099999999999999 109.765 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -95.57 -11.86 26.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 2.8999999999999999 110.27 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 31' ' ' SER . 8.9 p -60.82 149.52 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.532 -1.213 . . . . 1.75 111.893 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -106.55 166.23 10.71 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.943 -1.026 . . . . 1.53 111.122 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.75 100.22 5.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.39 -1.277 . . . . 1.6499999999999999 109.015 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p -89.77 119.85 37.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.183 0.516 . . . . 1.22 110.329 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.3400000000000001 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.81999999999999995 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.3300000000000001 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.1000000000000001 106.715 176.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.8200000000000001 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.46 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.3700000000000001 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.9399999999999999 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.5600000000000001 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.3700000000000001 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.21 112.043 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.1899999999999999 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.46 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.8400000000000001 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.3600000000000001 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.3899999999999999 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.6799999999999999 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.78 110.865 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.3899999999999999 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.4299999999999999 109.351 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.1899999999999999 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 0.80000000000000004 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 0.85999999999999999 111.778 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 0.94999999999999996 110.46 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.701 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 0.58999999999999997 108.941 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.90000000000000002 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.90000000000000002 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 79' ' ' LEU . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.3600000000000001 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 0.90000000000000002 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.59999999999999998 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.3899999999999999 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.97999999999999998 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 0.82999999999999996 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 0.81999999999999995 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 76' ' ' VAL . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.59999999999999998 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.601 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 0.56999999999999995 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.653 ' CG ' HG22 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.37 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' ILE . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.28999999999999998 109.538 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.3200000000000001 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 0.57999999999999996 110.256 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 0.63 110.905 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 0.78000000000000003 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.0 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.0800000000000001 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.29 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.5 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.5800000000000001 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 0.94999999999999996 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 0.95999999999999996 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 0.85999999999999999 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 0.81999999999999995 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.0900000000000001 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.24 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.52 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.53 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.33 122.9 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.9199999999999999 109.181 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.654 . . . . 2.1600000000000001 110.044 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 N-CA-C 110.659 -0.554 . . . . 6.0300000000000002 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 54.1 p90 44.01 32.4 0.63 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.292 1.037 . . . . 3.4100000000000001 112.383 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.501 ' HB2' HG22 ' A' ' 24' ' ' ILE . 14.2 p-10 -128.96 -42.89 1.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.927 -0.578 . . . . 5.1600000000000001 110.605 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -85.77 63.77 8.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.206 -0.452 . . . . 5.2199999999999998 110.557 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ASP . . . . . 0.417 ' OD1' ' HG2' ' B' ' 102' ' ' GLN . 10.9 t70 -74.03 -75.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.759 -0.46 . . . . 4.2300000000000004 109.759 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.417 ' HG2' ' OD1' ' B' ' 101' ' ' ASP . 73.6 mm-40 -118.25 -48.01 2.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 3.8100000000000001 110.551 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -144.6 145.22 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 4.6100000000000003 109.896 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.29 143.21 27.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.573 -0.529 . . . . 3.1000000000000001 109.573 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -117.77 144.67 45.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.833 -0.347 . . . . 2.4900000000000002 110.567 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.438 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt -135.65 128.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 1.6799999999999999 111.171 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 0.80000000000000004 110.872 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.3900000000000001 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.495 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.3999999999999999 110.349 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.917 0.389 . . . . 1.95 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.48 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.43 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.23 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.19 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.26 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.04 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.64 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.56 111.255 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' A' ' 10' ' ' ILE . 98.4 m-85 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.107 0.48 . . . . 0.92 110.627 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.8 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 0.92 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.67 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.635 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.66 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.07 109.613 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.2 pt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.42 110.662 -179.631 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 1.22 111.096 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.34 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.82 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.33 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.1 107.28 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.82 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.46 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.94 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.56 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.37 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.21 111.265 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.19 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.46 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.84 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.36 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.39 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.68 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.78 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.39 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.43 109.183 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.19 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.8 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 0.86 111.864 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.95 111.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD23 ' A' ' 79' ' ' LEU . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 0.59 108.663 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.9 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.9 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.36 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 0.9 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.6 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.39 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.98 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 0.83 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 0.82 108.281 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.439 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.6 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 0.57 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.37 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.29 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.32 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.649 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 0.58 110.383 178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 63' ' ' VAL . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.63 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 0.78 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.08 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.29 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.5 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.58 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 0.95 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 0.96 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 0.86 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.82 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.09 111.65 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.24 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.52 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.53 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.92 109.978 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.635 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.1 0.476 . . . . 1.68 110.765 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.439 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.8 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.39 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 17' ' ' TYR . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.4 110.974 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.594 0.235 . . . . 1.95 111.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.43 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.23 112.742 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.19 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.26 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.64 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.56 111.608 -179.616 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' HG21 ' A' ' 10' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.92 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.8 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 0.92 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 76' ' ' VAL . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.67 108.187 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.66 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.07 109.166 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.42 111.079 -179.13 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.284 0.564 . . . . 1.22 110.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.34 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.82 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.33 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.1 106.81 176.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.82 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.46 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 56' ' ' GLN . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.37 109.259 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.94 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.56 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.37 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.21 111.534 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.19 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.46 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.84 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.36 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.39 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.68 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.39 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.43 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.19 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 0.8 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 0.86 111.613 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 0.95 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 79' ' ' LEU . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 0.59 108.164 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.577 HD21 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.9 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.9 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' HD21 ' A' ' 79' ' ' LEU . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.36 110.913 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 0.9 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.6 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.39 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.98 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 0.83 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.679 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 0.82 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.408 ' ND1' ' HB2' ' A' ' 23' ' ' ALA . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.6 111.14 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 0.57 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.679 ' H ' HG23 ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.37 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.29 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.32 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 0.58 110.436 178.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 63' ' ' VAL . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 0.63 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 0.78 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.0 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.577 ' HB3' HD21 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.08 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.29 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.5 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.58 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 0.95 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 0.96 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 0.86 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 62' ' ' HIS . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 0.82 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.09 111.919 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.24 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.52 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.53 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.92 109.159 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.66 0.267 . . . . 1.68 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 0.8 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.39 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.4 110.571 -177.701 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.996 0.426 . . . . 1.95 110.416 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.48 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.43 112.11 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.23 112.594 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.19 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.26 110.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 17' ' ' TYR . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.04 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.64 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.56 110.917 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 10' ' ' ILE . 83.3 m-85 . . . . . 0 CA--C 1.516 -0.328 0 CA-C-O 121.401 0.619 . . . . 0.92 109.476 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.8 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 0.92 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.67 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.66 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.07 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.42 111.224 -178.846 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.363 0.601 . . . . 1.22 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.34 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.82 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.33 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.1 107.117 176.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.82 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.429 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.46 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.37 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.94 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.56 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.701 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.37 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.21 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.19 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.46 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.84 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.36 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.39 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.68 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.78 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.39 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.43 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.19 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 0.8 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.86 111.806 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 0.95 111.089 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' HD23 ' A' ' 79' ' ' LEU . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 0.59 108.63 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.9 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.9 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.716 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.36 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 0.9 110.885 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.6 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.39 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.98 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 0.83 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.788 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 0.82 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HG22 ' A' ' 76' ' ' VAL . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.6 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 0.57 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.788 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.37 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.474 ' HA ' HD12 ' A' ' 80' ' ' ILE . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.29 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.32 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 0.58 110.123 178.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 0.78 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.0 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.08 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.29 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.406 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.5 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.58 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 0.95 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 0.96 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 0.86 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 0.82 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.09 111.8 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.24 107.973 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.52 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.53 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.92 109.73 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.4 tt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.915 0.388 . . . . 1.68 110.875 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 0.8 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.39 108.743 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.418 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.4 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 1.95 110.588 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.48 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.43 111.897 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.23 112.707 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.19 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.26 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.04 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.64 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.56 111.151 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 80' ' ' ILE . 98.6 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.467 0.651 . . . . 0.92 109.7 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.8 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.466 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 0.92 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.66 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.07 109.452 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.42 110.382 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.0 0.429 . . . . 1.22 110.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.34 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.82 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.33 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.1 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.82 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.46 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 56' ' ' GLN . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.37 109.389 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.94 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.56 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.37 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.21 111.335 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.19 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.46 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.84 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.36 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.39 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.68 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.78 110.672 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.39 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.43 109.63 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.19 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 0.8 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 0.86 111.985 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 0.95 110.797 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.59 109.357 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.512 HD21 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.9 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.9 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.36 111.154 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 0.9 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.6 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.39 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.98 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.525 HD12 HG12 ' A' ' 76' ' ' VAL . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 0.83 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 0.82 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.6 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 0.57 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.73 ' H ' HG23 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 71' ' ' LEU . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.37 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.29 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.32 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 0.58 110.068 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 0.63 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.78 112.568 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.08 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.29 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.5 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.58 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 0.95 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 0.96 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 0.86 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 0.82 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.09 112.252 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.24 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.52 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.53 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.92 109.286 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.545 -0.168 . . . . 1.68 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 0.8 111.596 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.39 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 17' ' ' TYR . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.4 111.096 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.961 0.41 . . . . 1.95 110.613 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.43 111.353 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.23 113.512 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.19 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.26 110.44 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' HB3' ' A' ' 17' ' ' TYR . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.04 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.64 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.56 110.632 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CE2' HG22 ' A' ' 80' ' ' ILE . 91.7 m-85 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92 110.932 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.8 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 0.92 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.67 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.66 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.07 109.742 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.42 111.387 -178.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.502 0.668 . . . . 1.22 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.34 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.82 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.33 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.1 107.563 176.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.82 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.46 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.37 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.94 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.56 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.37 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.21 111.7 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.19 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.46 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.84 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.36 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.39 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.68 109.963 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.78 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.39 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.43 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.19 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 0.8 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 0.86 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.95 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 79' ' ' LEU . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 0.59 108.549 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 87' ' ' VAL . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.9 109.875 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.9 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.36 111.13 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 0.9 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.6 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.39 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 0.83 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 0.82 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.6 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 0.57 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.709 ' H ' HG23 ' A' ' 72' ' ' VAL . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.37 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.29 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.32 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 0.58 110.123 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 0.63 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 0.78 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.629 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.08 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.29 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.5 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.58 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 0.95 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 0.96 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 0.86 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 0.82 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.09 111.613 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.24 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.52 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.53 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.92 110.219 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.443 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.663 0.268 . . . . 1.68 111.117 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 0.8 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.39 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.4 110.863 -177.604 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.856 0.36 . . . . 1.95 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.48 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.43 111.811 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.23 112.582 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 10' ' ' ILE . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.19 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.26 110.068 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' HB3' ' A' ' 17' ' ' TYR . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.04 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.64 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 . . . . . 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.56 110.917 179.39 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HB3' HG21 ' A' ' 10' ' ' ILE . 72.9 m-85 . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 108.387 -0.968 . . . . 0.92 108.387 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.8 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 0.92 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.67 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.66 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.07 109.761 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.489 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.703 -0.48 . . . . 1.22 109.703 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.34 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.82 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.33 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.1 106.955 176.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.82 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.46 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.37 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.94 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.56 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.37 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.432 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.21 111.769 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.19 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.46 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.84 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.36 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.39 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.567 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.68 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.78 111.407 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.39 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.43 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 59' ' ' LEU . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.19 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 0.8 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 0.86 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 0.95 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 79' ' ' LEU . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 0.59 108.749 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.576 HD21 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.9 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.9 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 79' ' ' LEU . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.36 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 0.9 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.6 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.39 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.98 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 0.83 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 0.82 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.6 111.867 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 0.57 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' HG22 ' A' ' 72' ' ' VAL . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.37 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.29 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 0.58 110.137 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 63' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.63 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.78 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.0 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.576 ' HB3' HD21 ' A' ' 64' ' ' ASN . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.08 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.29 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.5 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.58 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 0.95 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 0.96 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 0.86 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 0.82 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.09 111.338 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.24 107.895 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.52 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.53 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.92 109.563 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.491 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 109.658 -0.497 . . . . 1.68 109.658 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 0.8 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.39 108.383 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.4 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.787 0.327 . . . . 1.95 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.43 111.818 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.23 113.0 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.19 109.422 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.26 110.408 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 17' ' ' TYR . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.64 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.56 111.533 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 10' ' ' ILE . 85.4 m-85 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.99 0.424 . . . . 0.92 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.8 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 0.92 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 76' ' ' VAL . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.67 108.281 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.66 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.07 109.364 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.42 110.952 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.491 0.662 . . . . 1.22 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.34 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.82 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.33 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.642 HG11 HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.1 107.133 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.82 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.46 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.37 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.94 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.56 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.37 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.21 111.642 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.19 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.46 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.84 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.36 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.39 114.028 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.642 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.68 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.78 111.268 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.39 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.43 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.19 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.8 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 0.86 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 0.95 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.748 ' HB ' HD23 ' A' ' 79' ' ' LEU . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 0.59 108.43 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.9 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.9 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.36 110.719 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 0.9 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.39 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.98 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 0.83 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 0.82 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' O ' HG22 ' A' ' 76' ' ' VAL . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.6 111.284 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 0.57 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 21' ' ' LEU . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.29 109.325 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.32 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.748 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 0.58 110.059 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 0.78 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.08 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.29 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.5 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.58 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 0.95 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 0.96 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 0.86 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 0.82 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.09 112.096 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.24 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.52 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.53 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.92 109.786 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.705 0.288 . . . . 1.68 110.655 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 0.8 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.39 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.4 110.469 -177.742 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 121.111 0.482 . . . . 1.95 110.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.48 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.43 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.23 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.19 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.26 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 17' ' ' TYR . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.04 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.64 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.56 110.792 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' HB3' HG21 ' A' ' 10' ' ' ILE . 87.6 m-85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.21 -0.663 . . . . 0.92 109.21 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.8 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 0.92 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.67 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.66 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.07 110.601 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 37' ' ' HIS . 10.7 pt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.42 109.841 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.191 0.52 . . . . 1.22 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 24' ' ' ILE . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.34 109.359 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.82 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.33 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.1 106.989 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.486 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.82 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.46 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.37 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.94 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.56 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.37 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.21 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.19 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.46 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.84 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.36 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.39 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.68 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.78 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.39 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.43 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.19 109.226 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 0.8 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 0.86 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.95 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 80' ' ' ILE . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.59 108.721 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.9 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.9 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.36 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 0.9 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.6 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.39 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.98 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 0.83 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' H ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 0.82 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.6 111.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 0.57 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.37 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.29 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.32 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 0.58 110.028 177.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.527 HG22 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 0.63 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 0.78 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 64' ' ' ASN . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.08 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.29 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.5 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.58 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 80' ' ' ILE . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 0.95 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 0.96 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 0.86 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 0.82 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.09 111.593 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.24 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.52 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.53 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.92 109.338 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.886 0.374 . . . . 1.68 111.023 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.8 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.39 108.08 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.4 110.292 -178.227 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 1.95 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.48 110.771 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.43 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.23 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.19 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.26 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.64 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.56 109.915 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' HB3' HG21 ' A' ' 10' ' ' ILE . 80.8 m-85 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.549 0.69 . . . . 0.92 109.474 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.8 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 0.92 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.67 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.66 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.07 109.48 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.42 110.45 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 121.401 0.619 . . . . 1.22 109.984 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.34 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.82 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.33 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.1 106.944 176.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.82 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.46 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.463 HG23 ' HG2' ' A' ' 56' ' ' GLN . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.37 109.621 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.94 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.56 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.37 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.21 111.351 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.19 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.46 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.84 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.36 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.39 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.68 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.78 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.39 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.43 109.724 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.19 109.552 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 0.8 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 0.86 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 0.95 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 80' ' ' ILE . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 0.59 108.755 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.504 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.9 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.9 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.36 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 0.9 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.529 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.6 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.39 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.98 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.83 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.677 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 0.82 108.328 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.6 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 0.57 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.677 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.37 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.29 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.32 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 0.58 109.848 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.512 HG13 HG11 ' A' ' 63' ' ' VAL . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 0.63 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 0.78 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.0 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.08 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.29 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.5 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.58 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 0.95 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 0.96 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 0.86 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 0.82 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.09 112.03 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.52 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.53 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.92 109.556 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--O 1.232 0.147 0 N-CA-C 108.849 -0.797 . . . . 1.68 108.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 0.8 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.39 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.4 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.742 0.306 . . . . 1.95 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.48 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.43 111.502 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.23 113.202 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.19 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.26 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.64 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.56 110.455 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' B' ' 109' ' ' VAL . 71.0 m-85 . . . . . 0 CA--C 1.513 -0.475 0 N-CA-C 107.721 -1.215 . . . . 0.92 107.721 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.8 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 0.92 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.67 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.66 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.07 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 37' ' ' HIS . 13.7 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.42 110.524 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.183 0.516 . . . . 1.22 110.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.34 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.82 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.33 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.1 106.715 176.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.82 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.46 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.94 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.56 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.37 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.21 112.043 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.19 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.46 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.84 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.36 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.39 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.68 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.78 110.865 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.39 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.43 109.351 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.19 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 0.8 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 0.86 111.778 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 0.95 110.46 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.701 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 0.59 108.941 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.9 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.9 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 79' ' ' LEU . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.36 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 0.9 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.6 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.39 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.98 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 0.83 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 0.82 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 76' ' ' VAL . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.6 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.601 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 0.57 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.653 ' CG ' HG22 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.37 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' ILE . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.29 109.538 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.32 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 0.58 110.256 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 0.63 110.905 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 0.78 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.0 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.08 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.29 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.5 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.58 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 0.95 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 0.96 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 0.86 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 0.82 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.09 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.24 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.52 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.53 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.92 109.181 179.336 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.438 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.843 0.354 . . . . 1.68 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 0.8 110.872 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.39 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 17' ' ' TYR . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.4 110.349 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.854 -0.499 . . . . 1.5 111.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.48 -56.82 4.11 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.939 -0.648 . . . . 1.3 112.406 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -95.68 103.21 15.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.874 -0.417 . . . . 1.54 109.874 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.9 tpt -142.97 -43.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 1.95 110.644 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -87.82 127.1 59.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 1.48 110.743 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 54.3 Cg_endo -67.13 132.17 27.17 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.865 2.377 . . . . 1.43 112.258 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.8 Cg_exo -72.53 152.64 54.44 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.432 2.088 . . . . 1.23 112.876 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 53' ' ' GLY . 5.5 mm -92.97 93.0 3.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.956 -1.02 . . . . 1.19 109.386 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.12 97.45 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.291 0.567 . . . . 1.26 110.857 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 27.5 mt -94.18 137.69 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 1.04 111.238 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -90.07 149.77 22.36 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.97 -0.559 . . . . 1.64 110.624 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.5 ptt180 -69.21 131.84 45.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.66 -0.7 . . . . 1.56 111.255 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -116.47 66.53 0.71 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.584 -0.524 . . . . 1.93 109.584 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.74 -54.69 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.894 -0.882 . . . . 1.64 110.894 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -159.05 -47.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.32 -0.622 . . . . 4.0 109.32 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 5.1 mmmm -82.34 157.96 23.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.599 -0.728 . . . . 3.06 110.724 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' A' ' 10' ' ' ILE . 98.4 m-85 -103.05 -7.8 21.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.107 0.48 . . . . 0.92 110.627 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.62 16.2 34.81 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.099 -1.048 . . . . 1.03 114.088 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -143.53 164.96 28.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.646 1.212 . . . . 0.8 113.587 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.4 m -107.09 124.52 49.79 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 112.568 -2.105 . . . . 0.92 109.969 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -100.45 133.31 45.07 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.049 -1.093 . . . . 0.67 108.049 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.635 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.1 mtp180 -131.48 128.3 39.11 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.344 0.592 . . . . 1.66 111.065 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 104' ' ' THR . . . -89.98 87.84 7.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.251 -0.886 . . . . 1.07 109.613 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.63 ' HA ' HG23 ' B' ' 104' ' ' THR . 12.2 pt -79.15 159.03 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.514 -0.766 . . . . 1.42 110.662 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.492 ' NE ' ' HB2' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -140.09 132.46 28.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.289 0.566 . . . . 4.04 111.305 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.47 119.12 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.225 -1.028 . . . . 1.72 108.225 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 40.8 m-85 -66.17 139.06 58.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.333 0.587 . . . . 2.1 111.572 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.6 mmt -71.34 134.31 46.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.808 -1.087 . . . . 2.05 110.249 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.41 63.76 3.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.99 -0.624 . . . . 2.77 113.065 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -167.83 -59.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.671 0.272 . . . . 2.62 110.972 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.621 ' HB2' HG12 ' A' ' 33' ' ' VAL . 24.2 m -110.17 -154.83 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.721 0.296 . . . . 2.61 110.807 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.0 -10.78 22.21 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.701 0.762 . . . . 2.9 109.68 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 31' ' ' SER . 6.0 p -63.18 148.95 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.549 -1.205 . . . . 1.75 110.967 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.3 p90 -113.23 172.14 7.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.35 -0.841 . . . . 1.53 110.652 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.53 99.02 5.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.878 -1.056 . . . . 1.65 109.058 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -85.47 130.72 35.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.014 -0.539 . . . . 1.22 111.096 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.7 151.97 47.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 1.34 109.717 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -106.14 105.75 15.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.329 0.585 . . . . 0.82 109.446 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -123.31 138.12 54.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.752 -0.658 . . . . 1.33 111.592 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG11 HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -73.67 120.73 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.28 -1.378 . . . . 1.1 107.28 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 74.7 t-105 -88.59 -24.46 22.84 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.98 0.733 . . . . 1.82 112.98 -176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -159.99 146.23 15.8 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.414 -0.514 . . . . 1.46 111.018 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.06 121.39 55.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.26 132.63 48.27 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.746 0.308 . . . . 1.54 110.446 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.11 116.07 4.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.972 -0.558 . . . . 1.94 110.714 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.89 11.36 81.6 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.873 -0.603 . . . . 1.56 111.853 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.3 169.74 54.86 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.946 -0.645 . . . . 1.37 111.921 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 75.9 Cg_exo -57.19 -47.08 24.23 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 123.37 2.714 . . . . 1.21 111.265 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.94 -38.22 85.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.567 -1.197 . . . . 1.19 110.976 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -64.73 -37.63 88.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.509 0.671 . . . . 1.46 109.256 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 36.3 mt-10 -70.81 -36.36 72.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.833 -1.076 . . . . 1.84 109.99 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.61 65.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 1.36 110.483 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 115.7 1.13 21.42 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.81 -0.709 . . . . 1.39 113.485 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.87 133.83 49.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.331 0.586 . . . . 1.26 110.515 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -120.56 168.36 11.44 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.277 -0.874 . . . . 1.68 109.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -99.71 138.06 37.32 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.463 -0.495 . . . . 1.78 110.012 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.35 8.53 54.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.855 -0.688 . . . . 1.39 112.741 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -84.88 -157.53 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.183 -0.673 . . . . 1.43 109.183 177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.1 mt -141.84 114.11 8.2 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.104 -0.702 . . . . 1.19 109.104 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.65 105.94 13.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.8 108.908 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -89.33 -33.02 17.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.802 -0.635 . . . . 0.86 111.864 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.47 145.12 33.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.262 0.553 . . . . 0.95 111.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD23 ' A' ' 79' ' ' LEU . 80.6 t -121.68 115.95 47.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.195 -0.911 . . . . 0.59 108.663 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.488 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.3 m-20 65.33 18.27 11.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.959 0.409 . . . . 0.9 110.281 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.68 12.8 60.39 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.9 112.269 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 12.7 mm-40 -107.0 132.53 20.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 O-C-N 122.974 -0.133 . . . . 1.36 110.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.0 Cg_exo -67.44 120.06 7.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.413 2.075 . . . . 0.9 110.377 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -109.1 7.35 9.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.356 -0.383 . . . . 0.6 111.878 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -71.73 88.26 0.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.098 -0.501 . . . . 1.39 110.456 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.96 -28.04 2.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.013 -0.613 . . . . 0.98 112.102 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.656 HD13 ' HB3' ' A' ' 75' ' ' GLU . 72.8 mt -65.56 166.46 10.51 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.877 0.846 . . . . 0.83 112.913 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.5 m -80.74 171.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 113.987 -1.46 . . . . 0.82 108.281 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.439 ' NE2' ' HB ' ' B' ' 107' ' ' THR . 75.1 t60 -60.81 -40.22 91.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.871 0.367 . . . . 0.6 111.035 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 16.1 p -74.32 -29.95 61.84 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.559 0.948 . . . . 0.57 113.559 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.75 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -62.02 -45.1 95.06 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.477 0.581 . . . . 0.88 110.5 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 68' ' ' VAL . 9.3 m -71.95 -36.07 56.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.359 -0.837 . . . . 0.37 109.828 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 6.0 t -59.49 -49.67 82.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.571 -0.529 . . . . 0.29 109.571 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 24.3 mt-10 -61.05 -47.98 83.89 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.808 -0.633 . . . . 1.32 109.875 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.649 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -46.09 -55.95 6.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.584 -1.189 . . . . 0.58 110.383 178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.489 HG13 HG11 ' A' ' 63' ' ' VAL . 21.9 mt -54.03 -53.2 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.63 110.598 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.4 mt -54.15 -41.6 68.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.504 -0.771 . . . . 0.78 112.418 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 29.9 mtmt -64.43 -22.47 66.97 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.013 1.116 . . . . 1.0 114.013 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 64' ' ' ASN . 60.5 p -48.06 -53.43 16.42 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.28 0.474 . . . . 1.08 112.28 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 79.64 120.74 0.35 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.062 -0.59 . . . . 1.29 113.09 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 11.7 t-20 73.73 -54.33 0.68 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.555 0.742 . . . . 1.5 112.076 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 37.6 pttt -146.8 163.09 37.13 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 108.832 -0.803 . . . . 1.58 108.832 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 ' HB ' ' OG ' ' A' ' 83' ' ' SER . 4.4 p -141.36 131.33 25.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.279 -0.873 . . . . 0.95 110.951 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.91 109.84 21.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.339 0.59 . . . . 0.96 109.829 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.07 112.58 40.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.581 -0.736 . . . . 0.86 110.961 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 55.8 m -78.63 106.69 10.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.82 109.828 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -104.33 143.62 32.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.162 0.506 . . . . 1.09 111.65 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -144.57 153.65 55.3 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.465 -0.939 . . . . 1.24 108.465 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.51 150.1 6.19 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.766 2.311 . . . . 1.52 113.949 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 20.8 tp -107.56 81.37 1.51 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.913 -1.04 . . . . 1.53 108.513 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -104.57 125.71 50.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.604 -0.725 . . . . 1.92 109.978 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 115.102 -0.954 . . . . 2.16 109.768 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.476 0.453 0 N-CA-C 111.161 -0.361 . . . . 6.03 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -72.99 -18.15 61.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.96 0.409 . . . . 3.41 110.417 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.13 23.28 3.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.685 -0.688 . . . . 5.16 111.296 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' B' ' 104' ' ' THR . 27.7 mt-10 -72.05 176.28 5.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 5.22 110.382 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -113.14 1.52 15.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.229 0.538 . . . . 4.23 109.956 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -67.89 -79.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 3.81 111.399 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.492 ' HB2' ' NE ' ' A' ' 25' ' ' ARG . 16.7 m80 -93.22 -18.91 21.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.98 0.419 . . . . 4.61 110.344 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' B' ' 100' ' ' GLU . 89.0 m -75.99 103.31 5.99 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.711 -0.477 . . . . 3.1 109.711 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -74.18 161.76 29.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 2.49 111.356 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.635 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -151.61 123.39 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.97 -0.559 . . . . 1.68 110.765 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.439 ' HB ' ' NE2' ' A' ' 73' ' ' HIS . 65.2 m -152.73 127.93 9.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.799 -0.637 . . . . 0.8 110.357 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -77.49 138.33 39.16 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.018 -1.105 . . . . 3.39 108.018 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.529 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.2 p . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.52 -0.752 . . . . 1.4 110.974 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.216 -0.354 . . . . 1.5 112.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.36 -58.22 1.99 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.641 . . . . 1.3 111.777 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 m -85.5 121.28 27.98 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.58 -0.526 . . . . 1.54 109.58 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.6 tpt -157.15 -59.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.523 -0.308 . . . . 1.95 111.191 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -81.12 127.45 74.17 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.358 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.49 122.98 9.11 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.567 2.178 . . . . 1.43 111.509 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.32 152.5 72.04 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.394 2.063 . . . . 1.23 112.742 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 mm -92.07 93.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.002 -0.999 . . . . 1.19 109.101 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.9 95.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.382 0.61 . . . . 1.26 110.709 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' A' ' 49' ' ' ALA . 37.8 mt -92.46 125.25 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.676 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -83.3 150.69 25.98 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.378 -0.828 . . . . 1.64 109.695 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -65.96 156.8 32.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.247 0.546 . . . . 1.56 111.608 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -130.8 -146.03 0.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.572 -0.74 . . . . 1.93 109.934 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 -66.13 2.57 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.515 -0.85 . . . . 1.64 112.538 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -134.82 -8.97 2.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.542 0.201 . . . . 4.0 111.542 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -135.95 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.243 -0.28 . . . . 3.06 110.243 -179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' HG21 ' A' ' 10' ' ' ILE . 96.6 m-85 -98.04 -5.39 34.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.202 0.525 . . . . 0.92 109.942 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.04 10.65 48.46 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.239 -0.982 . . . . 1.03 113.497 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -141.48 168.3 20.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.59 1.186 . . . . 0.8 113.476 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -114.17 121.61 44.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.202 -1.817 . . . . 0.92 110.47 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 76' ' ' VAL . 69.5 tp -94.8 125.29 39.36 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.187 -1.042 . . . . 0.67 108.187 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 3.7 mtp180 -118.62 134.16 55.32 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.436 0.636 . . . . 1.66 111.657 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -99.74 96.97 7.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.771 -1.104 . . . . 1.07 109.166 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.1 pt -91.31 134.1 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.658 -0.701 . . . . 1.42 111.079 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' B' ' 101' ' ' ASP . 3.9 mpt_? -105.97 100.83 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.993 -0.549 . . . . 4.04 110.517 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.8 t -105.89 136.11 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.376 -0.829 . . . . 1.72 108.79 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.08 142.95 53.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.48 0.657 . . . . 2.1 110.985 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HB2' HG13 ' A' ' 33' ' ' VAL . 1.2 mmt -72.59 -21.09 61.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.113 -0.949 . . . . 2.05 110.908 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.76 22.29 64.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 2.77 111.528 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -114.45 -51.25 2.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.913 0.387 . . . . 2.62 110.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 p -152.11 -109.49 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.125 -0.488 . . . . 2.61 110.865 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.72 -16.52 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.726 0.774 . . . . 2.9 109.045 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 28' ' ' MET . 2.9 p -59.07 149.21 6.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.573 -1.194 . . . . 1.75 111.175 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 25' ' ' ARG . 42.0 p90 -118.5 174.25 6.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.505 -0.77 . . . . 1.53 111.234 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 28' ' ' MET . 0.2 OUTLIER -125.67 102.94 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.564 -1.198 . . . . 1.65 109.315 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -83.97 115.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.284 0.564 . . . . 1.22 110.422 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -109.81 144.8 37.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.804 -0.634 . . . . 1.34 110.317 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -103.06 96.76 7.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.73 -1.123 . . . . 0.82 108.442 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.26 137.5 54.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.003 -0.544 . . . . 1.33 111.706 -177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.99 118.26 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.81 -1.552 . . . . 1.1 106.81 176.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 67.1 t-105 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.089 0.774 . . . . 1.82 113.089 -176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 53.8 t-80 -150.89 149.28 29.47 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.392 -0.523 . . . . 1.46 110.935 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.611 HG23 ' HG2' ' A' ' 56' ' ' GLN . 33.6 t -129.65 116.86 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.411 -0.813 . . . . 1.37 109.259 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.62 131.97 50.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.19 -0.459 . . . . 1.54 111.141 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.43 119.3 8.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 1.94 110.761 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.39 9.67 84.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.69 -0.767 . . . . 1.56 112.356 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.76 168.79 52.78 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.037 -0.601 . . . . 1.37 111.665 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 74.8 Cg_exo -57.07 -46.89 25.72 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 123.293 2.662 . . . . 1.21 111.534 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.73 -38.33 84.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.531 -1.213 . . . . 1.19 110.836 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -37.33 87.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.46 0.648 . . . . 1.46 109.323 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 38.3 mt-10 -71.12 -37.18 72.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.954 -1.021 . . . . 1.84 110.249 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.88 63.2 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.931 -1.031 . . . . 1.36 110.848 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.09 7.94 28.16 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.543 -0.837 . . . . 1.39 114.108 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -64.92 134.68 54.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.465 0.633 . . . . 1.26 110.134 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -120.33 137.9 54.01 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.706 -0.679 . . . . 1.68 110.595 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.21 140.2 40.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.844 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.74 3.27 60.97 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.782 -0.645 . . . . 1.39 112.966 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.78 -155.9 0.19 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.587 -0.523 . . . . 1.43 109.587 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.8 mt -139.97 114.78 9.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.223 -0.658 . . . . 1.19 109.223 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.7 mt -80.51 112.6 18.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.107 -0.701 . . . . 0.8 109.107 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 t -93.07 -33.73 13.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.103 -0.499 . . . . 0.86 111.613 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.404 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 30.7 m80 -142.9 146.97 34.55 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.064 0.459 . . . . 0.95 110.628 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 79' ' ' LEU . 69.2 t -124.0 111.61 29.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.164 -1.05 . . . . 0.59 108.164 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.577 HD21 ' HB3' ' A' ' 83' ' ' SER . 87.9 m-20 66.13 24.34 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.21 0.529 . . . . 0.9 109.575 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.17 9.19 80.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.316 -0.856 . . . . 0.9 112.621 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' HD21 ' A' ' 79' ' ' LEU . 4.6 mm-40 -99.47 132.36 23.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.708 -0.29 . . . . 1.36 110.913 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.15 109.94 1.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.662 2.241 . . . . 0.9 111.385 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 18.3 m -89.08 -5.74 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.6 111.044 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.99 92.81 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 1.39 110.588 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.29 -22.3 3.23 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.511 -0.852 . . . . 0.98 112.915 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 75' ' ' GLU . 3.7 mt -84.49 179.26 7.45 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.834 0.826 . . . . 0.83 111.538 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.679 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.6 m -92.25 -177.3 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.061 -1.427 . . . . 0.82 109.721 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.408 ' ND1' ' HB2' ' A' ' 23' ' ' ALA . 68.9 t60 -65.96 -42.65 89.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.172 -0.467 . . . . 0.6 111.14 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 10.8 p -71.75 -31.5 66.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.654 0.612 . . . . 0.57 112.654 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.679 ' H ' HG23 ' A' ' 72' ' ' VAL . 20.4 mm-40 -59.46 -44.69 92.93 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.209 0.528 . . . . 0.88 110.424 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 20.3 m -74.0 -36.28 44.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.398 -0.819 . . . . 0.37 110.335 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -58.16 -49.39 81.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.61 -0.515 . . . . 0.29 109.61 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 39.9 mt-10 -62.93 -48.99 76.54 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.489 -0.778 . . . . 1.32 109.632 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -43.81 -54.91 4.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.353 -1.294 . . . . 0.58 110.436 178.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 63' ' ' VAL . 20.7 mt -55.27 -54.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.266 -0.425 . . . . 0.63 110.858 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.3 mt -54.48 -42.24 70.47 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.873 -0.603 . . . . 0.78 112.425 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 54.1 mtmt -64.56 -13.4 52.69 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.257 1.206 . . . . 1.0 114.257 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.577 ' HB3' HD21 ' A' ' 64' ' ' ASN . 89.1 p -51.62 -55.85 16.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.803 0.335 . . . . 1.08 111.645 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 82.79 114.76 0.51 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.998 -0.62 . . . . 1.29 112.25 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.1 t-20 74.12 -48.63 0.66 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.499 0.72 . . . . 1.5 111.973 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' SER . 14.7 pttt -155.17 155.87 34.7 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.203 0.525 . . . . 1.58 109.976 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.9 p -134.75 131.69 53.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.05 -0.977 . . . . 0.95 111.173 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.91 108.74 20.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.254 0.55 . . . . 0.96 109.567 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.06 107.75 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.685 -0.689 . . . . 0.86 111.328 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 62' ' ' HIS . 1.4 m -76.41 111.76 12.21 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.034 0.445 . . . . 0.82 109.98 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.5 p -102.26 167.77 9.77 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.783 -0.644 . . . . 1.09 111.919 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -169.27 151.27 4.54 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.143 -1.058 . . . . 1.24 108.143 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.2 149.4 16.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.603 2.202 . . . . 1.52 114.104 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 19.6 tp -103.76 78.31 1.55 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.479 -0.934 . . . . 1.53 108.479 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.36 125.55 46.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.237 -0.892 . . . . 1.92 109.159 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 C--N 1.31 -1.117 0 CA-C-N 115.573 -0.74 . . . . 2.16 110.451 -178.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.475 0.42 0 N-CA-C 110.469 -0.627 . . . . 6.03 110.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.59 150.67 34.66 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.688 -0.856 . . . . 3.41 108.688 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -90.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.8 0.296 . . . . 5.16 111.8 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -153.79 124.66 7.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.682 0.277 . . . . 5.22 111.557 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ARG . 27.8 t0 -73.15 105.46 4.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.769 -0.826 . . . . 4.23 108.769 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -70.1 -89.5 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 3.81 112.053 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.75 86.36 6.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.212 0.529 . . . . 4.61 110.724 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.65 94.75 1.03 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.407 -0.815 . . . . 3.1 111.21 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 49.7 mt-30 -106.31 130.04 54.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.754 -0.461 . . . . 2.49 109.754 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -137.05 131.25 46.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.467 -0.333 . . . . 1.68 111.148 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.1 m -151.62 126.66 9.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.817 0.342 . . . . 0.8 110.748 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.04 141.68 35.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.806 -1.183 . . . . 3.39 107.806 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.515 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.5 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.624 -0.703 . . . . 1.4 110.571 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.13 -0.388 . . . . 1.5 112.13 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.34 -51.4 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.05 -0.595 . . . . 1.3 112.021 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -107.25 93.49 4.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.159 0.504 . . . . 1.54 110.382 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -129.08 -41.63 1.42 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.567 -0.742 . . . . 1.95 110.416 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -90.69 123.49 64.95 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 1.48 110.703 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -69.87 131.37 20.95 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.693 2.262 . . . . 1.43 112.11 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.3 Cg_exo -67.8 156.63 65.2 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.196 1.931 . . . . 1.23 112.594 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 53' ' ' GLY . 8.4 mm -96.79 91.67 2.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.198 -0.91 . . . . 1.19 109.591 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.13 96.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.598 . . . . 1.26 110.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 17' ' ' TYR . 22.6 mt -95.47 137.46 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.689 -0.687 . . . . 1.04 111.291 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -87.13 147.85 25.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.071 -0.513 . . . . 1.64 110.097 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 23.0 ptt180 -68.98 139.85 55.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.395 -0.366 . . . . 1.56 110.917 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -125.53 52.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.48 0.657 . . . . 1.93 109.997 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.15 -93.04 1.8 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.629 -0.714 . . . . 1.64 111.578 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -108.04 -25.76 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.191 0.519 . . . . 4.0 110.627 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' B' ' 108' ' ' LYS . 28.5 mtpt -114.73 177.89 4.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.686 -0.688 . . . . 3.06 111.414 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB3' HG21 ' A' ' 10' ' ' ILE . 83.3 m-85 -118.77 -7.26 10.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.92 109.476 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 109.35 12.16 20.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.132 -1.032 . . . . 1.03 114.066 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -141.26 171.3 14.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.658 1.218 . . . . 0.8 113.476 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -115.0 116.12 27.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.314 -1.766 . . . . 0.92 109.994 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.06 124.09 37.85 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.447 -0.946 . . . . 0.67 108.447 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 22' ' ' ARG . 17.9 mtp180 -126.89 129.67 48.67 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.321 0.582 . . . . 1.66 111.071 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -80.6 100.92 8.88 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.362 -0.835 . . . . 1.07 108.94 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -86.23 144.6 9.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.29 0.566 . . . . 1.42 111.224 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -106.9 111.22 23.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.529 -0.76 . . . . 4.04 110.568 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -115.53 123.98 71.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.947 -0.569 . . . . 1.72 110.357 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -75.49 143.1 42.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.131 0.491 . . . . 2.1 110.546 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.1 mmt -70.67 138.77 50.96 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.231 -0.895 . . . . 2.05 109.825 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.92 57.0 4.96 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.967 -0.635 . . . . 2.77 112.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.03 -57.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 2.62 110.622 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.6 m -110.27 -157.66 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 2.61 110.643 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.02 -8.31 21.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.14 0.495 . . . . 2.9 110.467 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 31' ' ' SER . 7.7 p -61.45 148.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.229 -0.896 . . . . 1.75 111.215 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -102.65 172.73 6.69 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.339 -0.846 . . . . 1.53 110.944 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 108.21 5.62 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.324 -1.307 . . . . 1.65 108.654 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.23 112.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.363 0.601 . . . . 1.22 110.789 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -106.4 151.61 24.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.465 -0.788 . . . . 1.34 109.956 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -103.69 102.65 12.5 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.339 -0.615 . . . . 0.82 109.339 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -119.92 138.12 53.63 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.889 -0.596 . . . . 1.33 111.536 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -72.18 116.45 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.117 -1.438 . . . . 1.1 107.117 176.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -82.66 -35.72 26.62 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.275 0.843 . . . . 1.82 113.275 -176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.429 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 48.1 t-80 -152.18 146.55 25.55 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.502 -0.479 . . . . 1.46 110.479 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.81 128.36 70.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.195 -0.668 . . . . 1.37 109.195 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.34 133.06 49.42 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 123.453 0.471 . . . . 1.54 111.056 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -61.28 105.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 1.94 110.689 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.73 17.13 73.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.955 -0.64 . . . . 1.56 112.179 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.701 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -77.88 175.63 54.33 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 121.255 -0.498 . . . . 1.37 112.124 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 77.1 Cg_exo -57.01 -47.54 22.54 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.299 2.666 . . . . 1.21 111.497 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -61.63 -37.73 85.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.844 -1.071 . . . . 1.19 110.658 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.332 -0.618 . . . . 1.46 109.332 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.701 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 39.3 mt-10 -70.79 -36.53 73.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.011 -0.995 . . . . 1.84 109.991 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.44 -25.46 64.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.882 -1.053 . . . . 1.36 110.913 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 113.15 6.0 22.74 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.56 -0.829 . . . . 1.39 114.052 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.88 131.41 43.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.393 0.616 . . . . 1.26 110.267 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -122.53 136.47 54.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.313 -0.858 . . . . 1.68 110.191 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' CD ' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.66 139.65 49.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.941 0.4 . . . . 1.78 110.95 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.66 5.87 57.53 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.781 -0.645 . . . . 1.39 113.379 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.41 -158.9 0.51 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.267 -0.642 . . . . 1.43 109.267 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.4 mt -135.82 112.86 10.38 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.382 -0.599 . . . . 1.19 109.382 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.9 mt -79.57 108.69 13.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.038 -0.727 . . . . 0.8 109.038 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 t -88.92 -34.55 16.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.86 111.806 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -142.87 152.21 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.032 0.444 . . . . 0.95 111.089 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' HD23 ' A' ' 79' ' ' LEU . 68.2 t -129.49 116.72 40.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 0.59 108.63 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.1 m-20 63.76 21.42 12.67 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.342 0.592 . . . . 0.9 110.077 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.64 19.66 59.59 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.425 -0.807 . . . . 0.9 112.673 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.716 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.0 mm-40 -112.79 133.25 21.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 122.875 -0.191 . . . . 1.36 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 16.5 Cg_exo -67.61 114.18 3.21 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.438 2.092 . . . . 0.9 110.885 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 33.3 m -98.77 -5.99 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.087 -0.506 . . . . 0.6 112.146 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.81 99.46 3.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.636 -0.505 . . . . 1.39 109.636 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.08 -29.11 2.75 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.802 -0.635 . . . . 0.98 112.069 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD13 ' HB3' ' A' ' 75' ' ' GLU . 5.0 mt -78.12 177.6 8.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.706 0.765 . . . . 0.83 111.223 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.788 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.3 m -82.43 171.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.636 -1.166 . . . . 0.82 108.909 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.514 ' O ' HG22 ' A' ' 76' ' ' VAL . 78.4 t60 -60.45 -40.23 90.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.027 0.441 . . . . 0.6 110.841 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 8.1 p -71.57 -33.01 68.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.987 0.736 . . . . 0.57 112.987 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.788 ' H ' HG23 ' A' ' 72' ' ' VAL . 10.0 mm-40 -58.38 -44.85 89.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.39 0.614 . . . . 0.88 110.371 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 2.1 m -71.91 -34.52 51.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.122 -0.944 . . . . 0.37 110.059 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.474 ' HA ' HD12 ' A' ' 80' ' ' ILE . 6.6 t -62.0 -48.65 87.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 109.476 -0.564 . . . . 0.29 109.476 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 74' ' ' THR . 72.9 mt-10 -58.69 -50.96 71.96 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.416 -0.811 . . . . 1.32 109.34 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -43.51 -56.2 3.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.975 -1.466 . . . . 0.58 110.123 178.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 63' ' ' VAL . 21.1 mt -54.5 -54.26 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.63 110.724 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.5 mt -52.61 -41.9 64.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.727 -0.67 . . . . 0.78 112.399 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.1 mtmt -74.41 -6.54 48.8 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.619 1.34 . . . . 1.0 114.619 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 39.5 p -47.42 -66.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.917 0.339 . . . . 1.08 111.917 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.04 99.77 2.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.889 -0.672 . . . . 1.29 112.562 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.406 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 73.61 -41.85 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.334 0.654 . . . . 1.5 112.231 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 83' ' ' SER . 31.9 pttt -152.94 156.39 38.81 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.355 0.598 . . . . 1.58 109.572 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.9 p -132.94 132.71 59.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.554 -1.203 . . . . 0.95 111.307 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.13 110.36 22.08 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.288 -0.634 . . . . 0.96 109.288 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.78 111.02 34.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.727 -0.67 . . . . 0.86 111.418 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 m -76.77 114.68 15.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.81 -0.441 . . . . 0.82 109.81 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 169.33 8.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.2 0.524 . . . . 1.09 111.8 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -173.16 150.32 1.9 Allowed Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 107.973 -1.121 . . . . 1.24 107.973 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.83 150.32 12.93 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.891 2.394 . . . . 1.52 114.004 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 14.2 tp -107.5 74.39 0.96 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.451 -0.944 . . . . 1.53 108.451 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.21 122.46 35.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.738 -0.665 . . . . 1.92 109.73 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.656 -0.688 . . . . 2.16 110.237 -179.429 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.5 0 N-CA-C 110.464 -0.629 . . . . 6.03 110.464 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.78 -166.01 0.23 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.46 0.475 . . . . 3.41 110.175 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -162.73 -78.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.005 -0.278 . . . . 5.16 111.075 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -132.73 149.3 52.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 5.22 111.239 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -137.87 25.31 2.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.733 -0.667 . . . . 4.23 110.042 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER -83.0 -50.61 8.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 3.81 110.075 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -112.44 78.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.814 -0.81 . . . . 4.61 108.814 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.9 p -127.67 172.71 10.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.293 -0.867 . . . . 3.1 110.013 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -132.22 164.1 27.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.049 -0.26 . . . . 2.49 110.319 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.403 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.4 tt -146.99 129.37 7.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.915 0.388 . . . . 1.68 110.875 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 90.3 m -135.14 127.69 30.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.397 0.618 . . . . 0.8 111.058 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 52.7 mttt -84.17 104.49 14.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.106 -0.952 . . . . 3.39 108.743 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.418 ' OXT' ' HD1' ' A' ' 17' ' ' TYR . 7.7 p . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.726 -1.131 . . . . 1.4 109.16 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.945 -0.462 . . . . 1.5 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.88 -45.03 8.66 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.749 -0.739 . . . . 1.3 112.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 m -75.2 116.18 15.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 1.54 110.953 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -165.82 -58.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.797 -0.638 . . . . 1.95 110.588 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -75.47 120.3 81.03 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 1.48 110.494 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 58.5 Cg_endo -68.74 133.6 27.93 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.773 2.315 . . . . 1.43 111.897 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.0 Cg_exo -68.83 148.69 71.54 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.139 1.893 . . . . 1.23 112.707 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 mm -89.76 91.96 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.171 -0.922 . . . . 1.19 109.305 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -69.38 97.39 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.32 0.581 . . . . 1.26 110.987 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 49' ' ' ALA . 34.0 mt -95.88 132.19 40.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 1.04 110.995 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -85.88 152.01 23.33 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.567 -0.742 . . . . 1.64 110.185 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 31.6 ptt180 -74.37 136.96 42.47 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 120.886 0.374 . . . . 1.56 111.151 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.3 84.73 2.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.278 -0.419 . . . . 1.93 110.2 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.04 -89.3 0.57 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.773 -0.727 . . . . 1.64 112.129 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -132.47 7.28 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.496 0.189 . . . . 4.0 110.993 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' B' ' 109' ' ' VAL . 0.0 OUTLIER -139.66 167.9 21.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.539 -0.301 . . . . 3.06 110.477 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 80' ' ' ILE . 98.6 m-85 -106.15 -6.96 18.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.467 0.651 . . . . 0.92 109.7 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 97.95 15.13 37.36 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.397 -0.906 . . . . 1.03 114.244 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -143.37 167.33 22.43 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.504 1.145 . . . . 0.8 113.304 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.466 ' OG1' ' HE3' ' B' ' 108' ' ' LYS . 56.1 m -109.16 121.18 44.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.976 -1.92 . . . . 0.92 110.671 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 tp -97.58 124.08 41.71 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.879 -1.156 . . . . 0.67 107.879 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 4.9 mtp180 -121.16 132.85 55.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.558 0.694 . . . . 1.66 111.673 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' O ' HG22 ' B' ' 104' ' ' THR . . . -91.98 101.65 14.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.655 -1.157 . . . . 1.07 109.452 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 37' ' ' HIS . 9.1 pt -94.0 132.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 1.42 110.382 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 23.0 ttt85 -102.64 119.83 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.033 -0.53 . . . . 4.04 111.108 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 27' ' ' TYR . 2.4 t -114.53 176.81 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.652 -1.24 . . . . 1.72 107.652 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' H ' HG12 ' A' ' 26' ' ' VAL . 1.1 m-85 -126.81 149.18 49.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.364 0.602 . . . . 2.1 111.011 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.464 ' HB2' HG13 ' A' ' 33' ' ' VAL . 95.8 mmm -93.58 117.4 30.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.064 -0.971 . . . . 2.05 109.782 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.36 84.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.133 -0.556 . . . . 2.77 112.074 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -176.43 -52.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.213 0.53 . . . . 2.62 110.075 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.6 m -130.4 -155.04 0.67 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.759 -0.655 . . . . 2.61 110.497 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 11.53 38.64 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.513 0.673 . . . . 2.9 109.393 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 28' ' ' MET . 7.8 p -77.34 146.67 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.102 -0.954 . . . . 1.75 110.389 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -109.11 165.84 11.3 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.116 -0.947 . . . . 1.53 110.944 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.57 99.12 6.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.814 -1.085 . . . . 1.65 109.886 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.28 118.86 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.0 0.429 . . . . 1.22 110.384 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 24' ' ' ILE . 62.0 m-70 -111.55 150.81 29.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.009 -0.541 . . . . 1.34 110.367 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.5 102.23 11.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.746 -0.835 . . . . 0.82 108.746 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -120.69 137.83 54.27 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 1.33 112.041 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.632 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -71.89 119.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.245 -1.391 . . . . 1.1 107.245 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -85.33 -33.69 22.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.965 0.728 . . . . 1.82 112.965 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -154.9 153.62 31.39 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.723 -0.391 . . . . 1.46 110.449 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 56' ' ' GLN . 25.3 t -132.64 123.71 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.611 . . . . 1.37 109.389 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -53.55 131.38 38.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 123.193 0.308 . . . . 1.54 110.884 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -59.05 113.87 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 1.94 111.092 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.09 83.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.927 -0.654 . . . . 1.56 112.665 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -76.79 177.37 51.95 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.134 -0.555 . . . . 1.37 112.059 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 18' ' ' GLY . 77.6 Cg_exo -58.37 -50.62 9.23 Favored 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 123.376 2.717 . . . . 1.21 111.335 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.92 -36.42 79.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.727 -1.124 . . . . 1.19 110.806 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -37.38 87.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.628 0.728 . . . . 1.46 109.405 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 21.0 mt-10 -73.62 -29.42 62.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.915 -1.039 . . . . 1.84 110.421 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.06 -22.54 52.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.899 . . . . 1.36 110.723 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.04 9.66 31.69 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.415 -0.898 . . . . 1.39 113.95 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.19 132.42 47.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.365 0.582 . . . . 1.26 109.861 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -116.69 131.22 57.01 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.758 -0.655 . . . . 1.68 110.516 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -74.14 133.11 42.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.094 -0.503 . . . . 1.78 110.672 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.45 3.21 47.33 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.612 -0.722 . . . . 1.39 112.573 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 15.0 m-20 -86.08 -153.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.63 -0.507 . . . . 1.43 109.63 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 59' ' ' LEU . 9.3 mt -141.66 115.76 9.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.57 -0.53 . . . . 1.19 109.57 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -82.03 115.47 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.683 -0.858 . . . . 0.8 108.683 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -96.99 -34.41 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.985 0.365 . . . . 0.86 111.985 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -141.72 148.59 39.28 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.554 -0.458 . . . . 0.95 110.797 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.2 t -127.52 116.76 44.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.59 109.357 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.512 HD21 ' HB3' ' A' ' 83' ' ' SER . 92.2 m-20 63.58 21.67 12.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.075 0.464 . . . . 0.9 110.376 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.6 22.98 48.68 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.575 -0.739 . . . . 0.9 112.644 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.654 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.7 mm-40 -117.23 141.36 28.44 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.795 0.298 . . . . 1.36 111.154 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.64 110.51 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.356 2.037 . . . . 0.9 111.161 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 24.4 m -88.81 -10.77 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.854 -0.612 . . . . 0.6 111.726 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -68.8 101.54 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.145 0.498 . . . . 1.39 110.051 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.14 -30.39 2.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.686 -0.688 . . . . 0.98 111.997 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.525 HD12 HG12 ' A' ' 76' ' ' VAL . 3.7 mt -79.56 179.17 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.555 0.693 . . . . 0.83 111.031 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' GLU . 21.7 m -87.84 177.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.859 -1.064 . . . . 0.82 108.84 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.3 t60 -63.9 -40.64 96.96 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.005 0.431 . . . . 0.6 110.979 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 1.6 p -72.36 -31.21 65.42 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.617 0.599 . . . . 0.57 112.617 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.73 ' H ' HG23 ' A' ' 72' ' ' VAL . 9.5 mm-40 -60.31 -43.62 96.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.482 0.658 . . . . 0.88 110.068 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 71' ' ' LEU . 2.5 m -73.59 -34.91 43.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.175 -0.92 . . . . 0.37 109.882 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 80' ' ' ILE . 5.8 t -60.81 -48.06 90.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.348 -0.612 . . . . 0.29 109.348 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.0 mt-10 -62.01 -48.26 81.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.396 -0.82 . . . . 1.32 109.753 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.3 tp -44.7 -55.56 5.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.559 -1.2 . . . . 0.58 110.068 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.25 -54.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 116.037 -0.529 . . . . 0.63 110.856 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 18.9 mt -54.67 -40.06 68.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.78 112.568 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 53.0 mtmt -69.26 -3.62 14.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 79.7 p -55.7 -56.54 19.28 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.18 0.437 . . . . 1.08 112.18 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 93.8 100.11 1.58 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.975 -0.631 . . . . 1.29 112.169 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 1.1 t-20 75.53 -45.36 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.526 0.731 . . . . 1.5 112.278 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 22.1 pttt -150.33 154.74 38.36 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.518 -0.549 . . . . 1.58 109.518 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.97 136.29 57.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.806 -1.088 . . . . 0.95 111.722 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.58 30.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.191 -0.67 . . . . 0.96 109.191 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.83 109.41 28.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.314 -0.403 . . . . 0.86 111.41 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -77.71 113.55 15.68 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.822 -0.436 . . . . 0.82 109.822 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.1 p -107.79 153.82 22.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 1.09 112.252 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -151.91 152.58 30.22 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.337 -0.986 . . . . 1.24 108.337 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -50.53 150.14 12.22 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.647 2.232 . . . . 1.52 113.383 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 28.6 tp -105.77 68.17 0.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 1.53 109.269 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -91.84 122.48 34.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.54 -0.755 . . . . 1.92 109.286 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.123 -0.944 . . . . 2.16 109.394 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo . . . . . 0 N--CA 1.478 0.604 0 N-CA-C 110.075 -0.779 . . . . 6.03 110.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.2 -173.65 3.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.72 0.295 . . . . 3.41 110.695 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.78 -148.4 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.963 -0.562 . . . . 5.16 110.218 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.436 ' HB3' ' OE1' ' B' ' 102' ' ' GLN . 9.6 mm-40 -77.84 70.51 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 5.22 110.387 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 8.2 p-10 -87.88 37.2 0.79 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 4.23 111.861 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' B' ' 100' ' ' GLU . 19.6 mp0 -59.63 -50.37 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 3.81 110.454 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -92.47 82.35 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.224 -0.658 . . . . 4.61 109.224 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -109.83 147.21 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.013 -0.54 . . . . 3.1 111.532 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.12 144.17 47.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 2.49 109.521 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.63 121.28 18.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.558 -0.292 . . . . 1.68 110.545 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 20.5 m -150.29 120.3 7.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.749 0.309 . . . . 0.8 111.596 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.466 ' HE3' ' OG1' ' A' ' 20' ' ' THR . 41.5 mtpt -77.19 139.51 39.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.32 -1.363 . . . . 3.39 107.32 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 7.3 p . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.993 -1.003 . . . . 1.4 111.096 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.614 -0.594 . . . . 1.5 111.614 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.35 -81.72 1.59 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.808 -0.71 . . . . 1.3 111.543 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -73.03 113.71 10.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.899 0.38 . . . . 1.54 110.05 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -155.62 -43.69 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.206 -0.452 . . . . 1.95 110.613 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -91.51 120.21 68.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.807 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 53.1 Cg_endo -67.71 124.23 11.69 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.527 2.152 . . . . 1.43 111.353 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 26.1 Cg_exo -61.54 154.51 59.04 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.358 2.038 . . . . 1.23 113.512 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 mm -93.89 90.51 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.19 108.968 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.14 96.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.125 0.488 . . . . 1.26 110.44 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.514 HG21 ' HB3' ' A' ' 17' ' ' TYR . 39.7 mt -92.81 126.45 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.706 -0.679 . . . . 1.04 111.148 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -83.45 147.84 27.61 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.695 -0.684 . . . . 1.64 109.805 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 26.5 ptt180 -70.82 142.62 51.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.315 -0.402 . . . . 1.56 110.632 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -99.26 -8.79 24.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.267 0.556 . . . . 1.93 110.036 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.0 -41.99 1.48 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.668 -0.697 . . . . 1.64 111.368 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.0 -37.79 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.507 0.194 . . . . 4.0 110.79 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 1.3 mtmp? -132.76 167.77 19.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 3.06 110.691 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CE2' HG22 ' A' ' 80' ' ' ILE . 91.7 m-85 -95.43 -10.58 29.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.92 110.932 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.87 55.89 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.031 -1.08 . . . . 1.03 113.947 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.48 164.87 21.82 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.353 1.073 . . . . 0.8 112.618 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.1 m -110.39 122.69 48.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.56 -1.655 . . . . 0.92 110.622 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.2 tp -97.58 120.61 38.26 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.17 -1.048 . . . . 0.67 108.17 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 9.7 mtp180 -116.05 115.88 26.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.536 0.684 . . . . 1.66 111.119 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -79.78 88.97 5.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.955 -1.021 . . . . 1.07 109.742 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' B' ' 104' ' ' THR . 12.3 pt -80.44 133.64 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.59 0.556 . . . . 1.42 111.387 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' B' ' 103' ' ' HIS . 29.4 mtt180 -107.75 108.67 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 4.04 110.208 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -109.27 120.48 60.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.529 -0.76 . . . . 1.72 109.53 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 11.9 m-85 -66.74 144.69 56.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.299 0.571 . . . . 2.1 110.626 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 50.0 mmm -67.27 -17.88 64.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.04 -0.982 . . . . 2.05 111.131 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.71 -53.72 4.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.068 -0.587 . . . . 2.77 113.353 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -85.31 14.18 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.841 0.353 . . . . 2.62 111.436 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' HG12 ' A' ' 33' ' ' VAL . 37.6 t -162.92 179.13 7.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.332 -0.395 . . . . 2.61 110.817 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -90.87 -14.46 31.7 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.035 0.922 . . . . 2.9 108.705 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 31' ' ' SER . 7.4 p -71.2 147.5 11.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.542 -1.208 . . . . 1.75 110.681 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 52.5 p90 -108.24 170.43 8.01 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.266 -0.879 . . . . 1.53 110.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 99.35 5.34 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.354 -1.294 . . . . 1.65 108.611 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -84.73 123.32 39.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.502 0.668 . . . . 1.22 111.139 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -114.98 146.87 40.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.259 -0.882 . . . . 1.34 109.656 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -102.2 96.05 6.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.76 -0.83 . . . . 0.82 108.76 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -114.39 135.77 53.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.799 . . . . 1.33 111.914 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -73.62 121.73 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.563 -1.273 . . . . 1.1 107.563 176.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.507 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.1 t-105 -90.64 -34.47 15.43 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.023 0.749 . . . . 1.82 113.023 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.481 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 58.9 t-80 -146.7 147.38 30.92 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.193 -0.603 . . . . 1.46 110.975 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.523 HG23 ' HG2' ' A' ' 56' ' ' GLN . 95.5 t -130.37 113.83 26.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.021 -0.991 . . . . 1.37 108.542 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -51.53 129.79 26.32 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.466 0.479 . . . . 1.54 111.657 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -63.99 115.41 4.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.666 . . . . 1.94 110.042 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.64 9.4 78.52 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.326 -0.709 . . . . 1.56 111.326 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.29 170.76 52.78 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.756 -0.537 . . . . 1.37 111.756 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 75.8 Cg_exo -57.5 -49.24 14.12 Favored 'Trans proline' 0 CA--C 1.507 -0.856 0 C-N-CA 123.575 2.85 . . . . 1.21 111.7 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.74 -37.29 81.28 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.827 -1.078 . . . . 1.19 111.33 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -36.61 83.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.651 0.738 . . . . 1.46 109.273 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 26.3 mt-10 -72.67 -28.87 62.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 1.84 110.425 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.91 49.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.309 -0.86 . . . . 1.36 110.796 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.1 8.21 29.79 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.83 -0.7 . . . . 1.39 113.793 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.56 131.84 46.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.369 0.585 . . . . 1.26 109.988 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -117.28 144.25 45.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.291 -0.868 . . . . 1.68 109.963 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.45 137.36 34.69 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.504 -0.478 . . . . 1.78 110.145 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.99 4.99 56.57 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.928 -0.653 . . . . 1.39 112.618 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -85.55 -160.33 0.51 Allowed 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.532 -0.544 . . . . 1.43 109.532 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 9.1 mt -136.6 112.22 9.38 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.68 -0.489 . . . . 1.19 109.68 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.1 mt -80.6 107.41 12.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.634 -0.876 . . . . 0.8 108.634 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.1 t -92.28 -30.35 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.284 -0.416 . . . . 0.86 111.954 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.17 144.75 33.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.95 110.89 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 79' ' ' LEU . 59.5 t -124.13 115.34 44.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.549 -0.908 . . . . 0.59 108.549 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 87' ' ' VAL . 92.8 m-20 65.49 19.68 11.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.242 0.544 . . . . 0.9 109.875 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.59 14.27 58.57 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.615 -0.72 . . . . 0.9 112.41 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 79' ' ' LEU . 6.7 mm-40 -106.04 131.62 21.58 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.13 0.048 . . . . 1.36 111.13 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.08 108.08 1.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.266 1.977 . . . . 0.9 110.124 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 76' ' ' VAL . 23.5 m -85.42 -8.06 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 112.068 0.396 . . . . 0.6 112.068 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.69 113.36 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.047 0.451 . . . . 1.39 110.154 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.1 12.64 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.489 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 82.9 mt -74.65 178.1 5.64 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 122.168 0.985 . . . . 0.83 112.695 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' GLU . 28.4 m -98.14 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 113.781 -1.554 . . . . 0.82 107.718 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 76' ' ' VAL . 75.4 t60 -58.84 -44.07 90.87 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.797 0.332 . . . . 0.6 111.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -70.3 -35.12 73.48 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.144 0.794 . . . . 0.57 113.144 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.709 ' H ' HG23 ' A' ' 72' ' ' VAL . 12.3 mm-40 -57.67 -43.74 85.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.136 0.494 . . . . 0.88 110.516 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 68' ' ' VAL . 8.1 m -74.42 -36.74 43.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.565 -0.743 . . . . 0.37 109.982 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.6 t -57.15 -49.82 78.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.629 -0.508 . . . . 0.29 109.629 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 74' ' ' THR . 78.3 mt-10 -61.93 -50.27 72.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.567 -0.742 . . . . 1.32 109.587 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -43.64 -56.42 3.74 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.318 -1.31 . . . . 0.58 110.123 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 17' ' ' TYR . 23.6 mt -53.8 -54.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.067 -0.515 . . . . 0.63 110.709 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -53.75 -43.82 69.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.671 . . . . 0.78 112.213 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 44.4 mtmt -65.89 -5.97 10.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.629 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 58.2 p -53.39 -62.05 1.9 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.99 0.424 . . . . 1.08 111.914 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.72 102.14 1.91 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.194 -0.527 . . . . 1.29 112.207 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 2.4 t-20 75.03 -43.64 0.52 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.751 0.821 . . . . 1.5 111.943 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 83' ' ' SER . 33.2 pttt -151.85 156.48 40.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.651 -0.5 . . . . 1.58 109.651 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.6 p -134.32 132.29 55.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.773 -1.103 . . . . 0.95 110.95 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.05 106.0 18.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.363 0.602 . . . . 0.96 109.667 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.97 108.71 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.401 -0.818 . . . . 0.86 110.741 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -78.41 105.86 9.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.093 0.473 . . . . 0.82 109.827 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -98.95 157.27 16.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.775 -0.648 . . . . 1.09 111.613 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.4 t -159.93 151.37 16.36 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 108.069 -1.086 . . . . 1.24 108.069 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -46.78 149.34 3.17 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.995 2.464 . . . . 1.52 114.321 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 25.3 tp -108.96 77.92 1.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.065 -1.087 . . . . 1.53 108.065 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.87 120.88 39.05 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.554 -0.748 . . . . 1.92 110.219 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.495 -0.775 . . . . 2.16 109.548 -179.464 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.475 0.422 0 N-CA-C 109.828 -0.874 . . . . 6.03 109.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 p90 47.71 -171.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.419 1.087 . . . . 3.41 113.388 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -162.87 154.4 17.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.574 -0.739 . . . . 5.16 109.221 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 74.62 159.74 0.22 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.006 0.816 . . . . 5.22 112.285 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . 0.531 ' O ' HG23 ' B' ' 104' ' ' THR . 10.9 t70 -162.82 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.445 -0.798 . . . . 4.23 109.387 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 57.7 -134.98 1.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.549 -0.75 . . . . 3.81 111.202 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.596 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 23.3 t-80 -78.33 84.3 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.137 0.494 . . . . 4.61 110.556 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 101' ' ' ASP . 11.0 p -98.08 151.86 19.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.989 -0.55 . . . . 3.1 110.921 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 2.6 mp0 -100.36 135.1 42.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.731 -0.84 . . . . 2.49 108.731 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.443 HG12 ' HE ' ' A' ' 22' ' ' ARG . 68.7 mt -130.12 124.14 57.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.663 0.268 . . . . 1.68 111.117 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.0 m -155.29 125.01 6.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.147 0.499 . . . . 0.8 110.94 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -79.19 138.96 38.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.259 -1.015 . . . . 3.39 108.259 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.509 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 7.0 p . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.417 -0.801 . . . . 1.4 110.863 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.003 -0.439 . . . . 1.5 112.003 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.32 -60.41 1.31 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 1.3 112.635 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -65.7 112.75 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 1.54 111.481 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tpt -155.42 -52.63 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 1.95 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -86.08 130.35 50.48 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 1.48 110.848 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.4 Cg_endo -70.69 127.11 13.42 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.653 2.235 . . . . 1.43 111.811 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 23.2 Cg_exo -64.0 153.48 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.051 1.834 . . . . 1.23 112.582 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 10' ' ' ILE . 8.2 mm -93.32 90.28 2.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.047 -0.979 . . . . 1.19 109.437 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.2 mp -70.31 96.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.304 0.573 . . . . 1.26 110.068 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' HB3' ' A' ' 17' ' ' TYR . 35.1 mt -94.7 124.31 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.455 -0.793 . . . . 1.04 111.775 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -78.85 148.25 32.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.097 -0.956 . . . . 1.64 110.364 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -65.48 141.95 58.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.803 0.335 . . . . 1.56 110.917 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -119.43 -42.49 2.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.366 -0.379 . . . . 1.93 110.636 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.58 -88.76 0.12 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.967 -0.635 . . . . 1.64 111.868 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -81.29 -36.24 30.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.839 0.352 . . . . 4.0 110.603 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 51.2 mtpt -138.55 153.88 48.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.131 -0.486 . . . . 3.06 110.654 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HB3' HG21 ' A' ' 10' ' ' ILE . 72.9 m-85 -78.63 1.15 23.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.387 -0.968 . . . . 0.92 108.387 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 107.03 11.67 25.56 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.103 -0.953 . . . . 1.03 112.02 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -151.36 165.12 35.05 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 123.248 1.499 . . . . 0.8 114.046 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.5 m -111.31 118.88 37.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 112.151 -2.295 . . . . 0.92 109.558 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -93.28 129.99 39.17 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.092 -0.707 . . . . 0.67 109.092 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 22.6 mtp180 -130.53 132.2 45.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 1.66 110.556 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -90.38 99.23 12.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 1.07 109.761 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 37' ' ' HIS . 14.8 pt -83.83 147.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.489 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' NH2' ' HB3' ' B' ' 103' ' ' HIS . 15.5 ttm180 -113.53 129.82 56.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.156 -0.475 . . . . 4.04 111.214 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.0 t -131.61 108.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.058 -0.719 . . . . 1.72 109.058 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 15.3 m-85 -70.36 139.45 51.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.576 0.703 . . . . 2.1 111.811 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.6 mmm -82.17 139.0 34.57 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.477 -1.238 . . . . 2.05 110.02 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.91 72.11 2.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.992 -0.623 . . . . 2.77 111.659 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -155.79 -58.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.014 0.435 . . . . 2.62 111.201 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -140.57 -145.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.277 -0.419 . . . . 2.61 110.915 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.21 -9.19 53.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.833 0.825 . . . . 2.9 109.112 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.96 145.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.969 -1.469 . . . . 1.75 110.645 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 39.0 p90 -131.83 167.21 19.95 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.318 -0.855 . . . . 1.53 111.04 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.13 114.86 22.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.805 -1.089 . . . . 1.65 109.534 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.35 117.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.703 -0.48 . . . . 1.22 109.703 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 24' ' ' ILE . 88.0 m-70 -109.06 143.87 37.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.875 -0.602 . . . . 1.34 110.399 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -99.63 101.8 13.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.116 -0.698 . . . . 0.82 109.116 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.76 135.43 54.85 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.783 -0.644 . . . . 1.33 111.952 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.94 117.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.955 -1.498 . . . . 1.1 106.955 176.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.477 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 76.6 t-105 -81.83 -35.01 29.89 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.993 0.738 . . . . 1.82 112.993 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -153.31 151.39 29.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.693 0.282 . . . . 1.46 110.549 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.18 123.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.657 -0.702 . . . . 1.37 109.347 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -58.73 129.67 43.24 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.741 0.416 . . . . 1.54 111.13 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.03 116.93 5.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 1.94 109.993 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.17 12.11 81.32 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.688 -0.768 . . . . 1.56 111.871 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -81.82 170.98 52.16 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.99 -0.624 . . . . 1.37 111.686 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 65.5 Cg_exo -58.43 -47.96 17.31 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 123.308 2.672 . . . . 1.21 111.769 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.47 -38.14 83.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 1.19 110.951 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -36.45 84.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 1.46 109.692 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 13.1 mt-10 -79.25 -21.9 45.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.715 -1.13 . . . . 1.84 110.779 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.23 -22.3 35.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.371 -0.831 . . . . 1.36 110.355 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 112.02 5.5 25.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.8 -0.714 . . . . 1.39 114.012 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.567 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -70.82 134.1 47.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.409 0.605 . . . . 1.26 110.486 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 55' ' ' ARG . 9.3 mmt180 -121.76 136.03 54.94 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.105 -0.952 . . . . 1.68 110.297 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -72.71 129.72 38.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.176 0.512 . . . . 1.78 111.407 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.75 32.0 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.557 -0.747 . . . . 1.39 112.854 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -87.9 -162.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.046 0.45 . . . . 1.43 109.997 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 59' ' ' LEU . 8.6 mt -133.4 114.03 13.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 109.074 -0.713 . . . . 1.19 109.074 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.3 mt -82.84 111.97 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.091 -0.707 . . . . 0.8 109.091 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 t -98.05 -29.44 13.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.236 0.458 . . . . 0.86 112.236 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -143.45 145.88 32.97 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.856 0.36 . . . . 0.95 110.604 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 79' ' ' LEU . 77.3 t -126.88 112.57 29.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.749 -0.834 . . . . 0.59 108.749 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.576 HD21 ' HB3' ' A' ' 83' ' ' SER . 86.2 m-20 62.74 30.12 16.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.253 0.549 . . . . 0.9 109.997 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.13 15.51 76.82 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.451 -0.795 . . . . 0.9 112.788 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 79' ' ' LEU . 7.6 mm-40 -106.62 128.11 26.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 O-C-N 122.709 -0.289 . . . . 1.36 110.697 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 15.5 Cg_exo -68.73 111.75 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.335 2.024 . . . . 0.9 110.532 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 23.0 m -93.75 1.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.305 -0.407 . . . . 0.6 111.938 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -63.58 102.83 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.28 -0.418 . . . . 1.39 110.05 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -25.07 7.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.441 -0.885 . . . . 0.98 112.779 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 57.2 mt -67.75 166.36 15.46 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.934 0.873 . . . . 0.83 112.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 75' ' ' GLU . 27.3 m -86.71 174.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.056 -1.429 . . . . 0.82 107.989 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' B' ' 105' ' ' GLN . 73.5 t60 -59.68 -42.8 93.76 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.867 0.321 . . . . 0.6 111.867 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.4 p -73.27 -33.97 65.54 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.353 0.872 . . . . 0.57 113.353 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' HG22 ' A' ' 72' ' ' VAL . 10.4 mm-40 -57.64 -42.18 82.89 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.07 0.462 . . . . 0.88 110.912 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 68' ' ' VAL . 10.4 m -76.38 -35.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.567 -0.742 . . . . 0.37 110.164 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 3.8 t -58.34 -49.79 80.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.1 0.476 . . . . 0.29 109.747 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' THR . 54.3 mt-10 -62.54 -48.42 79.57 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.939 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -44.49 -55.09 5.37 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.252 -1.34 . . . . 0.58 110.137 177.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.472 HG13 HG11 ' A' ' 63' ' ' VAL . 23.3 mt -54.63 -54.62 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.056 -0.52 . . . . 0.63 110.845 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.8 mt -52.97 -41.17 64.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.78 112.365 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 46.7 mtmt -67.58 -9.22 40.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.209 1.188 . . . . 1.0 114.209 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.576 ' HB3' HD21 ' A' ' 64' ' ' ASN . 59.1 p -51.78 -63.1 1.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 1.08 111.86 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 95.95 104.87 2.11 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.987 -0.625 . . . . 1.29 111.869 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.5 t-20 75.73 -46.13 0.55 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.338 0.655 . . . . 1.5 111.802 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 83' ' ' SER . 27.6 pttt -151.86 152.25 32.35 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.467 0.651 . . . . 1.58 110.474 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' OD1' ' A' ' 64' ' ' ASN . 4.2 p -133.42 129.9 56.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 114.375 -1.284 . . . . 0.95 111.237 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.19 110.81 22.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.212 0.529 . . . . 0.96 109.774 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -105.89 111.1 33.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.721 -0.672 . . . . 0.86 111.262 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -78.34 112.37 15.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.268 -0.424 . . . . 0.82 110.026 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -102.28 169.77 8.5 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.995 -0.548 . . . . 1.09 111.338 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -169.02 151.63 4.88 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 107.895 -1.15 . . . . 1.24 107.895 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.33 149.89 16.06 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.58 2.187 . . . . 1.52 113.587 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 26.3 tp -107.28 63.57 0.63 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 122.082 0.944 . . . . 1.53 108.459 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.53 118.81 21.01 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.966 -1.015 . . . . 1.92 109.563 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 115.475 -0.784 . . . . 2.16 110.19 -178.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.649 -0.558 . . . . 6.03 110.649 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 19.8 t80 63.6 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.91 0.756 . . . . 3.41 111.796 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -45.79 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.191 0.52 . . . . 5.16 110.545 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.46 160.68 26.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.429 -0.805 . . . . 5.22 109.069 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.75 -23.56 0.23 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.104 -0.239 . . . . 4.23 111.568 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -179.4 -47.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.136 0.493 . . . . 3.81 110.09 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.538 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 8.1 t-160 -158.39 115.6 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 4.61 109.63 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -120.5 155.53 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.995 -0.548 . . . . 3.1 110.492 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.6 mp0 -115.68 164.6 14.11 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 2.49 111.587 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.491 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.1 tt -157.45 118.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.668 -0.696 . . . . 1.68 109.658 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 88.7 m -142.17 135.19 28.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.411 0.624 . . . . 0.8 111.618 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.416 ' HB3' ' HE3' ' A' ' 16' ' ' LYS . 39.2 mttp -79.31 127.9 32.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.383 -0.969 . . . . 3.39 108.383 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.449 -0.786 . . . . 1.4 110.224 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.339 -0.304 . . . . 1.5 112.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.56 -64.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.129 -0.557 . . . . 1.3 111.813 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -93.51 98.86 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.899 0.381 . . . . 1.54 110.257 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.1 tpt -138.66 -46.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 1.95 111.044 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 5' ' ' ARG . 2.2 mpt_? -80.73 124.31 81.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.437 -0.347 . . . . 1.48 110.756 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 49.5 Cg_endo -66.42 126.28 15.32 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.694 2.263 . . . . 1.43 111.818 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 18.9 Cg_exo -65.13 157.37 57.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.306 2.004 . . . . 1.23 113.0 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 mm -96.94 89.96 2.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.954 -1.021 . . . . 1.19 109.422 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.21 97.96 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.302 0.572 . . . . 1.26 110.408 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 17' ' ' TYR . 34.0 mt -94.75 131.19 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.338 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -86.8 144.66 26.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.566 -0.743 . . . . 1.64 109.71 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 22.4 ptt180 -67.42 143.46 56.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.954 0.407 . . . . 1.56 111.533 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -128.57 80.44 1.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.04 -0.527 . . . . 1.93 109.688 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.17 -78.92 1.52 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.48 -0.648 . . . . 1.64 111.48 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -139.87 -4.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.763 -0.218 . . . . 4.0 111.104 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 9.2 mtpm? -129.63 170.54 13.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.506 0.193 . . . . 3.06 110.986 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HB3' HG21 ' A' ' 10' ' ' ILE . 85.4 m-85 -107.4 -7.7 16.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.92 111.277 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 95.84 19.73 28.29 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.056 -1.068 . . . . 1.03 114.448 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -144.01 167.63 21.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 122.409 1.099 . . . . 0.8 112.869 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.3 m -111.56 119.7 39.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.347 -1.751 . . . . 0.92 110.225 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 HG23 ' A' ' 76' ' ' VAL . 49.6 tp -97.19 131.67 43.7 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.281 -1.007 . . . . 0.67 108.281 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 5.9 mtp180 -133.08 143.56 49.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.253 0.549 . . . . 1.66 111.494 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -104.06 118.38 36.53 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.369 -0.832 . . . . 1.07 109.364 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 9.0 pt -109.19 128.06 65.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.714 -0.676 . . . . 1.42 110.952 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -91.76 89.16 6.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.255 0.55 . . . . 4.04 110.441 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -83.72 115.98 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.234 -0.439 . . . . 1.72 110.012 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 74.2 m-85 -74.92 136.55 41.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.568 0.699 . . . . 2.1 111.011 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 33.1 mmt -87.27 143.23 27.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.761 -1.109 . . . . 2.05 110.875 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.25 68.72 2.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.943 -0.646 . . . . 2.77 111.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.135 0.493 . . . . 2.62 110.07 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.2 m -135.46 -137.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.774 -0.648 . . . . 2.61 109.783 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -101.47 1.15 37.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.056 0.932 . . . . 2.9 109.229 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.36 144.64 14.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 113.787 -1.551 . . . . 1.75 111.679 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -122.5 165.81 15.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 1.53 109.678 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -131.24 98.89 4.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.851 -1.068 . . . . 1.65 108.785 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 2.5 p -75.51 110.64 10.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.615 -0.72 . . . . 1.22 110.989 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -100.21 155.48 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.321 -0.854 . . . . 1.34 110.015 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.7 103.87 12.47 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.671 -0.863 . . . . 0.82 108.671 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -124.82 141.11 52.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.84 -0.618 . . . . 1.33 111.931 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.642 HG11 HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -72.08 117.59 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.133 -1.432 . . . . 1.1 107.133 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 66.6 t-105 -85.77 -28.17 24.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.162 0.801 . . . . 1.82 113.162 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -157.75 149.08 21.52 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 121.115 -0.234 . . . . 1.46 110.408 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.6 130.21 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.602 -0.518 . . . . 1.37 109.602 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -58.86 134.53 56.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.221 -0.445 . . . . 1.54 110.768 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.31 103.86 1.09 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.897 -0.592 . . . . 1.94 110.441 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.14 15.5 57.39 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.272 -0.731 . . . . 1.56 111.272 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.6 169.02 53.17 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.189 -0.529 . . . . 1.37 111.89 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 76.7 Cg_exo -57.1 -46.19 30.48 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 C-N-CA 123.505 2.803 . . . . 1.21 111.642 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -60.65 -39.84 89.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.54 -1.209 . . . . 1.19 111.3 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -65.51 -36.63 84.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.366 0.603 . . . . 1.46 109.572 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 52.9 mt-10 -68.06 -36.65 80.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.161 -0.927 . . . . 1.84 109.571 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.81 -22.65 61.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.651 -1.158 . . . . 1.36 110.781 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.54 2.53 27.47 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.632 -0.794 . . . . 1.39 114.028 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.642 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -67.51 129.0 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.388 0.594 . . . . 1.26 110.026 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -123.05 142.6 50.69 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.351 -0.84 . . . . 1.68 110.139 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -71.73 144.61 49.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 1.78 111.268 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.67 62.64 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 1.39 113.913 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -88.48 -156.61 0.38 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.754 0.777 . . . . 1.43 109.574 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 94' ' ' LEU . 8.9 mt -140.85 116.24 10.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 109.685 -0.487 . . . . 1.19 109.685 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.95 111.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.8 109.024 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.7 t -90.32 -33.67 16.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.476 -0.329 . . . . 0.86 111.609 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -146.78 148.35 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.997 0.427 . . . . 0.95 110.689 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.748 ' HB ' HD23 ' A' ' 79' ' ' LEU . 57.9 t -123.39 113.9 39.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.43 -0.952 . . . . 0.59 108.43 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 83' ' ' SER . 89.7 m-20 64.62 24.69 13.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.264 0.554 . . . . 0.9 109.741 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.92 71.71 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.402 -0.817 . . . . 0.9 112.768 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' HD21 ' A' ' 79' ' ' LEU . 3.1 mm-40 -106.51 132.78 20.62 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.876 0.338 . . . . 1.36 110.719 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.69 112.7 2.26 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 0.9 111.389 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 29.2 m -92.14 -12.13 9.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.049 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.67 102.99 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.85 -0.614 . . . . 1.39 109.913 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.25 -24.29 4.75 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.515 -0.85 . . . . 0.98 112.849 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 75' ' ' GLU . 7.5 mt -80.48 -169.37 2.09 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 122.049 0.928 . . . . 0.83 111.657 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG23 ' H ' ' A' ' 75' ' ' GLU . 27.6 m -103.6 176.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.207 -1.361 . . . . 0.82 108.685 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' O ' HG22 ' A' ' 76' ' ' VAL . 63.7 t60 -61.41 -41.91 97.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.97 0.414 . . . . 0.6 111.284 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 1.9 p -74.48 -27.86 60.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.921 0.711 . . . . 0.57 112.921 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.678 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.0 mm-40 -62.36 -44.07 97.34 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.187 0.518 . . . . 0.88 110.257 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD21 ' A' ' 21' ' ' LEU . 12.3 m -72.73 -35.13 49.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.326 -0.852 . . . . 0.37 109.911 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 4.9 t -58.98 -49.91 81.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 109.325 -0.62 . . . . 0.29 109.325 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 32.2 mt-10 -60.53 -48.77 80.32 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.556 -0.747 . . . . 1.32 109.99 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.748 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -44.84 -55.29 5.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.29 -1.323 . . . . 0.58 110.059 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 17' ' ' TYR . 22.2 mt -55.25 -54.13 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.89 -0.595 . . . . 0.63 110.622 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.0 mt -52.94 -41.4 64.45 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.821 -0.627 . . . . 0.78 112.526 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 49.4 mtmt -71.01 -4.43 24.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.38 1.252 . . . . 1.0 114.38 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.646 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 43.7 p -52.66 -67.12 0.28 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.983 0.42 . . . . 1.08 111.638 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 101.78 99.12 2.4 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.983 -0.627 . . . . 1.29 112.158 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 75.76 -42.62 0.47 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.637 0.775 . . . . 1.5 111.94 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 83' ' ' SER . 25.2 pttt -150.79 156.2 40.79 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.285 0.564 . . . . 1.58 109.948 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.03 128.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.499 -1.228 . . . . 0.95 111.251 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 104.86 17.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.419 0.628 . . . . 0.96 109.56 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.3 109.85 26.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.247 -0.888 . . . . 0.86 111.009 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -76.86 112.67 13.71 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.812 -0.44 . . . . 0.82 109.812 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -104.11 160.96 14.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.34 0.591 . . . . 1.09 112.096 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -160.83 150.48 14.19 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.089 -1.078 . . . . 1.24 108.089 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.56 152.25 6.5 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.64 2.226 . . . . 1.52 113.892 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . 29.0 tp -115.13 81.91 1.65 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.978 -1.01 . . . . 1.53 108.91 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.06 111.68 19.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.629 -0.714 . . . . 1.92 109.786 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.418 -0.801 . . . . 2.16 109.737 -179.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 N--CA 1.477 0.555 0 N-CA-C 110.44 -0.639 . . . . 6.03 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.75 118.48 31.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.168 -0.469 . . . . 3.41 110.2 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.405 ' HA ' ' CH2' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -156.86 132.79 9.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 5.16 110.955 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.37 29.99 5.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.388 -0.823 . . . . 5.22 113.1 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -106.95 -35.46 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.861 0.363 . . . . 4.23 110.504 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -131.32 127.43 37.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.043 -0.526 . . . . 3.81 109.958 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -126.41 44.63 2.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.12 0.486 . . . . 4.61 110.617 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -82.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.831 -0.622 . . . . 3.1 111.782 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 1.8 mm-40 -116.28 146.33 42.47 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.801 -0.36 . . . . 2.49 111.33 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.477 ' HB ' ' CD ' ' A' ' 22' ' ' ARG . 2.1 tt -152.87 122.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.986 -0.552 . . . . 1.68 110.655 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 37.9 m -145.22 118.19 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.265 0.555 . . . . 0.8 111.295 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.17 128.18 33.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.231 -1.026 . . . . 3.39 108.231 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.566 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 9.8 p . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.618 -0.706 . . . . 1.4 110.469 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.994 -0.443 . . . . 1.5 111.994 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.17 -78.53 0.91 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.891 -0.671 . . . . 1.3 112.589 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 111.02 11.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.953 0.406 . . . . 1.54 111.143 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.0 tpt -140.47 -43.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.967 -0.561 . . . . 1.95 110.231 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.26 128.07 50.76 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.913 -0.585 . . . . 1.48 110.193 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 56.3 Cg_endo -66.95 132.42 28.18 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.672 2.248 . . . . 1.43 112.047 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.3 Cg_exo -68.42 152.86 75.04 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.448 2.099 . . . . 1.23 112.996 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -94.15 92.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.04 -0.982 . . . . 1.19 109.173 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.47 97.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.269 0.557 . . . . 1.26 110.731 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 17' ' ' TYR . 29.8 mt -95.95 134.61 32.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.654 -0.703 . . . . 1.04 111.234 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -81.78 155.33 25.51 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.776 -0.647 . . . . 1.64 110.302 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 14.3 ptt180 -69.22 168.58 13.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.134 -0.485 . . . . 1.56 110.792 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -159.39 -134.33 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.392 -0.367 . . . . 1.93 111.071 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.88 -106.07 0.64 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.846 -0.692 . . . . 1.64 112.425 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -17.4 36.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.651 0.263 . . . . 4.0 111.02 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HA ' ' OXT' ' B' ' 109' ' ' VAL . 11.9 ptmt -144.75 158.11 43.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.917 0.389 . . . . 3.06 111.028 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' HB3' HG21 ' A' ' 10' ' ' ILE . 87.6 m-85 -75.83 4.53 7.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.674 -0.694 . . . . 0.92 109.21 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 16' ' ' LYS . . . 106.96 14.04 20.09 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.299 -0.953 . . . . 1.03 112.54 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.35 159.04 44.14 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 123.018 1.39 . . . . 0.8 113.362 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.6 m -106.77 116.55 32.13 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 112.298 -2.228 . . . . 0.92 109.693 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.77 130.05 38.5 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.877 -0.786 . . . . 0.67 108.877 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' NE ' ' HB ' ' B' ' 106' ' ' ILE . 23.2 mtp180 -128.99 128.7 44.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.167 0.508 . . . . 1.66 110.07 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -89.02 99.41 12.41 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.51 -0.768 . . . . 1.07 110.601 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 37' ' ' HIS . 10.7 pt -82.24 131.51 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.42 109.841 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HB3' ' HA ' ' B' ' 101' ' ' ASP . 9.2 ttm180 -91.6 114.84 27.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.416 0.627 . . . . 4.04 111.798 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -106.82 151.11 8.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 107.181 -1.414 . . . . 1.72 107.181 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.6 146.93 38.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.995 -0.682 . . . . 2.1 111.627 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.0 mmt -82.46 109.52 16.76 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.826 -1.079 . . . . 2.05 108.804 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.28 54.89 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.233 -0.508 . . . . 2.77 113.449 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -12.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.493 0.187 . . . . 2.62 111.474 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' A' ' 32' ' ' ASP . 2.1 p -155.31 -151.1 0.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.253 -0.179 . . . . 2.61 111.276 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 31' ' ' SER . 6.7 t70 -115.75 -0.14 13.02 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.514 0.673 . . . . 2.9 110.414 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -75.42 150.41 6.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.15 -0.932 . . . . 1.75 110.914 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -101.91 166.14 10.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.036 0.922 . . . . 1.53 111.065 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.65 101.52 4.5 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 113.812 -1.54 . . . . 1.65 108.337 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.43 124.37 38.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.191 0.52 . . . . 1.22 111.253 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' HB2' HG13 ' A' ' 24' ' ' ILE . 65.8 m-70 -107.15 150.79 26.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.686 . . . . 1.34 109.359 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -109.01 103.65 12.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.292 0.568 . . . . 0.82 109.628 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -121.53 137.01 54.91 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.626 -0.715 . . . . 1.33 111.786 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.6 117.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.989 -1.485 . . . . 1.1 106.989 176.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.486 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.6 t-105 -84.11 -34.18 24.18 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.758 0.651 . . . . 1.82 112.758 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.46 ' HA ' ' OE1' ' A' ' 56' ' ' GLN . 62.7 t-80 -152.7 152.62 31.93 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.809 -0.357 . . . . 1.46 110.386 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.95 126.41 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 1.37 109.446 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -59.39 136.35 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 122.486 0.314 . . . . 1.54 110.979 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.58 112.49 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.94 110.574 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.66 80.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.69 -0.766 . . . . 1.56 112.2 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -75.0 170.8 54.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.925 -0.655 . . . . 1.37 111.918 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.51 -45.51 33.62 Favored 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 123.294 2.663 . . . . 1.21 111.114 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.74 -37.77 88.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.622 -1.172 . . . . 1.19 110.633 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -37.53 87.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.769 -0.651 . . . . 1.46 109.372 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 28.2 mt-10 -74.8 -30.43 61.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.978 -1.01 . . . . 1.84 110.736 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.2 -21.82 58.42 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.294 -0.866 . . . . 1.36 111.007 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.28 7.25 30.75 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.39 113.263 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -69.6 130.83 43.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.26 109.509 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -120.11 135.63 54.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.338 -0.846 . . . . 1.68 110.242 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -71.17 137.0 48.4 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.502 -0.479 . . . . 1.78 110.079 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 8.42 49.69 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 116.025 -0.534 . . . . 1.39 113.031 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -90.12 -161.08 0.75 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.983 -0.747 . . . . 1.43 108.983 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 59' ' ' LEU . 8.9 mt -137.31 114.42 10.75 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.226 -0.657 . . . . 1.19 109.226 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -80.99 114.16 21.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.312 -0.625 . . . . 0.8 109.312 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 t -96.85 -31.63 12.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.228 -0.442 . . . . 0.86 112.069 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -143.01 148.59 37.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.95 110.797 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 80' ' ' ILE . 53.3 t -124.26 111.3 28.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.721 -0.844 . . . . 0.59 108.721 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.2 m-20 66.19 19.4 11.09 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 0.9 110.267 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.06 12.99 59.54 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.91 -0.586 . . . . 0.9 112.187 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 5.3 mm-40 -102.53 129.63 25.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.402 -0.221 . . . . 1.36 110.402 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.4 Cg_exo -68.39 106.7 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.25 1.967 . . . . 0.9 110.416 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 76' ' ' VAL . 25.8 m -95.87 1.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.6 111.882 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.75 92.23 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.068 -0.514 . . . . 1.39 109.946 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.05 -26.21 2.86 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.836 -0.62 . . . . 0.98 112.302 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 63.3 mt -68.79 171.79 7.36 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.928 0.87 . . . . 0.83 112.871 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' H ' ' A' ' 75' ' ' GLU . 35.5 m -88.32 173.22 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.149 -1.387 . . . . 0.82 108.466 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 77.7 t60 -58.35 -45.4 88.25 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.794 0.331 . . . . 0.6 111.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 11.4 p -72.57 -32.58 66.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.56 0.948 . . . . 0.57 113.56 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -59.61 -44.31 93.47 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.401 0.546 . . . . 0.88 110.341 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' A' ' 68' ' ' VAL . 5.2 m -73.59 -37.15 49.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.665 -0.698 . . . . 0.37 110.211 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.1 t -56.71 -51.28 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.809 -0.441 . . . . 0.29 109.809 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.2 mt-10 -63.03 -46.79 85.92 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.669 -0.696 . . . . 1.32 110.286 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -46.12 -54.74 8.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.576 -1.193 . . . . 0.58 110.028 177.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.527 HG22 ' CE1' ' A' ' 17' ' ' TYR . 21.5 mt -53.93 -54.88 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 116.075 -0.511 . . . . 0.63 110.518 177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.7 mt -51.68 -40.62 60.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.319 -0.855 . . . . 0.78 112.509 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 33.4 mtmt -65.57 -12.08 49.81 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 64' ' ' ASN . 80.8 p -49.06 -62.21 1.65 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.283 0.475 . . . . 1.08 112.283 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 85' ' ' ASN . . . 97.56 105.2 2.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.621 . . . . 1.29 112.154 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.4 t-20 75.38 -46.11 0.57 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.521 0.728 . . . . 1.5 111.726 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 83' ' ' SER . 30.5 pttt -152.45 158.2 42.27 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.751 -0.463 . . . . 1.58 109.751 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.466 HG21 HG23 ' A' ' 80' ' ' ILE . 4.2 p -135.85 132.53 50.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.033 -0.985 . . . . 0.95 111.414 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.18 104.39 16.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.392 0.615 . . . . 0.96 109.586 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -101.26 112.03 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.377 -0.828 . . . . 0.86 111.036 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -78.1 112.42 15.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.206 -0.452 . . . . 0.82 109.953 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.6 p -103.4 171.4 7.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 1.09 111.593 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -174.52 152.95 1.76 Allowed Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.701 -1.222 . . . . 1.24 107.701 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -47.93 151.51 3.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.848 2.365 . . . . 1.52 113.858 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 13.8 tp -105.38 81.61 1.72 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.21 -1.033 . . . . 1.53 108.21 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.45 121.62 43.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.398 -0.819 . . . . 1.92 109.338 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.375 -0.829 . . . . 2.16 109.827 -178.757 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.477 0.542 0 N-CA-C 110.208 -0.728 . . . . 6.03 110.208 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -99.05 153.13 19.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.575 0.226 . . . . 3.41 110.56 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.4 -146.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.492 -0.776 . . . . 5.16 111.58 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -98.22 45.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.449 -0.342 . . . . 5.22 111.133 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 12.0 t70 -67.97 137.53 55.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 4.23 111.55 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -137.72 11.75 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.462 -0.79 . . . . 3.81 109.768 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -173.24 81.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.533 -0.758 . . . . 4.61 109.659 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.42 ' HB ' ' NH2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -84.66 106.68 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.078 -0.51 . . . . 3.1 110.555 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 9.4 mm100 -72.77 154.93 40.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.543 -0.299 . . . . 2.49 110.261 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' NE ' ' A' ' 22' ' ' ARG . 3.5 tt -153.02 132.16 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.886 0.374 . . . . 1.68 111.023 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.8 m -159.27 135.53 9.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.8 110.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 51.2 mtmt -74.96 125.19 28.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.08 -1.082 . . . . 3.39 108.08 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.589 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 3.0 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.605 -0.712 . . . . 1.4 110.292 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.002 -0.439 . . . . 1.5 112.002 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.58 -81.73 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 1.3 111.89 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.69 110.69 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.003 -0.369 . . . . 1.54 110.003 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -153.55 -38.53 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.268 -0.424 . . . . 1.95 111.019 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 6.7 mpt_? -98.37 114.18 64.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.061 -0.518 . . . . 1.48 110.771 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 36.4 Cg_endo -63.08 127.28 19.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.073 2.515 . . . . 1.43 112.14 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -65.8 153.05 79.8 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.514 2.142 . . . . 1.23 112.841 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 mm -94.18 90.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.893 -1.049 . . . . 1.19 109.368 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.67 97.62 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.518 0.675 . . . . 1.26 110.997 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 mt -95.36 131.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.382 -0.826 . . . . 1.04 111.165 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -82.39 153.88 25.5 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.683 -0.689 . . . . 1.64 110.655 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 85' ' ' ASN . 27.9 ptt180 -75.27 143.24 43.11 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.915 -0.402 . . . . 1.56 109.915 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -120.97 -132.45 0.3 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.643 -0.253 . . . . 1.93 110.699 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.82 -67.79 0.89 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.738 -0.744 . . . . 1.64 112.771 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -49.48 5.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.639 0.257 . . . . 4.0 111.172 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 6.5 ptpt -128.5 168.09 16.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 3.06 110.54 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.527 ' H ' HG23 ' B' ' 109' ' ' VAL . 80.8 m-85 -74.49 3.3 7.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.549 0.69 . . . . 0.92 109.474 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 48' ' ' PRO . . . 106.61 -0.34 36.84 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.502 -0.856 . . . . 1.03 112.547 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' B' ' 109' ' ' VAL . 27.8 p90 -138.78 167.89 21.0 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.802 1.287 . . . . 0.8 113.406 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.0 m -112.52 121.17 44.05 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 112.589 -2.096 . . . . 0.92 109.798 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.8 tp -94.03 134.33 36.55 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.727 -0.842 . . . . 0.67 108.727 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 41' ' ' TRP . 6.8 mtp180 -133.7 138.92 46.09 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.933 0.397 . . . . 1.66 110.556 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' B' ' 105' ' ' GLN . . . -100.07 118.38 36.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.619 . . . . 1.07 109.48 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 pt -99.39 144.14 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 1.42 110.45 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -107.0 93.04 4.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 4.04 110.509 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.32 116.22 46.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.698 -0.683 . . . . 1.72 109.417 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 43.4 m-85 -77.49 140.86 39.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.334 0.588 . . . . 2.1 111.495 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.458 ' HB2' HG13 ' A' ' 33' ' ' VAL . 14.7 mmt -74.27 123.71 25.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.82 -1.082 . . . . 2.05 109.494 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.86 73.57 0.65 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.131 -0.557 . . . . 2.77 112.938 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -169.65 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 2.62 110.268 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HB2' HG12 ' A' ' 33' ' ' VAL . 13.8 m -123.07 -150.72 0.46 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 2.61 111.02 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -99.39 -17.08 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.78 0.8 . . . . 2.9 110.105 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 28' ' ' MET . 7.5 p -54.37 147.39 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.548 -1.205 . . . . 1.75 112.144 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 45.2 p90 -116.84 164.1 15.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.727 -1.124 . . . . 1.53 110.252 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.51 103.45 7.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.596 -1.184 . . . . 1.65 109.615 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.88 106.45 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.401 0.619 . . . . 1.22 109.984 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -99.59 146.49 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.877 -0.601 . . . . 1.34 110.507 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -102.42 99.95 10.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.394 -0.821 . . . . 0.82 108.957 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -119.87 136.93 54.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.755 -0.657 . . . . 1.33 111.932 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -70.99 119.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.944 -1.502 . . . . 1.1 106.944 176.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 22' ' ' ARG . 75.8 t-105 -82.85 -38.95 22.29 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.135 0.791 . . . . 1.82 113.135 -176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.44 ' HA ' ' CD ' ' A' ' 56' ' ' GLN . 45.8 t-80 -152.36 147.77 26.7 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.73 -0.388 . . . . 1.46 110.944 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG23 ' HG2' ' A' ' 56' ' ' GLN . 52.8 t -126.91 124.26 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.606 -0.725 . . . . 1.37 109.621 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -61.33 129.68 42.42 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 122.362 0.265 . . . . 1.54 110.792 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.45 109.7 2.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.155 0.502 . . . . 1.94 110.463 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.76 3.17 57.22 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.707 -0.759 . . . . 1.56 111.853 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -79.0 171.95 55.2 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.883 -0.675 . . . . 1.37 111.671 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 74.9 Cg_exo -56.41 -46.25 31.66 Favored 'Trans proline' 0 CA--C 1.508 -0.797 0 C-N-CA 123.498 2.799 . . . . 1.21 111.351 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -63.03 -36.35 83.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.751 -1.113 . . . . 1.19 111.091 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 t -65.53 -36.85 85.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.46 109.25 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 25.9 mt-10 -74.21 -33.43 63.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.527 -1.215 . . . . 1.84 110.338 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.17 62.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.037 -0.983 . . . . 1.36 110.958 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.9 10.85 27.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.651 -0.785 . . . . 1.39 113.82 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -66.16 138.69 57.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.103 0.452 . . . . 1.26 109.95 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 55' ' ' ARG . 15.3 mmt180 -122.4 129.32 51.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.884 -0.598 . . . . 1.68 110.302 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.83 135.16 45.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.029 0.442 . . . . 1.78 110.569 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 94' ' ' LEU . . . 101.71 7.48 47.9 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.676 -0.693 . . . . 1.39 112.403 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 44.7 m-20 -90.19 -157.12 0.45 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.213 0.53 . . . . 1.43 109.724 178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 59' ' ' LEU . 9.9 mt -137.28 113.64 10.08 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.937 -0.574 . . . . 1.19 109.552 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.7 mt -83.08 109.15 16.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.134 -0.691 . . . . 0.8 109.134 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.8 t -93.13 -34.12 13.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.094 -0.503 . . . . 0.86 111.935 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -136.91 144.73 43.64 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.044 0.45 . . . . 0.95 111.153 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 80' ' ' ILE . 75.1 t -125.24 113.05 33.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.755 -0.832 . . . . 0.59 108.755 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.504 HD21 ' HB3' ' A' ' 83' ' ' SER . 90.3 m-20 65.62 23.57 11.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.201 0.524 . . . . 0.9 109.944 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.83 10.6 66.71 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.763 -0.653 . . . . 0.9 112.523 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -106.32 130.12 23.46 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.835 -0.215 . . . . 1.36 111.02 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.87 109.44 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.401 2.067 . . . . 0.9 110.189 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.529 ' HB ' HG12 ' A' ' 76' ' ' VAL . 32.6 m -92.77 -0.36 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.6 112.422 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -63.76 100.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.838 0.351 . . . . 1.39 110.21 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.48 -23.88 3.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.688 -0.768 . . . . 0.98 112.652 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 94.6 mt -76.93 175.18 9.78 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.83 112.537 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.677 HG23 ' H ' ' A' ' 75' ' ' GLU . 16.4 m -87.03 175.38 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.223 -1.353 . . . . 0.82 108.328 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 76' ' ' VAL . 82.4 t60 -60.97 -44.18 97.7 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.831 0.348 . . . . 0.6 111.446 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 77' ' ' VAL . 2.2 p -71.3 -35.08 71.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.98 1.104 . . . . 0.57 113.98 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.677 ' H ' HG23 ' A' ' 72' ' ' VAL . 5.3 mm-40 -58.17 -44.03 87.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.335 0.516 . . . . 0.88 110.629 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' HB ' ' A' ' 68' ' ' VAL . 2.3 m -73.8 -34.75 41.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.476 -0.784 . . . . 0.37 109.737 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 80' ' ' ILE . 4.5 t -58.81 -50.1 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.489 -0.56 . . . . 0.29 109.489 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 21.3 mt-10 -60.53 -48.42 81.84 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.514 -0.766 . . . . 1.32 109.995 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -45.67 -55.34 6.54 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.469 -1.241 . . . . 0.58 109.848 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.512 HG13 HG11 ' A' ' 63' ' ' VAL . 22.4 mt -53.3 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.792 -0.64 . . . . 0.63 110.747 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -53.57 -42.44 67.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.448 -0.796 . . . . 0.78 112.509 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 45.0 mtmt -73.6 -0.93 16.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.326 1.232 . . . . 1.0 114.326 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 30.9 p -51.46 -65.06 0.62 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.903 0.334 . . . . 1.08 111.903 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.12 101.04 2.67 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.29 112.016 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' HA ' ' CD ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 72.47 -40.82 0.49 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.689 0.796 . . . . 1.5 112.356 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.7 pttt -154.9 157.47 37.83 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.331 -0.618 . . . . 1.58 109.331 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 64' ' ' ASN . 3.5 p -133.22 130.42 57.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.875 -1.057 . . . . 0.95 111.383 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.86 113.68 25.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.207 -0.664 . . . . 0.96 109.207 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.89 109.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.088 -0.505 . . . . 0.86 111.528 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.3 m -77.03 109.69 11.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.714 -0.476 . . . . 0.82 109.714 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 p -104.12 168.03 9.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.422 0.63 . . . . 1.09 112.03 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 t -169.11 148.86 3.77 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 107.891 -1.151 . . . . 1.24 107.891 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -52.01 147.56 26.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.671 2.247 . . . . 1.52 113.776 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 25.7 tp -106.17 79.75 1.43 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.011 . . . . 1.53 108.768 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -107.4 119.21 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.218 -0.901 . . . . 1.92 109.556 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 115.441 -0.799 . . . . 2.16 110.181 -179.106 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo . . . . . 0 N--CA 1.48 0.711 0 N-CA-C 110.367 -0.666 . . . . 6.03 110.367 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -120.52 172.08 8.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.524 -0.307 . . . . 3.41 110.319 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -93.01 -78.42 0.42 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.672 0.273 . . . . 5.16 110.455 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -132.32 159.15 40.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.884 0.373 . . . . 5.22 110.696 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.83 125.09 41.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.834 -0.621 . . . . 4.23 110.447 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.75 169.72 10.46 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.553 -0.536 . . . . 3.81 109.553 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -93.4 107.55 19.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 4.61 110.282 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -135.09 -81.35 0.43 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.743 -0.662 . . . . 3.1 109.842 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.689 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 6.3 mp0 -136.8 153.1 50.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.147 0.499 . . . . 2.49 111.294 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 tt -156.06 123.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.404 -0.816 . . . . 1.68 108.849 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 52.1 m -154.73 138.22 15.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.345 0.593 . . . . 0.8 111.559 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -72.32 141.15 48.82 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.534 -0.914 . . . . 3.39 108.534 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.641 HG21 ' CE1' ' A' ' 19' ' ' PHE . 14.1 m . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.326 -0.845 . . . . 1.4 110.991 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.011 -0.436 . . . . 1.5 112.011 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.54 -85.3 1.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.778 -0.725 . . . . 1.3 112.02 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -72.35 102.95 3.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.075 -0.343 . . . . 1.54 110.075 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.5 tpt -129.29 -53.05 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.487 -0.324 . . . . 1.95 110.791 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.12 129.4 48.11 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.284 -0.416 . . . . 1.48 110.64 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.2 Cg_endo -66.51 135.05 37.77 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.677 2.251 . . . . 1.43 111.502 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 17.3 Cg_exo -66.54 155.13 71.71 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.242 1.961 . . . . 1.23 113.202 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 53' ' ' GLY . 6.1 mm -94.06 92.48 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 1.19 108.868 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.97 95.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.366 0.603 . . . . 1.26 110.646 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 49' ' ' ALA . 30.0 mt -93.64 131.42 40.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.719 -0.673 . . . . 1.04 110.527 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -88.95 154.04 20.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.719 -0.673 . . . . 1.64 109.924 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 30.0 ptt180 -71.29 151.32 44.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.794 0.331 . . . . 1.56 110.455 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -122.54 -43.25 2.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.122 -0.49 . . . . 1.93 110.325 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.99 -72.52 0.27 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.945 -0.645 . . . . 1.64 111.572 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -85.74 -39.11 17.52 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.863 0.363 . . . . 4.0 110.345 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 47.9 mtpt -142.67 164.28 30.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.013 -0.54 . . . . 3.06 110.161 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' B' ' 109' ' ' VAL . 71.0 m-85 -84.51 -2.54 57.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.721 -1.215 . . . . 0.92 107.721 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.41 10.18 24.09 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 114.886 -1.052 . . . . 1.03 112.267 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -149.08 165.3 32.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 123.019 1.39 . . . . 0.8 114.121 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.0 m -114.15 123.89 50.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.464 -2.153 . . . . 0.92 109.715 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.6 tp -97.87 123.53 41.89 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.205 -0.665 . . . . 0.67 109.205 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HE ' ' HB ' ' B' ' 106' ' ' ILE . 23.4 mtp180 -124.15 121.33 34.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.065 0.459 . . . . 1.66 110.278 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . . . -81.17 102.83 10.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.547 -0.752 . . . . 1.07 109.558 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' B' ' 99' ' ' ASP . 13.7 pt -86.51 127.69 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.137 0.494 . . . . 1.42 110.524 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -102.35 109.37 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.628 -0.715 . . . . 4.04 110.998 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 t -109.09 166.5 4.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.367 -1.345 . . . . 1.72 107.367 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.15 145.13 47.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 118.645 0.657 . . . . 2.1 111.14 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mmm -78.47 114.87 17.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.148 -0.933 . . . . 2.05 110.239 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.29 73.06 0.74 Allowed Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.127 -0.488 . . . . 2.77 112.966 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.89 -33.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.553 -0.536 . . . . 2.62 109.553 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.589 ' HB2' HG12 ' A' ' 33' ' ' VAL . 49.2 m -132.88 -167.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.752 -0.658 . . . . 2.61 109.765 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -95.57 -11.86 26.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 2.9 110.27 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 31' ' ' SER . 8.9 p -60.82 149.52 7.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.532 -1.213 . . . . 1.75 111.893 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -106.55 166.23 10.71 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.943 -1.026 . . . . 1.53 111.122 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.75 100.22 5.42 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.39 -1.277 . . . . 1.65 109.015 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 p -89.77 119.85 37.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.183 0.516 . . . . 1.22 110.329 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' HB2' HG13 ' A' ' 24' ' ' ILE . 75.1 m-70 -110.24 144.97 38.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.016 -0.538 . . . . 1.34 110.105 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -102.87 97.45 7.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.741 -0.837 . . . . 0.82 108.741 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -119.22 138.3 53.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.722 -0.672 . . . . 1.33 111.846 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.56 HG11 HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -69.92 116.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.715 -1.587 . . . . 1.1 106.715 176.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CG ' ' HD3' ' A' ' 22' ' ' ARG . 75.8 t-105 -79.53 -40.1 30.39 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.869 0.692 . . . . 1.82 112.869 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -149.33 146.04 27.33 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.853 -0.339 . . . . 1.46 110.799 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.1 t -119.27 118.91 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 1.37 108.845 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -56.96 123.54 15.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.629 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.14 119.67 9.42 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.515 . . . . 1.94 109.611 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.79 14.9 68.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.593 -0.813 . . . . 1.56 111.526 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 51' ' ' GLU . . . -91.47 169.86 33.36 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.937 -0.649 . . . . 1.37 111.726 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HG2' ' HB2' ' A' ' 13' ' ' ALA . 77.8 Cg_exo -58.89 -45.11 30.54 Favored 'Trans proline' 0 CA--C 1.508 -0.781 0 C-N-CA 123.405 2.736 . . . . 1.21 112.043 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.478 ' HA ' HG12 ' A' ' 10' ' ' ILE . . . -59.35 -37.97 79.19 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.906 -1.043 . . . . 1.19 111.105 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -37.53 86.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.667 0.746 . . . . 1.46 109.13 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 34.3 mt-10 -73.7 -27.74 61.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.818 -1.083 . . . . 1.84 110.504 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.11 -24.86 47.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.379 -0.828 . . . . 1.36 110.682 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 109.9 6.72 28.04 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.582 -0.818 . . . . 1.39 113.818 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -68.35 132.57 47.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.71 -0.478 . . . . 1.26 109.71 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.05 129.75 55.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.581 -0.736 . . . . 1.68 110.488 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.8 pt20 -72.65 124.84 26.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.841 -0.618 . . . . 1.78 110.865 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.13 8.57 25.38 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.65 -0.704 . . . . 1.39 113.185 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 59' ' ' LEU . 88.4 m-20 -91.3 -150.73 0.25 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.351 -0.611 . . . . 1.43 109.351 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 9.3 mt -141.2 115.16 9.16 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.016 -0.538 . . . . 1.19 109.56 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -79.86 109.71 14.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.837 -0.801 . . . . 0.8 108.837 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.3 t -88.52 -35.44 16.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.528 -0.306 . . . . 0.86 111.778 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -144.09 147.05 33.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 0.95 110.46 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.701 ' HB ' HD23 ' A' ' 79' ' ' LEU . 73.1 t -122.94 116.05 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.941 -0.763 . . . . 0.59 108.941 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 83' ' ' SER . 85.6 m-20 61.94 27.81 16.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.28 0.562 . . . . 0.9 110.311 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.77 20.74 70.28 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.313 -0.858 . . . . 0.9 112.798 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 79' ' ' LEU . 23.2 mm-40 -113.07 138.57 22.33 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.936 0.368 . . . . 1.36 110.554 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 12.1 Cg_exo -69.11 115.43 4.0 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.563 2.176 . . . . 0.9 111.29 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 28.0 m -99.45 -6.79 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.257 -0.429 . . . . 0.6 110.854 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -71.5 88.49 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.802 -0.636 . . . . 1.39 110.102 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.77 -24.32 2.29 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.761 -0.733 . . . . 0.98 112.879 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' HB3' ' A' ' 75' ' ' GLU . 10.4 mt -77.14 -168.24 1.05 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.862 0.839 . . . . 0.83 111.551 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CG ' ' A' ' 75' ' ' GLU . 32.2 m -103.29 -177.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 114.138 -1.392 . . . . 0.82 108.598 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' HG22 ' A' ' 76' ' ' VAL . 73.7 t60 -66.01 -45.67 80.7 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.65 0.262 . . . . 0.6 111.503 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.601 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 2.2 p -68.73 -33.07 73.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.669 0.618 . . . . 0.57 112.669 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.653 ' CG ' HG22 ' A' ' 72' ' ' VAL . 7.2 mm-40 -57.27 -42.56 81.84 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.14 0.495 . . . . 0.88 111.199 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 73' ' ' HIS . 11.2 m -76.48 -34.41 24.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.688 -0.687 . . . . 0.37 109.954 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 80' ' ' ILE . 12.4 t -60.2 -49.41 84.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.538 -0.542 . . . . 0.29 109.538 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 74' ' ' THR . 76.8 mt-10 -59.69 -50.87 72.18 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.435 -0.802 . . . . 1.32 109.43 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 66' ' ' GLU . 1.1 tp -43.97 -55.67 4.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.208 -1.36 . . . . 0.58 110.256 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.523 HG13 HG11 ' A' ' 63' ' ' VAL . 20.4 mt -53.97 -53.28 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.017 0.437 . . . . 0.63 110.905 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -54.6 -41.56 70.09 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.66 -0.7 . . . . 0.78 112.281 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 40.5 mtmt -69.04 -4.46 17.09 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.009 1.115 . . . . 1.0 114.009 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 37.5 p -53.39 -62.56 1.57 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.429 0.529 . . . . 1.08 112.429 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.88 88.75 2.07 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.812 -0.709 . . . . 1.29 112.25 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 0.3 OUTLIER 75.36 -37.43 0.33 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.648 0.779 . . . . 1.5 112.038 179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 83' ' ' SER . 19.6 pttt -148.52 149.65 32.0 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 1.58 109.991 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.52 131.94 62.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.646 -1.161 . . . . 0.95 111.365 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.34 113.28 25.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.741 -0.663 . . . . 0.96 109.579 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.87 110.6 32.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.101 -0.499 . . . . 0.86 111.573 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 m -76.35 119.0 19.62 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.41 -0.589 . . . . 0.82 109.41 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.45 160.5 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.272 0.558 . . . . 1.09 112.324 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -161.41 150.33 13.25 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.717 -1.216 . . . . 1.24 107.717 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.37 152.96 10.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.617 2.212 . . . . 1.52 113.838 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 27.7 tp -110.76 76.4 0.98 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.236 -0.893 . . . . 1.53 108.969 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.33 122.9 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.181 -0.674 . . . . 1.92 109.181 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.654 . . . . 2.16 110.044 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 N-CA-C 110.659 -0.554 . . . . 6.03 110.659 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 54.1 p90 44.01 32.4 0.63 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.292 1.037 . . . . 3.41 112.383 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.501 ' HB2' HG22 ' A' ' 24' ' ' ILE . 14.2 p-10 -128.96 -42.89 1.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.927 -0.578 . . . . 5.16 110.605 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -85.77 63.77 8.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.206 -0.452 . . . . 5.22 110.557 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ASP . . . . . 0.417 ' OD1' ' HG2' ' B' ' 102' ' ' GLN . 10.9 t70 -74.03 -75.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.759 -0.46 . . . . 4.23 109.759 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.417 ' HG2' ' OD1' ' B' ' 101' ' ' ASP . 73.6 mm-40 -118.25 -48.01 2.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 3.81 110.551 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -144.6 145.22 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.901 -0.59 . . . . 4.61 109.896 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.29 143.21 27.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.573 -0.529 . . . . 3.1 109.573 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -117.77 144.67 45.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.833 -0.347 . . . . 2.49 110.567 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.438 ' HB ' ' HE ' ' A' ' 22' ' ' ARG . 2.3 tt -135.65 128.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 1.68 111.171 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -141.6 131.24 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.393 0.616 . . . . 0.8 110.872 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.03 129.19 34.84 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.502 -0.925 . . . . 3.39 108.502 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.495 ' OXT' ' HA ' ' A' ' 16' ' ' LYS . 10.0 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.404 -0.808 . . . . 1.4 110.349 -178.404 . . . . . . . . 1 1 . 1 stop_ save_